Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

CDC Science Clips

Immunity and Immunization

  1. Policy statement--Recommended childhood and adolescent immunization schedules--United States, 2010
    Pediatrics. 2010 Jan;125(1):195-6.

  2. Update: Vaccines for women, adolescence through adulthood
    Akinsanya-Beysolow I, Wolfe CS.
    J Womens Health (Larchmt). 2009 Aug;18(8):1101-8.

  3. Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials
    Aponte JJ, Schellenberg D, Egan A, Breckenridge A, Carneiro I, Critchley J, Danquah I, Dodoo A, Kobbe R, Lell B, May J, Premji Z, Sanz S, Sevene E, Soulaymani-Becheikh R, Winstanley P, Adjei S, Anemana S, Chandramohan D, Issifou S, Mockenhaupt F, Owusu-Agyei S, Greenwood B, Grobusch MP, Kremsner PG, Macete E, Mshinda H, Newman RD, Slutsker L, Tanner M, Alonso P, Menendez C.
    Lancet. 2009 Oct 31;374(9700):1533-42.

  4. How much could rotavirus vaccines reduce diarrhea-associated mortality in northern Ghana? A model to assess impact
    Arvay ML, Curns AT, Terp S, Armah G, Wontuo P, Parashar UD, Binka F, Glass RI, Widdowson MA.
    J Infect Dis. 2009 Nov 1;200 Suppl 1:S85-91.

  5. Influenza immunization coverage among residents of long-term care facilities certified by CMS, 2005-2006: the newest MDS quality indicator
    Bardenheier BH, Wortley P, Ahmed F, Hales C, Shefer A.
    J Am Med Dir Assoc. 2010 Jan;11(1):59-69.

  6. Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB)
    Bar-On ES, Goldberg E, Fraser A, Vidal L, Hellmann S, Leibovici L.
    Cochrane Database Syst Rev. 2009 (3):CD005530.

  7. Real-time surveillance to assess risk of intussusception and other adverse events after pentavalent, bovine-derived rotavirus vaccine
    Belongia EA, Irving SA, Shui IM, Kulldorff M, Lewis E, Yin R, Lieu TA, Weintraub E, Yih WK, Li R, Baggs J, The Vaccine Safety Datalink Investigation Group.
    Pediatr Infect Dis J. 2009 Nov 10.

  8. Does vitamin A supplementation interact with routine vaccinations? An analysis of the Ghana vitamin A supplementation trial
    Benn CS, Aaby P, Nielsen J, Binka FN, Ross DA.
    Am J Clin Nutr. 2009 Sep;90(3):629-39.

  9. Impact of routine hepatitis B immunization on the prevalence of chronic hepatitis B virus infection in the Marshall Islands and the Federated States of Micronesia
    Bialek SR, Helgenberger L, Fischer GE, Bower WA, Konelios M, Chaine JP, Armstrong G, Williams IT, Bell BP.
    Pediatr Infect Dis J. 2009 Oct 16.

  10. Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines
    Black S, Eskola J, Siegrist CA, Halsey N, Macdonald N, Law B, Miller E, Andrews N, Stowe J, Salmon D, Vannice K, Izurieta HS, Akhtar A, Gold M, Oselka G, Zuber P, Pfeifer D, Vellozzi C.
    Lancet. 2009 Oct 30;374(9707):2115-22.

  11. Policy statement--Recommended childhood and adolescent immunization schedules--United States, 2010
    Bocchini J, Bradley J, Brady M, Bernstein H, Byington C, Fisher M, Glode M, Jackson M, Keyserling H, Kimberlin D, Orenstein W, Schutze G, Willoughby R, Bell B, Bortolussi R, Clover R, Fischer M, Gorman R, Lee L, Pratt R, Read J, Gellin B, Starke J, Swanson J, Meissner H, Rubin L, Pickering L, Baker C, Long S, Frantz J, Committee on Infectious Diseases.
    Pediatrics. 2010 Jan;125(1):195-6.

  12. Food allergy among children in the United States
    Branum AM, Lukacs SL.
    Pediatrics. 2009 Nov 16.

  13. A multinational, randomized, placebo-controlled trial to assess the immunogenicity, safety, and tolerability of live attenuated influenza vaccine coadministered with oral poliovirus vaccine in healthy young children
    Breiman RF, Brooks WA, Goswami D, Lagos R, Borja-Tabora C, Lanata CF, Londono JA, Lum LC, Rappaport R, Razmpour A, Walker RE, Gruber WC, Forrest BD.
    Vaccine. 2009 Sep 4;27(40):5472-9.

  14. Reduction in hospitalizations for diarrhea and rotavirus infections in New York state following introduction of rotavirus vaccine
    Chang HG, Smith PF, Tserenpuntsag B, Markey K, Parashar U, Morse DL.
    Vaccine. 2010 Jan 8;28(3):754-8.

  15. The yin and yang of paracetamol and paediatric immunisations
    Chen RT, Clark TA, Halperin SA.
    Lancet. 2009 Oct 17;374(9698):1305-6.

  16. Nasopharyngeal carriage of streptococcus pneumoniae in Gambian children who participated in a 9-valent pneumococcal conjugate vaccine trial and in their younger siblings
    Cheung YB, Zaman SM, Nsekpong ED, Van Beneden CA, Adegbola RA, Greenwood B, Cutts FT.
    Pediatr Infect Dis J. 2009 Nov;28(11):990-995.

  17. MCV vaccination in the presence of vaccine-associated Guillain-Barre Syndrome risk: a decision analysis approach
    Cho BH, Clark TA, Messonnier NE, Ortega-Sanchez IR, Weintraub E, Messonnier ML.
    Vaccine. 2010 Jan 8;28(3):817-22.

  18. Willingness of Hong Kong healthcare workers to accept pre-pandemic influenza vaccination at different WHO alert levels: two questionnaire surveys
    Chor JS, Ngai KL, Goggins WB, Wong MC, Wong SY, Lee N, Leung TF, Rainer TH, Griffiths S, Chan PK.
    BMJ. 2009 ;339:b3391.

  19. The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination
    Civen R, Chaves SS, Jumaan A, Wu H, Mascola L, Gargiullo P, Seward JF.
    Pediatr Infect Dis J. 2009 Nov;28(11):954-9.

  20. Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease
    Cohn AC, Macneil JR, Harrison LH, Hatcher C, Theodore J, Schmidt M, Pondo T, Arnold KE, Baumbach J, Bennett N, Craig AS, Farley M, Gershman K, Petit S, Lynfield R, Reingold A, Schaffner W, Shutt KA, Zell ER, Mayer LW, Clark T, Stephens D, Messonnier NE.
    Clin Infect Dis. 2009 Dec 14.

  21. Underestimates of intussusception rates among US infants based on inpatient discharge data: implications for monitoring the safety of rotavirus vaccines
    Cortese MM, Staat MA, Weinberg GA, Edwards K, Rice MA, Szilagyi PG, Hall CB, Payne DC, Parashar UD.
    J Infect Dis. 2009 Nov 1;200 Suppl 1:S264-70.

  22. Projected impact of the new rotavirus vaccination program on hospitalizations for gastroenteritis and rotavirus disease among US children <5 years of age during 2006-2015
    Curns AT, Coffin F, Glasser JW, Glass RI, Parashar UD.
    J Infect Dis. 2009 Nov 1;200 Suppl 1:S49-56.

  23. Adolescent immunization delivery in school-based health centers: a national survey
    Daley MF, Curtis CR, Pyrzanowski J, Barrow J, Benton K, Abrams L, Federico S, Juszczak L, Melinkovich P, Crane LA, Kempe A.
    J Adolesc Health. 2009 Nov;45(5):445-52.

  24. Evaluation of smallpox vaccines using variola neutralization
    Damon IK, Davidson WB, Hughes CM, Olson VA, Smith SK, Holman RC, Frey SE, Newman F, Belshe RB, Yan L, Karem K.
    J Gen Virol. 2009 Aug;90(Pt 8):1962-6.

  25. The expanding vaccine development pipeline, 1995-2008
    Davis MM, Butchart AT, Coleman MS, Singer DC, Wheeler JR, Pok A, Freed GL.
    Vaccine. 2009 Nov 20.

  26. Seasonal influenza vaccine provides priming for A/H1N1 immunization
    Del Giudice G, Stittelaar K, van Amerongen G, Simon J, Osterhaus A, Stohr K, Rappuoli R.
    Sci Transl Med. 2009 Dec 23;1(12):12re1.

  27. H1N1 vaccine safety monitoring: beyond background rates
    Destefano F, Tokars J.
    Lancet. 2009 Oct 30.

  28. Successful seroresponses to measles and rubella following aerosolized Triviraten vaccine, but poor response to aerosolized mumps (Rubini) component: comparisons with injected MMR
    Diaz-Ortega JL, Bennett JV, Castaneda D, Vieyra JR, Valdespino-Gomez JL, de Castro JF.
    Vaccine. 2010 Jan 8;28(3):692-8.

  29. Optimizing tactics for use of the U.S. antiviral strategic national stockpile for pandemic (H1N1) influenza, 2009
    Dimitrov N, Goll S, Meyers LA, Pourbohloul B, Hupert N.
    PLoS Curr Influenza. 2009 :RRN1127.

  30. Development of a new candidate H5N1 avian influenza virus for pre-pandemic vaccine production
    Dong J, Matsuoka Y, Maines TR, Swayne DE, O'Neill E, Davis CT, Van-Hoven N, Balish A, Yu HJ, Katz JM, Klimov A, Cox N, Li DX, Wang Y, Guo YJ, Yang WZ, Donis RO, Shu YL.
    Influenza Other Respi Viruses. 2009 Nov;3(6):287-295.

  31. Rapid decline in presentations for genital warts after the implementation of a national quadrivalent human papillomavirus vaccination program for young women
    Fairley C, Hocking J, Gurrin L, Chen M, Donovan B, Bradshaw C.
    Sex Transm Infect. 2009 .

  32. Seasonal influenza vaccines
    Fiore AE, Bridges CB, Cox NJ.
    Curr Top Microbiol Immunol. 2009 ;333:43-82.

  33. 2009 influenza A(H1N1) monovalent vaccines for children
    Fiore AE, Neuzil KM.
    JAMA. 2009 Dec 21.

  34. Impact of rotavirus vaccination: the importance of monitoring strains
    Gentsch JR, Parashar UD, Glass RI.
    Future Microbiol. 2009 Dec;4:1231-4.[Request a copy via DocExpress]

  35. Parental refusal of varicella vaccination and the associated risk of varicella infection in children
    Glanz JM, McClure DL, Magid DJ, Daley MF, France EK, Hambidge SJ.
    Arch Pediatr Adolesc Med. 2010 Jan;164(1):66-70.

  36. Toward optimal health: a review of vaccine recommendations for women. Interview by Jodi R Godfrey
    Godfrey JR, Jamieson DJ, Harpaz R, Markowitz LE.
    J Womens Health (Larchmt). 2009 Dec;18(12):1919-22.

  37. The interferon alpha/beta receptor provides protection against influenza virus replication but is dispensable for inflammatory response signaling
    Goodman AG, Zeng H, Proll SC, Peng X, Cilloniz C, Carter VS, Korth MJ, Tumpey TM, Katze MG.
    J Virol. 2009 Nov 25.

  38. Impact of measles outbreak response vaccination campaign in Dar es Salaam, Tanzania
    Goodson JL, Wiesen E, Perry RT, Mach O, Kitambi M, Kibona M, Luman ET, Cairns KL.
    Vaccine. 2009 Aug 2.

  39. Availability of human papillomavirus vaccine at medical practices in an area with elevated rates of cervical cancer
    Gottlieb SL, Brewer NT, Smith JS, Keating KM, Markowitz LE.
    J Adolesc Health. 2009 Nov;45(5):438-44.

  40. Human papillomavirus vaccine initiation in an area with elevated rates of cervical cancer
    Gottlieb SL, Brewer NT, Sternberg MR, Smith JS, Ziarnowski K, Liddon N, Markowitz LE.
    J Adolesc Health. 2009 Nov;45(5):430-7.

  41. An outbreak of varicella in elementary school children with two-dose varicella vaccine recipients--Arkansas, 2006
    Gould PL, Leung J, Scott C, Schmid DS, Deng H, Lopez A, Chaves SS, Reynolds M, Gladden L, Harpaz R, Snow S.
    Pediatr Infect Dis J. 2009 Aug;28(8):678-81.

  42. Response to a monovalent 2009 influenza A (H1N1) vaccine.
    Greenberg ME, Lai MH, Hartel GF, Wichems CH, Gittleson C, Bennet J, Dawson G, Hu W, Leggio C, Washington D, Basser RL.
    N Engl J Med. 2009 ;361(25):2405-13.

  43. Endogenous nitric oxide protects bacteria against a wide spectrum of antibiotics
    Gusarov I, Shatalin K, Starodubtseva M, Nudler E.
    Science. 2009 Sept 11;325(5946):1380-4.

  44. Kawasaki disease after vaccination: reports to the vaccine adverse event reporting system 1990-2007
    Hua W, Izurieta HS, Slade B, Belay ED, Haber P, Tiernan R, Woo EJ, Iskander J, Braun MM, Ball R.
    Pediatr Infect Dis J. 2009 Sep 12;28(11):943-7.

  45. Safety assessment of recalled Haemophilus influenzae type b (Hib) conjugate vaccines-United States, 2007-2008
    Huang WT, Chang S, Miller ER, Woo EJ, Hoffmaster AR, Gee JE, Clark TA, Iskander JK, Ball R, Broder KR.
    Pharmacoepidemiol Drug Saf. 2010 Jan 18.

  46. Role of T lymphocytes in the pathogenesis of chlamydia disease
    Igietseme JU, He Q, Joseph K, Eko FO, Lyn D, Ananaba G, Campbell A, Bandea C, Black CM.
    J Infect Dis. 2009 Aug 5;200(6):926-34.

  47. Evaluation of self-reported and registry-based influenza vaccination status in a Wisconsin cohort
    Irving SA, Donahue JG, Shay DK, Ellis-Coyle TL, Belongia EA.
    Vaccine. 2009 Nov 5;27(47):6546-9.

  48. Risk of medically attended local reactions following diphtheria toxoid containing vaccines in adolescents and young adults: a Vaccine Safety Datalink study
    Jackson LA, Yu O, Nelson J, Belongia EA, Hambidge SJ, Baxter R, Naleway A, Nordin J, Baggs J, Iskander J.
    Vaccine. 2009 Aug 6;27(36):4912-6.

  49. Hepatitis B vaccination coverage among U.S. adolescents, National Immunization Survey-Teen, 2006
    Jain N, Hennessey K.
    J Adolesc Health. 2009 Jun;44(6):561-7.

  50. Determining accurate vaccination coverage rates for adolescents: the National Immunization Survey-Teen 2006
    Jain N, Singleton JA, Montgomery M, Skalland B.
    Public Health Rep. 2009 Sep-Oct;124(5):642-51.

  51. Adverse reactions to vaccines
    Kelso J, Li J, Nicklas R, Blessing-Moore J, Cox L, Lang D, Oppenheimer J, Portnoy J, Randolph C, Schuller D, Spector S, Tilles S, Wallace D, Ballas Z, Baker J, Bellanti J, Ein D, Grammer L.
    Ann Allergy Asthma Immunol. 2009 Oct;103(Suppl 2):S1-14.

  52. Adoption of rotavirus vaccination by pediatricians and family medicine physicians in the United States
    Kempe A, Patel MM, Daley MF, Crane LA, Beaty B, Stokley S, Barrow J, Babbel C, Dickinson LM, Tempte JL, Parashar UD.
    Pediatrics. 2009 Oct 12.

  53. Rates of autoimmune diseases in Kaiser Permanente for use in vaccine adverse event safety studies
    Klein NP, Ray P, Carpenter D, Hansen J, Lewis E, Fireman B, Black S, et al.
    Vaccine. 2009 Nov 5.

  54. Provider chart audits and outreach to parents: impact in improving childhood immunization coverage and immunization information system completeness
    Kolasa MS, Lutz JP, Cofsky A, Jones T.
    J Public Health Manag Pract. 2009 Nov-Dec;15(6):459-63.

  55. Naturally occurring human monoclonal antibodies neutralize both 1918 and 2009 A(H1N1) pandemic influenza viruses
    Krause JC, Tumpey TM, Huffman CJ, McGraw PA, Pearce MB, Tsibane T, Hai R, Basler CF, Crowe JE.
    J Virol. 2009 Dec 30.

  56. [Post vaccination rotavirus surveillance in Hungary, in 2007]
    Laszlo B, Czellar E, Deak J, Juhasz A, Kovacs J, Konya J, Meszaros J, Meszner Z, Mihaly I, Molnar P, Nyul Z, Patri L, Puskas E, Schneider F, Siffel C, Toth A, Toth E, Szucs G, Banyai K.
    Orv Hetil. 2009 Aug 2;150(31):1443-50.

  57. Persistence of rubella antibodies after 2 doses of measles-mumps-rubella vaccine
    Lebaron CW, Forghani B, Matter L, Reef SE, Beck C, Bi D, Cossen C, Sullivan BJ.
    J Infect Dis. 2009 Aug 6;200(6):888-99.

  58. Acceptability of human papillomavirus vaccine for males: a review of the literature
    Liddon N, Hood J, Wynn BA, Markowitz LE.
    J Adolesc Health. 2010 Feb;46(2):113-23.

  59. Measurement of influenza vaccination coverage among healthcare personnel in US hospitals
    Lindley MC, Yonek J, Ahmed F, Perz JF, Williams Torres G.
    Infect Control Hosp Epidemiol. 2009 Oct 22.

  60. Uptake of meningococcal conjugate vaccine among adolescents in large managed care organizations, United States, 2005: demand, supply and seasonality
    Lorick SA, Fishbein D, Weintraub E, Wortley PM, Lee GM, Zhou F, Davis R.
    BMC Infect Dis. 2009 ;9:175.

  61. Adult clinical and immunologic outcomes of the national antiretroviral treatment program in Rwanda during 2004-2005
    Lowrance DW, Ndamage F, Kayirangwa E, Ndagije F, Lo W, Hoover DR, Hanson J, Elul B, Ayaba A, Ellerbrock T, Rukundo A, Shumbusho F, Nash D, Mugabo J, Assimwe A.
    J Acquir Immune Defic Syndr. 2009 Sep 1;52(1):49-55.

  62. Influenza vaccination among adults with asthma findings from the 2007 BRFSS survey
    Lu PJ, Euler GL, Callahan DB.
    Am J Prev Med. 2009 Aug;37(2):109-15.

  63. Meningococcal conjugate vaccination among adolescents aged 13-17 years, United States, 2007
    Lu PJ, Jain N, Cohn AC.
    Vaccine. 2009 Dec 28.

  64. Development and characterization of candidate rotavirus vaccine strains derived from children with diarrhoea in Vietnam
    Luan le T, Trang NV, Phuong NM, Nguyen HT, Ngo HT, Tran HB, Dang HN, Dang AD, Gentsch JR, Wang Y, Esona MD, Glass RI, Steele AD, Kilgore PE, Nguyen MV, Jiang B, Nguyen HD.
    Vaccine. 2009 Nov 20;27 Suppl 5:F130-8.

  65. Evaluating the potential public health impact of a Staphylococcus aureus vaccine through use of population-based surveillance for invasive methicillin-resistant S. aureus disease in the United States
    Lucero CA, Hageman J, Zell ER, Bulens S, Nadle J, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM, Schaffner W, Fridkin SK, Active Bacterial Core Surveillance MRSA Investigators.
    Vaccine. 2009 Aug 13;27(37):5061-8.

  66. Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose
    McMahon BJ, Dentinger CM, Bruden D, Zanis C, Peters H, Hurlburt D, Bulkow L, Fiore AE, Bell BP, Hennessy TW.
    J Infect Dis. 2009 Sep 28;200(9):1390-6.

  67. Optimizing influenza vaccine distribution
    Medlock J, Galvani AP.
    Science. 2009 Sep 25;325(5948):1705-8.

  68. Vaccine preventable diseases and vaccination policy for indigenous populations
    Menzies RI, Singleton RJ.
    Pediatr Clin North Am. 2009 Dec;56(6):1263-83.

  69. Immunogenicity and reactogenicity of pneumococcal polysaccharide and conjugate vaccines in Alaska native adults 55-70 years of age
    Miernyk KM, Butler JC, Bulkow LR, Singleton RJ, Hennessy TW, Dentinger CM, Peters HV, Knutsen B, Hickel J, Parkinson AJ.
    Clin Infect Dis. 2009 Jul 15;49(2):241-8.

  70. Evaluation of rotavirus vaccines in Asia--are there lessons to be learnt?
    Mirzayeva R, Steele AD, Parashar UD, Zaman K, Neuzil KM, Nelson EA.
    Vaccine. 2009 Nov 20;27 Suppl 5:F120-9.

  71. Comparative efficacy of inactivated and live attenuated influenza vaccines
    Monto AS, Ohmit SE, Petrie JG, Johnson E, Truscon R, Teich E, Rotthoff J, Boulton M, Victor JC.
    N Engl J Med. 2009 Sep 24;361(13):1260-7.

  72. Generation and characterization of candidate vaccine viruses for prepandemic influenza vaccines
    O'Neill E, Donis RO.
    Curr Top Microbiol Immunol. 2009 ;333:83-108.

  73. Invasive pneumococcal infections among vaccinated children in the United States
    Park SY, Van Beneden CA, Pilishvili T, Martin M, Facklam RR, Whitney CG, for the Active Bacterial Core surveillance team.
    J Pediatr. 2009 Dec 2.

  74. Stockpiling antiviral drugs for the next influenza pandemic
    Patel A, Gorman SE.
    Clin Pharmacol Ther. 2009 Sep;86(3):241-3.

  75. Oral rotavirus vaccines: how well will they work where they are needed most?
    Patel M, Shane AL, Parashar UD, Jiang B, Gentsch JR, Glass RI.
    J Infect Dis. 2009 Nov 1;200 Suppl 1:S39-48.

  76. Intussusception and rotavirus vaccination: a review of the available evidence
    Patel MM, Haber P, Baggs J, Zuber P, Bines JE, Parashar UD.
    Expert Rev Vaccines. 2009 Nov;8(11):1555-64.

  77. Assessing the effectiveness and public health impact of rotavirus vaccines after introduction in immunization programs
    Patel MM, Parashar UD.
    J Infect Dis. 2009 Nov 1;200 Suppl 1:S291-9.

  78. Secular variation in United States rotavirus disease rates and serotypes: implications for assessing the rotavirus vaccination program
    Payne DC, Szilagyi PG, Staat MA, Edwards KM, Gentsch JR, Weinberg GA, Hall CB, Curns AT, Clayton H, Griffin MR, Fairbrother G, Parashar UD.
    Pediatr Infect Dis J. 2009 Nov;28(11):948-953.

  79. Support for universal childhood vaccination against influenza among private pediatric clinics and public health departments in Georgia
    Pazol K, Prill MM, Gazmararian JA, O'Malley EM, Jelks D, Coleman MS, Hinman AR, Orenstein WA.
    J Public Health Manag Pract. 2009 Sep-Oct;15(5):393-400.

  80. Immunization programs for infants, children, adolescents, and adults: clinical practice guidelines by the Infectious Diseases Society of America
    Pickering LK, Baker CJ, Freed GL, Gall SA, Grogg SE, Poland GA, Rodewald LE, Schaffner W, Stinchfield P, Tan L, Zimmerman RK, Orenstein WA.
    Clin Infect Dis. 2009 Aug 6;49(6):817-40.

  81. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine
    Pilishvili T, Lexau C, Farley MM, Hadler J, Harrison LH, Bennett NM, Reingold A, Thomas A, Schaffner W, Craig AS, Smith PJ, Beall BW, Whitney CG, Moore MR.
    J Infect Dis. 2009 Nov 30.

  82. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine
    Pilishvili T, Lexau C, Farley MM, Hadler J, Harrison LH, Bennett NM, Reingold A, Thomas A, Schaffner W, Craig AS, Smith PJ, Beall BW, Whitney CG, Moore MR, Active Bacterial Core Surveillance/Emerging Infections Program Network.
    J Infect Dis. 2010 Jan 1;201(1):32-41.

  83. Recommended adult immunization schedule: United States, 2010
    Advisory Committee on Immunization Practices.
    Ann Intern Med. 2010 Jan 5;152(1):36-9.

  84. National, state, and local area vaccination coverage among adolescents aged 13-17 years--United States, 2008
    Centers for Disease Control and Prevention.
    MMWR Morb Mortal Wkly Rep. 2009 Sep 18;58(36):997-1001.

  85. Vaccination focusing immunity on conserved antigens protects mice and ferrets against virulent H1N1 and H5N1 influenza A viruses
    Price GE, Soboleski MR, Lo CY, Misplon JA, Pappas C, Houser KV, Tumpey TM, Epstein SL.
    Vaccine. 2009 Sep 1;27(47):6512-21.

  86. Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials
    Prymula R, Siegrist CA, Chlibek R, Zemlickova H, Vackova M, Smetana J, Lommel P, Kaliskova E, Borys D, Schuerman L.
    Lancet. 2009 Oct 20;374(9698):1339-50.

  87. Providing monovalent oral polio vaccine type 1 to newborns: Findings from a pilot birth-dose project in Moradabad district, India
    Rainey JJ, Bhatnagar P, Estivariz CF, Durrani S, Galway M, Sandhu H, Bahl S, Jafari H, Wenger J.
    Bull World Health Organ. 2009 December;87(12):955-959.

  88. Cytoplasmic nucleic acid sensors in antiviral immunity
    Ranjan P, Bowzard JB, Schwerzmann JW, Jeisy-Scott V, Fujita T, Sambhara S.
    Trends Mol Med. 2009 Aug 6;15(8):359-68.

  89. Parents' health beliefs and HPV vaccination of their adolescent daughters
    Reiter PL, Brewer NT, Gottlieb SL, McRee AL, Smith JS.
    Soc Sci Med. 2009 Aug;69(3):475-80.

  90. How much will it hurt? HPV vaccine side effects and influence on completion of the three-dose regimen
    Reiter PL, Brewer NT, Gottlieb SL, McRee AL, Smith JS.
    Vaccine. 2009 Nov 16;27(49):6840-4.

  91. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand
    Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R, Premsri N, Namwat C, de Souza M, Adams E, Benenson M, Gurunathan S, Tartaglia J, McNeil JG, Francis DP, Stablein D, Birx DL, Chunsuttiwat S, Khamboonruang C, Thongcharoen P, Robb ML, Michael NL, Kunasol P, Kim JH, the Moph-Taveg Investigators.
    N Engl J Med. 2009 Oct 20.

  92. Effect of rotavirus vaccination on death from childhood diarrhea in Mexico
    Richardson V, Hernandez-Pichardo J, Quintanar-Solares M, Esparza-Aguilar M, Johnson B, Gomez-Altamirano CM, Parashar U, Patel M.
    N Engl J Med. 2010 Jan 28;362(4):299-305.

  93. Vaccinating adolescents--new evidence of challenges and opportunities
    Rodewald LE, Orenstein WA.
    J Adolesc Health. 2009 Nov;45(5):427-9.

  94. Immunosenescence and influenza vaccine efficacy
    Sambhara S, McElhaney JE.
    Curr Top Microbiol Immunol. 2009 ;333:413-29.

  95. Behavior and beliefs about influenza vaccine among adults aged 50-64 years
    Santibanez TA, Mootrey GT, Euler GL, Janssen AP.
    Am J Health Behav. 2010 Jan-Feb;34(1):77-89.

  96. Rotavirus vaccine--a powerful tool to combat deaths from diarrhea
    Santosham M.
    N Engl J Med. 2010 Jan 28;362(4):358-60.

  97. Impact of varicella vaccine on varicella-zoster virus dynamics
    Schmid DS, Jumaan AO.
    Clin Microbiol Rev. 2010 Jan;23(1):202-17.

  98. Prioritization of pandemic influenza vaccine: rationale and strategy for decision making
    Schwartz B, Orenstein WA.
    Curr Top Microbiol Immunol. 2009 ;333:495-507.

  99. Reduction in hepatitis B virus seroprevalence among U.S.-born children of foreign-born Asian parents-Benefit of universal infant hepatitis B vaccination
    Shuler CM, Fiore AE, Neeman R, Bell BP, Kuhnert W, Watkins S, Kilgour K, Arnold KE.
    Vaccine. 2009 Aug 10.

  100. Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine
    Slade BA, Leidel L, Vellozzi C, Woo EJ, Hua W, Sutherland A, Izurieta HS, Ball R, Miller N, Braun MM, Markowitz LE, Iskander J.
    JAMA. 2009 Aug 19;302(7):750-7.

  101. The influence of the multi-basic cleavage site of the H5 hemagglutinin on the attenuation, immunogenicity and efficacy of a live attenuated influenza A H5N1 cold-adapted vaccine virus
    Suguitan AL, Marino MP, Desai PD, Chen LM, Matsuoka Y, Donis RO, Jin H, Swayne DE, Kemble G, Subbarao K.
    Virology. 2009 Dec 20;395(2):280-8.

  102. Decline and change in seasonality of US rotavirus activity after the introduction of rotavirus vaccine
    Tate JE, Panozzo CA, Payne DC, Patel MM, Cortese MM, Fowlkes AL, Parashar UD.
    Pediatrics. 2009 Aug;124(2):465-71.

  103. Varicella-zoster virus subunit vaccine
    Vafai A.
    Open Vaccine Journal. 2009 ;2:17-27.

  104. Shedding of vaccine viruses with increased antigenic and genetic divergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine
    van der Sanden S, Pallansch MA, van de Kassteele J, El-Sayed N, Sutter RW, Koopmans M, van der Avoort H.
    J Virol. 2009 Sep;83(17):8693-704.

  105. RotaTeq((R)), a pentavalent rotavirus vaccine: efficacy and safety among infants in Europe
    Vesikari T, Itzler R, Karvonen A, Korhonen T, Van Damme P, Behre U, Bona G, et al.
    Vaccine. 2009 Oct 29.

  106. Evaluating the capability and cost of a mass influenza and pneumococcal vaccination clinic via computer simulation
    Washington ML.
    Med Decis Making. 2009 Jul;29(4):414-423.

  107. Vaccine safety: current systems and recent findings
    Wharton M.
    Curr Opin Pediatr. 2009 Nov 27.

  108. Viscerotropic disease following yellow fever vaccination in Peru
    Whittembury A, Ramirez G, Hernandez H, Ropero AM, Waterman S, Ticona M, Brinton M, Uchuya J, Gershman M, Toledo W, Staples E, Campos C, Martinez M, Chang GJ, Cabezas C, Lanciotti R, Zaki S, Montgomery JM, Monath T, Hayes E.
    Vaccine. 2009 Oct 9;27(43):5974-81.

  109. Global rotavirus surveillance: determining the need and measuring the impact of rotavirus vaccines
    Widdowson MA, Steele D, Vojdani J, Wecker J, Parashar U.
    J Infect Dis. 2009 Nov 1;200 Suppl 1:S1-8.

  110. Invasive and in situ cervical cancer reported to the Vaccine Adverse Event Reporting System (VAERS)
    Wong C, Krashin J, Rue-Cover A, Saraiya M, Unger E, Calugar A, Markowitz L.
    J Womens Health (Larchmt). 2010 Feb 8.

  111. Ethnically diverse female university students' knowledge and attitudes toward human papillomavirus (HPV), HPV vaccination and cervical cancer
    Wong LP, Sam IC.
    Eur J Obstet Gynecol Reprod Biol. 2009 Nov 10.

  112. Successful immunization of an allogeneic bone marrow transplant recipient with live, attenuated yellow fever vaccine
    Yax JA, Farnon EC, Cary Engleberg N.
    J Travel Med. 2009 Sep-Oct;16(5):365-7.

  113. Influence of cytokine gene variations on immunization to childhood vaccines
    Yucesoy B, Johnson VJ, Fluharty K, Kashon ML, Slaven JE, Wilson NW, Weissman DN, Biagini RE, Germolec DR, Luster MI.
    Vaccine. 2009 Nov 23;27(50):6991-7.

  114. Characterization of the cellular immune response in hepatitis C virus infection
    Zhang X, Dou J, Germann MW.
    Med Res Rev. 2009 Nov;29(6):843-66.

  115. Trends in early childhood vaccination coverage: progress towards US Healthy People 2010 goals
    Zhao Z, Smith PJ, Luman ET.
    Vaccine. 2009 Aug 6;27(36):5008-12.

  116. Antibody-mediated synergy and interference in the neutralization of SARS-CoV at an epitope cluster on the spike protein
    Zhong L, Haynes L, Struble EB, Tamin A, Virata-Theimer ML, Zhang P.
    Biochem Biophys Res Commun. 2009 Dec 18;390(3):1056-60.

  117. Factorial design for improving influenza vaccination among employees of a large health system
    Zimmerman RK, Nowalk MP, Lin CJ, Raymund M, Fox DE, Harper JD, Tanis MD, Willis BC.
    Infect Control Hosp Epidemiol. 2009 Jul;30(7):691-7.

  118. Safety of influenza vaccination in patients with myasthenia gravis: a population-based study
    Zinman L, Thoma J, Kwong JC, Kopp A, Stukel TA, Juurlink DN.
    Muscle Nerve. 2009 Dec;40(6):947-51.

  119. Recommended adult immunization schedule: United States, 2010
    Baker CJ, Pickering LK, Chilton ., Cieslak P, Ehresmann KR, Englund J, Friedman C, Judson FN, Keitel WA, Lett SM, Plain J, Marcy MS, Meissner CH, Neuzil K, Sawyer MH, Sumaya CV, Temte J, Advisory Committee on Immunization Practices.
    Ann Intern Med. 2010 Jan 5;152(1):36-9.

  120. Improved anamnestic response among adolescents boosted with a higher dose of the hepatitis B vaccine
    Chaves SS, Groeger J, Helgenberger L, Auerbach SB, Bialek S, Hu DJ, Drobeniuc J.
    Vaccine. 2010 Feb 11.

  121. Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted cervical cancer vaccine coadministered with combined diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine to girls and young women
    Garcia-Sicilia J, Schwarz TF, Carmona A, Peters K, Malkin JE, Tran PM, Behre U, et al.
    J Adolesc Health. 2010 Feb;46(2):142-51.

  122. Public health response to influenza A(H1N1) as an opportunity to build public trust
    Larson HJ, Heymann DL.
    JAMA. 2010 Jan 20;303(3):271-2.

  123. Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adults
    Musher DM, Manof SB, Liss C, McFetridge RD, Marchese RD, Bushnell B, Alvarez F, et al.
    J Infect Dis. 2010 Feb 15;201(4):516-24.

  124. A phase 1/2 study of a multiclade HIV-1 DNA plasmid prime and recombinant adenovirus serotype 5 boost vaccine in HIV-uninfected East Africans (RV 172)
    Kibuuka H, Kimutai R, Maboko L, Sawe F, Schunk MS, Kroidl A, Shaffer D, Eller LA, Kibaya R, Eller MA, Schindler KB, Schuetz A, Millard M, Kroll J, Dally L, Hoelscher M, Bailer R, Cox JH, Marovich M, Birx DL, Graham BS, Michael NL, de Souza MS, Robb ML.
    J Infect Dis. 2010 Feb 15;201(4):600-7.

  125. Revaccination with a 23-valent pneumococcal polysaccharide vaccine induces elevated and persistent functional antibody responses in adults aged 65 > or = years
    Manoff SB, Liss C, Caulfield MJ, Marchese RD, Silber J, Boslego J, Romero-Steiner S, Rajam G, Glass NE, Whitney CG, Carlone GM.
    J Infect Dis. 2010 Feb 15;201(4):525-33.

  126. Epidemiological, antigenic and genetic characteristics of seasonal influenza A(H1N1), A(H3N2) and B influenza viruses: basis for the WHO recommendation on the composition of influenza vaccines for use in the 2009-2010 Northern Hemisphere season
    Barr IG, McCauley J, Cox N, Daniels R, Engelhardt OG, Fukuda K, Grohmann G, Hay A, Kelso A, Klimov A, Odagiri T, Smith D, Russell C, Tashiro M, Webby R, Wood J, Ye Z, Zhang W.
    Vaccine. 2010 Feb 3;28(5):1156-67.

  127. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States
    Boom JA, Tate JE, Sahni LC, Rench MA, Hull JJ, Gentsch JR, Patel MM, Baker CJ, Parashar UD.
    Pediatrics. 2010 Feb;125(2):e199-207.

  128. Effectiveness of monovalent rotavirus vaccine (Rotarix) against severe diarrhea caused by serotypically unrelated G2P[4] strains in Brazil
    Correia JB, Patel MM, Nakagomi O, Montenegro FM, Germano EM, Correia NB, Cuevas LE, Parashar UD, Cunliffe NA, Nakagomi T.
    J Infect Dis. 2010 Feb 1;201(3):363-9.

  129. Post-licensure monitoring of HPV vaccine in the United States
    Markowitz LE, Hariri S, Unger ER, Saraiya M, Datta SD, Dunne EF.
    Vaccine. 2010 Feb 24.

  130. Mothers' preferences and willingness to pay for vaccinating daughters against human papillomavirus
    Brown DS, Johnson FR, Poulos C, Messonnier ML.
    Vaccine. 2010 Feb 17;28(7):1702-8.

  131. Measles outbreak in a highly vaccinated population, San Diego, 2008: role of the intentionally undervaccinated
    Sugerman DE, Barskey AE, Delea MG, Ortega-Sanchez IR, Bi D, Ralston KJ, Rota PA, Waters-Montijo K, Lebaron CW.
    Pediatrics. 2010 Mar 22.

  132. Incremental effectiveness of second dose varicella vaccination for outbreak control at an elementary school in Philadelphia, Pennsylvania, 2006
    Nguyen MD, Perella D, Watson B, Marin M, Renwick M, Spain CV.
    Pediatr Infect Dis J. 2010 Mar 29.

  133. Reduction in acute gastroenteritis hospitalizations among US children after introduction of rotavirus vaccine: analysis of hospital discharge data from 18 US states
    Curns AT, Steiner CA, Barrett M, Hunter K, Wilson E, Parashar UD.
    J Infect Dis. 2010 Apr 19.

  134. Invasive pneumococcal disease a decade after pneumococcal conjugate vaccine use in an American Indian population at high risk for disease
    Weatherholtz R, Millar EV, Moulton LH, Reid R, Rudolph K, Santosham M, O'Brien KL.
    Clin Infect Dis. 2010 May 1;50(9):1238-46.

  135. Inhibitory effect of breast milk on infectivity of live oral rotavirus vaccines
    Moon SS, Wang Y, Shane AL, Nguyen T, Ray P, Dennehy P, Baek LJ, Parashar U, Glass RI, Jiang B.
    Pediatr Infect Dis J. 2010 May 3.

  136. Pneumococcal vaccination and risk of acute myocardial infarction and stroke in men
    Tseng HF, Slezak JM, Quinn VP, Sy LS, Van den Eeden SK, Jacobsen SJ.
    JAMA. 2010 May 5;303(17):1699-706.

  137. Advances in the development of vaccines against Neisseria meningitidis
    Tan LK, Carlone GM, Borrow R.
    N Engl J Med. 2010 Apr 22;362(16):1511-20.

  138. On-time vaccine receipt in the first year does not adversely affect neuropsychological outcomes
    Smith MJ, Woods CR.
    Pediatrics. 2010 May 24.

  139. Infectivity and vaccination efficacy studies in animal models of HBV S and pol gene mutants
    Kamili S.
    Antivir Ther. 2010 ;15(3 Pt B):477-85.

  140. Rotavirus vaccines for global use: what are the remaining issues and challenges?
    Jiang B, Patel M, Parashar U.
    Hum Vaccin. 2010 May 12;6(5).

  141. Safety, tolerability, and immunogenicity of gardasil given concomitantly with menactra and adacel
    Reisinger KS, Block SL, Collins-Ogle M, Marchant C, Catlett M, Radley D, Sings HL, et al.
    Pediatrics. 2010 Jun;125(6):1142-51.

  142. Use of respiratory syncytial virus surveillance data to optimize the timing of immunoprophylaxis
    Panozzo CA, Stockman LJ, Curns AT, Anderson LJ.
    Pediatrics. 2010 Jun 14.

  143. A dynamic model of pneumococcal infection in the United States: implications for prevention through vaccination
    Van Effelterre T, Moore MR, Fierens F, Whitney CG, White L, Pelton SI, Hausdorff WP.
    Vaccine. 2010 May 7;28(21):3650-60.

  144. The new H1N1 and HPV vaccines and old fears
    Balofsky A, Agmon-Levin N, Shoenfeld Y.
    Curr Opin Rheumatol. 2010 Jul;22(4):431-6.

  145. Current controversies in the USA regarding vaccine safety
    Chatterjee A, O'Keefe C.
    Expert Rev Vaccines. 2010 May;9(5):497-502.

  146. Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine compared to those of a 7-valent pneumococcal conjugate vaccine given as a three-dose series with routine vaccines in healthy infants and toddlers
    Esposito S, Tansey S, Thompson A, Razmpour A, Liang J, Jones TR, Ferrera G, et al.
    Clin Vaccine Immunol. 2010 Jun;17(6):1017-26.

  147. Safety of herpes zoster vaccine in the shingles prevention study: a randomized trial
    Simberkoff MS, Arbeit RD, Johnson GR, Oxman MN, Boardman KD, Williams HM, Levin MJ, et al.
    Ann Intern Med. 2010 May 4;152(9):545-54.

  148. Factors underlying parental decisions about combination childhood vaccinations including MMR: a systematic review
    Brown KF, Kroll JS, Hudson MJ, Ramsay M, Green J, Long SJ, Vincent CA, et al.
    Vaccine. 2010 Jun 11;28(26):4235-48.

  149. Perceived seriousness of seasonal and A(H1N1) influenzas, attitudes toward vaccination, and vaccine uptake among U.S. adults: does the source of information matter?
    Maurer J, Uscher-Pines L, Harris KM.
    Prev Med. 2010 May 24.

  150. A population-based evaluation of a publicly funded, school-based HPV vaccine program in British Columbia, Canada: parental factors associated with HPV vaccine receipt
    Ogilvie G, Anderson M, Marra F, McNeil S, Pielak K, Dawar M, McIvor M, et al.
    PLoS Med. 2010 ;7(5):e1000270.

  151. Safety and immunogenicity of a booster dose of the 10-valent pneumococcal nontypeable haemophilus influenzae protein D conjugate vaccine coadministered with measles-mumps-rubella-varicella vaccine in children aged 12 to 16 months
    Vesikari T, Karvonen A, Lindblad N, Korhonen T, Lommel P, Willems P, Dieussaert I, et al.
    Pediatr Infect Dis J. 2010 Jun;29(6):e47-56.

  152. Multiple vaccinations and the risk of medically attended fever
    Lin ND, Kleinman K, Chan KA, Soumerai S, Mehta J, Mullooly JP, Shay DK, Kolczak M, Lieu TA.
    Vaccine. 2010 Jun 7;28(25):4169-74.

  153. Increases in levels of schistosome-specific immunoglobulin E and CD23(+) B cells in a cohort of Kenyan children undergoing repeated treatment and reinfection with Schistosoma mansoni
    Black CL, Muok EM, Mwinzi PN, Carter JM, Karanja DM, Secor WE, Colley DG.
    J Infect Dis. 2010 Jun 18.

  154. Effectiveness of adolescent and adult tetanus, reduced-dose diphtheria, and acellular pertussis vaccine against pertussis
    Wei SC, Tatti K, Cushing K, Rosen J, Brown K, Cassiday P, Clark T, Olans R, Pawloski L, Martin M, Tondella ML, Martin SW.
    Clin Infect Dis. 2010 Jun 25.

  155. Optimal vaccine stockpile design for an eradicated disease: application to polio
    Tebbens RJ, Pallansch MA, Alexander JP, Thompson KM.
    Vaccine. 2010 Jun 11;28(26):4312-27.

  156. Maternal or infant antiretroviral drugs to reduce HIV-1 transmission
    Chasela CS, Hudgens MG, Jamieson DJ, Kayira D, Hosseinipour MC, Kourtis AP, Martinson F, Tegha G, Knight RJ, Ahmed YI, Kamwendo DD, Hoffman IF, Ellington SR, Kacheche Z, Soko A, Wiener JB, Fiscus SA, Kazembe P, Mofolo IA, Chigwenembe M, Sichali DS, van der Horst CM.
    N Engl J Med. 2010 Jun 17;362(24):2271-81.

  157. The association between intentional delay of vaccine administration and timely childhood vaccination coverage
    Smith PJ, Humiston SG, Parnell T, Vannice KS, Salmon DA.
    Public Health Rep. 2010 Jul-Aug;125(4):534-41.

  158. Guillain-Barre syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data
    Sejvar JJ, Kohl KS, Gidudu J, Amato A, Bakshi N, Baxter R, Burwen D, Cornblath DR, Cleerbout J, Edwards KM, Heininger U, Hughes R, Khuri-Bulos N, Korinthenberg R, Law BJ, Munro U, Maltezou HC, Nell P, Oleske J, Sparks R, Velentgas P, Vermeer P, Wiznitzer M.
    Vaccine. 2010 Jun 17.

  159. Microneedle delivery of H5N1 influenza virus-like particles to the skin induces long-lasting B and T cell responses in mice
    Song JM, Kim YC, Lipatov AS, Pearton M, Davis CT, Yoo DG, Park KM, Chen LM, Quan FS, Birchall J, Donis RO, Prausnitz MR, Compans RW, Kang SM.
    Clin Vaccine Immunol. 2010 Jul 14.

  160. Performance of rotavirus vaccines in developed and developing countries
    Jiang V, Jiang B, Tate J, Parashar UD, Patel MM.
    Hum Vaccin. 2010 Jul 21;6(7).

  161. Protective immunity to Chlamydia trachomatis genital infection: evidence from human studies
    Batteiger BE, Xu F, Johnson RE, Rekart ML.
    J Infect Dis. 2010 Jun 15;201 Suppl 2:S178-89.

  162. Hospitalizations for invasive pneumococcal disease among HIV-1-infected adolescents and adults in the United States in the era of highly active antiretroviral therapy and the conjugate pneumococcal vaccine
    Kourtis AP, Ellington S, Bansil P, Jamieson DJ, Posner SF.
    J Acquir Immune Defic Syndr. 2010 Jul 8.

  163. Lack of association between acellular pertussis vaccine and seizures in early childhood
    Huang WT, Gargiullo PM, Broder KR, Weintraub ES, Iskander JK, Klein NP, Baggs JM.
    Pediatrics. 2010 Jul 19.

  164. Seroconversion following incomplete human rabies postexposure prophylaxis
    Robertson K, Recuenco S, Niezgoda M, Garcia ER, Rupprecht CE.
    Vaccine. 2010 Jul 13.

  165. Generation of Trypanosoma cruzi-specific CD8+ T-cell immunity is unaffected by the absence of type I interferon signaling
    Martin DL, Murali-Krishna K, Tarleton RL.
    Infect Immun. 2010 Jul;78(7):3154-9.

  166. Fractional doses of inactivated poliovirus vaccine in Oman
    Mohammed AJ, AlAwaidy S, Bawikar S, Kurup PJ, Elamir E, Shaban MM, Sharif SM, van der Avoort HG, Pallansch MA, Malankar P, Burton A, Sreevatsava M, Sutter RW.
    N Engl J Med. 2010 Jun 24;362(25):2351-9.

  167. Sustained protection from pentavalent rotavirus vaccination during the second year of life at a large, urban US pediatric hospital
    Boom JA, Tate JE, Sahni LC, Rench MA, Quaye O, Mijatovic-Rustempasic S, Patel MM, Baker CJ, Parashar UD.
    Pediatr Infect Dis J. 2010 Jul 14.

  168. Vaccine-induced HIV seropositivity/reactivity in noninfected HIV vaccine recipients
    Cooper CJ, Metch B, Dragavon J, Coombs RW, Baden LR.
    JAMA. 2010 Jul 21;304(3):275-83.

  169. Varicella vaccine safety and immunogenicity in patients with juvenile rheumatic diseases receiving methotrexate and corticosteroids
    Frenck Jr RW, Seward JF.
    Arthritis Care Res (Hoboken). 2010 Jul;62(7):903-6.

  170. Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures
    Klein NP, Fireman B, Yih WK, Lewis E, Kulldorff M, Ray P, Baxter R, Hambidge S, Nordin J, Naleway A, Belongia EA, Lieu T, Baggs J, Weintraub E.
    Pediatrics. 2010 Jul;126(1):e1-8.

  171. Supporting new vaccine introduction decisions: Lessons learned from the Hib Initiative experience
    Hajjeh RA, Privor-Dumm L, Edmond K, O'Loughlin R, Shetty S, Griffiths UK, Bear AP, Cohen AL, Chandran A, Schuchat A, Mulholland EK, Santosham M.
    Vaccine. 2010 Jul 23.

  172. Recombinant H1N1 virus-like particle vaccine elicits protective immunity in ferrets against the 2009 pandemic H1N1 influenza virus
    Pushko P, Kort T, Nathan M, Pearce MB, Smith G, Tumpey TM.
    Vaccine. 2010 Jul 5;28(30):4771-6.

  173. Estimating the vaccine-preventable burden of hospitalized pneumonia among young Mozambican children
    Roca A, Sigauque B, Quinto L, Morais L, Berenguera A, Corachan M, Ribo JL, Naniche D, Bassat Q, Sacoor C, Nhalungo D, Macete E, Schuchat A, Soriano-Gabarro M, Flannery B, Alonso PL.
    Vaccine. 2010 Jul 5;28(30):4851-7.

  174. Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies-recommendations of the Advisory Committee on Immunization Practice
    Centers for Disease Control and Prevention.
    Ann Emerg Med. 2010 Jul;56(1):64-7.

  175. Addition of 7 days of zidovudine plus lamivudine to peripartum single-dose nevirapine effectively reduces nevirapine resistance postpartum in HIV-infected mothers in Malawi
    Farr SL, Nelson JA, Ng'ombe TJ, Kourtis AP, Chasela C, Johnson JA, Kashuba AD, Tegha GL, Wiener J, Eron JJ, Banda HN, Mpaso M, Lipscomb J, Matiki C, Fiscus SA, Jamieson DJ, van der Horst C.
    J Acquir Immune Defic Syndr. 2010 Aug 15;54(5):515-23.

  176. Human papillomavirus vaccination practices: survey of US physicians 18 months after licensure
    Daley MF, Crane LA, Markowitz LE, Black SR, Beaty BL, Barrow J, Babbel C, Gottlieb SL, Liddon N, Stokley S, Dickinson LM, Kempe A.
    Pediatrics. 2010 Aug 2.

  177. Global use of Haemophilus influenzae type b conjugate vaccine
    Ojo LR, O'Loughlin RE, Cohen AL, Loo JD, Edmond KM, Shetty SS, Bear AP, Privor-Dumm L, Griffiths UK, Hajjeh R.
    Vaccine. 2010 Aug 3.

  178. An augmented passive immune therapy to treat fulminant bacterial infections
    Rajam G, Sampson J, Carlone GM, Ades EW.
    Recent Pat Antiinfect Drug Discov. 2010 Jun 1;5(2):157-67.

  179. Receipt of tetanus-containing vaccinations among adolescents aged 13 to 17 years in the United States: National Immunization Survey-Teen 2007
    Jain N, Stokley S, Cohn A.
    Clin Ther. 2010 Aug;32(8):1468-1478.

  180. Hepatitis E vaccine: not a moment too soon
    Holmberg SD.
    Lancet. 2010 Aug 20.

  181. The effectiveness of varicella vaccine in China
    Fu C, Wang M, Liang J, Xu J, Wang C, Bialek S.
    Pediatr Infect Dis J. 2010 Aug;29(8):690-3.

  182. Inactivated rotavirus vaccine induces protective immunity in gnotobiotic piglets
    Wang Y, Azevedo M, Saif LJ, Gentsch JR, Glass RI, Jiang B.
    Vaccine. 2010 Jul 26;28(33):5432-6.

  183. Influenza vaccination of household contacts of newborns: a hospital-based strategy to increase vaccination rates
    Walter EB, Allred NJ, Swamy GK, Hellkamp AS, Dolor RJ.
    Infect Control Hosp Epidemiol. 2010 Aug 30.

  184. Risk of fatal adverse events after H1N1 influenza vaccine: limitations of passive surveillance data
    McNeil MM, Broder KR, Vellozzi C, Destefano F.
    Clin Infect Dis. 2010 Oct 1;51(7):871-2.

  185. Protective immunity against H5N1 influenza virus by a single dose vaccination with virus-like particles
    Song JM, Hossain J, Yoo DG, Lipatov AS, Davis CT, Quan FS, Chen LM, Hogan RJ, Donis RO, Compans RW, Kang SM.
    Virology. 2010 Sep 15;405(1):165-75.

  186. Factors associated with effectiveness of the first dose of hepatitis B vaccine in China: 1992-2005
    Cui F, Li L, Hadler SC, Wang F, Zheng H, Chen Y, Gong X, Hutin YJ, Cairns KL, Liang X, Yang W.
    Vaccine. 2010 Aug 23;28(37):5973-8.

  187. Pneumococcal polysaccharide vaccination among adults aged 65 years and older, U.S., 1989-2008
    Lu PJ, Pekka Nuorti J.
    Am J Prev Med. 2010 Oct;39(4):287-95.

  188. Statewide HPV vaccine initiation among adolescent females in North Carolina
    Reiter PL, Cates JR, McRee AL, Gottlieb SL, Shafer A, Smith JS, Brewer NT.
    Sex Transm Dis. 2010 Sep;37(9):549-56.

  189. Human papillomavirus vaccination practices: a survey of US physicians 18 months after licensure
    Daley MF, Crane LA, Markowitz LE, Black SR, Beaty BL, Barrow J, Babbel C, Gottlieb SL, Liddon N, Stokley S, Dickinson LM, Kempe A.
    Pediatrics. 2010 Sep;126(3):425-33.

  190. Induction of broadly neutralizing H1N1 influenza antibodies by vaccination
    Wei CJ, Boyington JC, McTamney PM, Kong WP, Pearce MB, Xu L, Andersen H, Rao S, Tumpey TM, Yang ZY, Nabel GJ.
    Science. 2010 Aug 27;329(5995):1060-4.

  191. Methodology and measurement of the effectiveness of Haemophilus influenzae type b vaccine: systematic review
    O'Loughlin RE, Edmond K, Mangtani P, Cohen AL, Shetty S, Hajjeh R, Mulholland K.
    Vaccine. 2010 Aug 31;28(38):6128-36.

  192. HPV vaccine for adolescent males: acceptability to parents post-vaccine licensure
    Reiter PL, McRee AL, Gottlieb SL, Brewer NT.
    Vaccine. 2010 Aug 31;28(38):6292-7.

  193. Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the vaccine adverse events reporting system, United States, October 1, 2009-January 31, 2010
    Vellozzi C, Broder KR, Haber P, Guh A, Nguyen M, Cano M, Lewis P, McNeil MM, Bryant M, Singleton J, Martin D, Destefano F.
    Vaccine. 2010 Sep 15.

  194. The impact of indirect benefits of vaccination on postlicensure vaccine effectiveness estimates: a scenario analysis
    Patel MM, Tate J, Cortese M, Payne D, Armstrong G, Parashar UD, Lopman B.
    Vaccine. 2010 Sep 24.

  195. Maternal influenza vaccination and effect on influenza virus infection in young infants
    Eick AA, Uyeki TM, Klimov A, Hall H, Reid R, Santosham M, O'Brien KL.
    Arch Pediatr Adolesc Med. 2010 Oct 4.

  196. Effects of adverse events on the projected population benefits and cost-effectiveness of using live attenuated influenza vaccine in children aged 6 months to 4 years
    Prosser LA, Meltzer MI, Fiore A, Epperson S, Bridges CB, Hinrichsen V, Lieu TA.
    Arch Pediatr Adolesc Med. 2010 Oct 4.

  197. Emergence and localized circulation of a vaccine-derived poliovirus in an isolated mountain community in Guangxi, China
    Yan D, Li L, Zhu S, Zhang Y, An J, Wang D, Wen N, Jorba J, Liu W, Zhong G, Huang L, Kew O, Liang X, Xu W.
    J Clin Microbiol. 2010 Sep;48(9):3274-80.

  198. Report of the 6th meeting on the evaluation of pandemic influenza vaccines in clinical trials World Health Organization, Geneva, Switzerland, 17-18 February 2010
    Girard MP, Katz J, Pervikov Y, Palkonyay L, Kieny MP.
    Vaccine. 2010 Oct 4;28(42):6811-20.

  199. Similar immunogenicity and safety of the A/H1N1 2009 pandemic influenza strain when used as a monovalent or a trivalent vaccine
    Van der Vliet D, Pepin S, Lambert M, Fauchoux N, Donazzolo Y, Dupuy M, Dakowski C, et al.
    Hum Vaccin. 2010 Oct 12;6(10).

  200. Risk perceptions, worry, or distrust: what drives pregnant women's decisions to accept the H1N1 vaccine?
    Tucker Edmonds BM, Coleman J, Armstrong K, Shea JA.
    Matern Child Health J. 2010 Oct 9.

  201. MF59(TM) as a vaccine adjuvant: a review of safety and immunogenicity
    El Sahly H.
    Expert Rev Vaccines. 2010 Oct;9(10):1135-41.

  202. Parental reports of adverse events following simultaneously given dT-IPV and MMR vaccines in healthy 9-year-old children
    Kemmeren JM, van der Maas NA, de Melker HE.
    Eur J Pediatr. 2010 Sep 21.

  203. Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in infants and toddlers
    Yeh SH, Gurtman A, Hurley DC, Block SL, Schwartz RH, Patterson S, Jansen KU, et al.
    Pediatrics. 2010 Sep;126(3):e493-505.

  204. Safety of MF59-adjuvanted versus non-adjuvanted influenza vaccines in children and adolescents: an integrated analysis
    Black S, Della Cioppa G, Malfroot A, Nacci P, Nicolay U, Pellegrini M, Sokal E, et al.
    Vaccine. 2010 Oct 21;28(45):7331-6.

  205. Frequency of medically attended events following rapid revaccination with trivalent inactivated influenza vaccine
    Schmidt MA, Crane B, Mullooly JP, Naleway AL.
    Vaccine. 2010 Sep 25.

  206. The safety of immunizing with tetanus-diphtheria-acellular pertussis vaccine (Tdap) less than 2 years following previous tetanus vaccination: experience during a mass vaccination campaign of healthcare personnel during a respiratory illness outbreak
    Talbot EA, Brown KH, Kirkland KB, Baughman AL, Halperin SA, Broder KR.
    Vaccine. 2010 Sep 24.

  207. Adverse events in pregnant women following administration of trivalent inactivated influenza vaccine and live attenuated influenza vaccine in the Vaccine Adverse Event Reporting System, 1990-2009
    Moro PL, Broder K, Zheteyeva Y, Walton K, Rohan P, Sutherland A, Guh A, Haber P, Destefano F, Vellozzi C.
    Am J Obstet Gynecol. 2010 Oct 19.

  208. A norovirus vaccine on the horizon?
    Vinje J.
    J Infect Dis. 2010 Oct 27.

  209. Practice and child characteristics associated with influenza vaccine uptake in young children
    Poehling KA, Fairbrother G, Zhu Y, Donauer S, Ambrose S, Edwards KM, Staat MA, Prill MM, Finelli L, Allred NJ, Bardenheier B, Szilagyi PG.
    Pediatrics. 2010 Oct;126(4):665-73.

  210. Adverse event reports following Japanese encephalitis vaccination in the United States, 1999-2009
    Lindsey NP, Staples JE, Jones JF, Sevjar JJ, Griggs A, Iskander J, Miller ER, Fischer M.
    Vaccine. 2010 Oct 20.

  211. Approaches to monitoring biological outcomes for HPV vaccination: challenges of early adopter countries
    Wong CA, Saraiya M, Hariri S, Eckert L, Howlett RI, Markowitz LE, Brotherton JM, Sinka K, Martinez-Montanez OG, Kjaer SK, Dunne EF.
    Vaccine. 2010 Oct 21.

  212. Adverse events following trivalent inactivated influenza vaccination in children: analysis of the Vaccine Adverse Event Reporting System
    Muhammad RD, Haber P, Broder KR, Leroy Z, Ball R, Braun MM, Davis RL, McMahon AW.
    Pediatr Infect Dis J. 2010 Oct 29.

  213. Decline in rotavirus hospitalizations and health care visits for childhood diarrhea following rotavirus vaccination in El Salvador
    Yen C, Armero Guardado JA, Alberto P, Rodriguez Araujo DS, Mena C, Cuellar E, Nolasco JB, De Oliveira LH, Pastor D, Tate JE, Parashar UD, Patel M.
    Pediatr Infect Dis J. 2010 Nov 2.

  214. Inside this year's flu vaccine
    Bridges C.
    Consum Rep Health. 2010 ;22(11):6-6.[Request a copy via DocExpress]

  215. Improved protection against avian influenza H5N1 virus by a single vaccination with virus-like particles in skin using microneedles
    Song JM, Kim YC, Barlow PG, Hossain MJ, Park KM, Donis RO, Prausnitz MR, Compans RW, Kang SM.
    Antiviral Res. 2010 Nov;88(2):244-7.

  216. Type 2 vaccine-derived poliovirus from patients with acute flaccid paralysis in China: current immunization strategy effectively prevented its sustained transmission
    Zhang Y, Yan D, Zhu S, Wen N, Li L, Wang H, Liu J, Ye X, Ding Z, Wang D, Zhu H, Chen L, Hou X, An H, Liang X, Luo H, Kew O, Xu W.
    J Infect Dis. 2010 Nov 4.

  217. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data
    Donovan B, Franklin N, Guy R, Grulich AE, Regan DG, Ali H, Wand H, Fairley CK.
    Lancet Infect Dis. 2010 Nov 8.

  218. Controversy undermines support for state mandates on the human papillomavirus vaccine
    Gollust SE, Dempsey AF, Lantz PM, Ubel PA, Fowler EF.
    Health Aff (Millwood). 2010 Nov;29(11):2041-6.

  219. Single-dose mucosal immunization with a candidate universal influenza vaccine provides rapid protection from virulent H5N1, H3N2 and H1N1 viruses
    Price GE, Soboleski MR, Lo CY, Misplon JA, Quirion MR, Houser KV, Pearce MB, Pappas C, Tumpey TM, Epstein SL.
    PLoS ONE. 2010 ;5(10):e13162.

  220. Diarrhea: case definition and guidelines for collection, analysis, and presentation of immunization safety data
    Gidudu J, Sack DA, Pina M, Hudson MJ, Kohl KS, Bishop P, Chatterjee A, Chiappini E, Compingbutra A, da Costa C, Fernandopulle R, Fischer TK, Haber P, Masana W, de Menezes MR, Kang G, Khuri-Bulos N, Killion LA, Nair C, Poerschke G, Rath B, Salazar-Lindo E, Setse R, Wenger P, Wong VC, Zaman K.
    Vaccine. 2010 Dec 2.

  221. The safety of immunizing with tetanus-diphtheria-acellular pertussis vaccine (Tdap) less than 2 years following previous tetanus vaccination: Experience during a mass vaccination campaign of healthcare personnel during a respiratory illness outbreak
    Talbot EA, Brown KH, Kirkland KB, Baughman AL, Halperin SA, Broder KR.
    Vaccine. 2010 Nov 23;28(50):8001-7.

  222. Safety and effectiveness of a 2009 H1N1 vaccine in Beijing
    Wu J, Xu F, Lu L, Lu M, Miao L, Gao T, Ji W, Suo L, Liu D, Ma R, Yu R, Zhangzhu J, Liu W, Zeng Y, Li X, Zhang X, Pang X, Deng Y.
    N Engl J Med. 2010 Dec 16;363(25):2416-23.

  223. NS-based live attenuated H1N1 pandemic vaccines protect mice and ferrets
    Zhou B, Li Y, Belser JA, Pearce MB, Schmolke M, Subba AX, Shi Z, Zaki SR, Blau DM, Garcia-Sastre A, Tumpey TM, Wentworth DE.
    Vaccine. 2010 Nov 23;28(50):8015-25.

  224. Nasopharyngeal carriage of Streptococcus pneumoniae in very low-birth-weight infants after administration of heptavalent pneumococcal conjugate vaccine
    Ang JY, Lua JL, Asmar BI, Shankaran S, Heyne RJ, Schelonka RL, Das A, Li L, Jackson DM, Higgins RD, D'Angio CT.
    Arch Pediatr Adolesc Med. 2010 Dec;164(12):1173-5.

  225. Long-term immunogenicity of inactivated hepatitis A vaccine: follow-up at 15 years
    Byrd KK, Bruden DL, Bruce MG, Bulkow LR, Zanis CL, Snowball MM, Homan CE, Hennessy TW, Williams JL, Dunaway E, Chaves SS, McMahon BJ.
    J Pediatr Infect Dis. 2010 ;5(4):321-326.

  226. Varicella-related hospitalizations in the United States, 2000-2006: the 1-dose varicella vaccination era
    Lopez AS, Zhang J, Brown C, Bialek S.
    Pediatrics. 2011 Jan 3.

  227. Impact of 2-dose vaccination on varicella epidemiology: Connecticut--2005-2008
    Kattan JA, Sosa LE, Bohnwagner HD, Hadler JL.
    J Infect Dis. 2011 Jan 3.

  228. Early estimate of the effectiveness of quadrivalent meningococcal conjugate vaccine
    MacNeil JR, Cohn AC, Zell ER, Schmink S, Miller E, Clark T, Messonnier NE.
    Pediatr Infect Dis J. 2011 Jan 4.

  229. Remarkable postvaccination spatiotemporal changes in United States rotavirus activity
    Curns AT, Panozzo CA, Tate JE, Payne DC, Patel MM, Cortese MM, Parashar UD.
    Pediatr Infect Dis J. 2011 Jan;30(1 Suppl):S54-5.

  230. Influenza vaccination status is not associated with influenza testing among children: implications for observational studies of vaccine effectiveness
    Ferdinands JM, Belongia EA, Nwasike C, Shay DK.
    Vaccine. 2011 Jan 7.

  231. Real-world impact of rotavirus vaccination
    Patel MM, Steele D, Gentsch JR, Wecker J, Glass RI, Parashar UD.
    Pediatr Infect Dis J. 2011 Jan;30(1 Suppl):S1-5.

  232. Uptake, impact, and effectiveness of rotavirus vaccination in the United States: review of the first 3 years of postlicensure data
    Tate JE, Cortese MM, Payne DC, Curns AT, Yen C, Esposito DH, Cortes JE, Lopman BA, Patel MM, Gentsch JR, Parashar UD.
    Pediatr Infect Dis J. 2011 Jan;30(1 Suppl):S56-60.

  233. Sustained decline in rotavirus detections in the United States following the introduction of rotavirus vaccine in 2006
    Tate JE, Mutuc JD, Panozzo CA, Payne DC, Cortese MM, Cortes JE, Yen C, Esposito DH, Lopman BA, Patel MM, Parashar UD.
    Pediatr Infect Dis J. 2011 Jan;30(1 Suppl):S30-4.

  234. Increased potency of an inactivated trivalent polio vaccine with oil-in-water emulsions
    Baldwin SL, Fox CB, Pallansch MA, Coler RN, Reed SG, Friede M.
    Vaccine. 2011 Jan 17;29(4):644-9.

  235. Herpes zoster vaccination among adults aged 60 years and older, in the U.S., 2008
    Lu PJ, Euler GL, Harpaz R.
    Am J Prev Med. 2011 Feb;40(2):e1-6.

  236. Genetic characterization of bulgarian rotavirus isolates and detection of rotavirus variants: challenges for the rotavirus vaccine program?
    Mladenova Z, Iturriza-Gomara M, Esona MD, Gray J, Korsun N.
    J Med Virol. 2011 Feb;83(2):348-56.

  237. Projected health benefits and costs of pneumococcal and rotavirus vaccination in Uganda
    Tate JE, Kisakye A, Mugyenyi P, Kizza D, Odiit A, Braka F.
    Vaccine. 2011 Jan 14.

  238. Diarrhea-associated hospitalizations among US children over 2 rotavirus seasons after vaccine introduction
    Yen C, Tate JE, Wenk JD, Harris JM, Parashar UD.
    Pediatrics. 2011 Jan;127(1):e9-e15.

  239. Repeat revaccination with 23-valent pneumococcal polysaccharide vaccine among adults aged 55-74 years living in Alaska: no evidence of hyporesponsiveness
    Hammitt LL, Bulkow LR, Singleton RJ, Nuorti JP, Hummel KB, Miernyk KM, Zanis C, Whaley M, Romero-Steiner S, Butler JC, Rudolph K, Hennessy TW.
    Vaccine. 2011 Jan 18.

  240. 2009 pandemic influenza A (H1N1) and vaccine failure in pregnancy
    Louie JK, Wadford DA, Norman A, Jamieson DJ.
    Obstet Gynecol. 2011 Feb;117(2 Pt 2):470-2.

  241. Influenza, hepatitis B, and tetanus vaccination coverage among health care personnel in the United States
    Lu PJ, Euler GL.
    Am J Infect Control. 2011 Jan 31.

  242. Recommended adult immunization schedule: United States, 2011
    Ann Intern Med. 2011 Feb 1;154(3):168-73.

  243. Projected impact and cost-effectiveness of a rotavirus vaccination program in India, 2008
    Esposito DH, Tate JE, Kang G, Parashar UD.
    Clin Infect Dis. 2011 Jan;52(2):171-7.

  244. Considerations for human papillomavirus (HPV) vaccination of mid-adult women in the United States
    Grant LA, Dunne EF, Chesson H, Markowitz LE.
    Vaccine. 2011 Jan 27.

  245. Getting under the hood: exploring issues that affect provider-based recall using an immunization information system
    Saville AW, Albright K, Nowels C, Barnard J, Daley MF, Stokley S, Irby K, Kempe A.
    Acad Pediatr. 2011 January - February;11(1):44-49.

  246. A group-randomized evaluation of a quality improvement intervention to improve influenza vaccination rates in dialysis centers
    Bond TC, Patel PR, Krisher J, Sauls L, Deane J, Strott K, McClellan W.
    Am J Kidney Dis. 2011 Feb;57(2):283-90.

  247. Tdap and GBS letter
    Nordin JD, Yih WK, Kulldorff M, Weintraub E.
    Vaccine. 2011 Feb 1;29(6):1122.

  248. Are Kenyan healthcare workers willing to receive the pandemic influenza vaccine? Results from a cross-sectional survey of healthcare workers in Kenya about knowledge, attitudes and practices concerning infection with and vaccination against 2009 pandemic influenza A (H1N1), 2010
    Oria PA, Matini W, Nelligan I, Emukule G, Scherzer M, Oyier B, Ochieng HN, Hooper L, Kanyuga A, Muthoka P, Morales KF, Nzioka C, Breiman RF, Katz MA.
    Vaccine. 2011 Feb 3.

  249. Use of standing orders for adult influenza vaccination: a national survey of primary care physicians
    Zimmerman RK, Albert SM, Nowalk MP, Yonas MA, Ahmed F.
    Am J Prev Med. 2011 Feb;40(2):144-8.

  250. Carriage of Haemophilus influenzae among Brazilian children attending day care centers in the era of widespread Hib vaccination
    de Carvalho CX, Kipnis A, Thorn L, de Andrade JG, Pimenta F, Brandileone MC, Zanella RC, Flannery B, Sgambatti S, Andrade AL.
    Vaccine. 2011 Feb 4;29(7):1438-42.

  251. Intradermal influenza vaccine and new devices: a promising chance for vaccine improvement
    Ansaldi F, Durando P, Icardi G.
    Expert Opin Biol Ther. 2011 Mar;11(3):415-27.

  252. Guillain-Barre syndrome following receipt of influenza A (H1N1) 2009 monovalent vaccine in Korea with an emphasis on Brighton Collaboration case definition
    Choe YJ, Cho H, Bae GR, Lee JK.
    Vaccine. 2011 Jan 19.

  253. Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted vaccine administered according to an alternative dosing schedule compared with the standard dosing schedule in healthy women aged 15 to 25 years: results from a randomized study
    Esposito S, Birlutiu V, Jarcuska P, Perino A, Man SC, Vladareanu R, Meric D, et al.
    Pediatr Infect Dis J. 2011 Mar;30(3):e49-e55.

  254. Safety of the HPV bivalent and quadrivalent vaccines during pregnancy
    Forinash AB, Yancey AM, Pitlick JM, Myles TD.
    Ann Pharmacother. 2011 Feb 1.

  255. Wakefield's article linking MMR vaccine and autism was fraudulent
    Godlee F, Smith J, Marcovitch H.
    BMJ. 2011 ;342:c7452.

  256. The fifth dose of diphtheria and tetanus toxoids and acellular pertussis vaccine
    Jackson LA, Yu O, Nelson JC, Dominguez C, Peterson D, Baxter R, Hambidge SJ, et al.
    Pediatrics. 2011 Feb 7.

  257. Vaccine safety in special populations
    Klein NP.
    Hum Vaccin. 2011 Feb 1;7(2).

  258. Safety and reactogenicity of DTPa-HBV-IPV/Hib and DTPa-IPV/I-Hib vaccines in a post-marketing surveillance setting
    Lim FS, Phua KB, Lee BW, Quak SH, Teoh YL, Ramakrishnan G, Han HH, et al.
    Southeast Asian J Trop Med Public Health. 2011 Jan;42(1):138-47.

  259. Efficacy of seasonal live attenuated influenza vaccine against virus replication and transmission of a pandemic 2009 H1N1 virus in ferrets
    Pearce MB, Belser JA, Houser KV, Katz JM, Tumpey TM.
    Vaccine. 2011 Feb 18.

  260. Vaccines against Lyme disease: what happened and what lessons can we learn?
    Poland GA.
    Clin Infect Dis. 2011 Feb;52 Suppl 3:s253-8.

  261. Quadrivalent human papillomavirus (HPV) vaccine: a review of safety, efficacy, and pharmacoeconomics
    Pomfret TC, Gagnon JM, Gilchrist AT.
    J Clin Pharm Ther. 2011 Feb;36(1):1-9.

  262. Safety of influenza immunizations and treatment during pregnancy: the Vaccines and Medications in Pregnancy Surveillance System
    Schatz M, Chambers CD, Jones KL, Louik C, Mitchell AA.
    Am J Obstet Gynecol. 2011 Feb 17.

  263. Predictors of hepatitis A vaccination among young children in the United States
    Byrd KK, Santibanez TA, Chaves SS.
    Vaccine. 2011 Feb 22.

  264. Comment on the contribution by Souayah et al., "Guillain-Barre syndrome after Gardasil vaccination: data from Vaccine Adverse Event Reporting System 2006-2009"
    Slade BA, Gee J, Broder KR, Vellozzi C.
    Vaccine. 2011 Jan 29;29(5):865-6.

  265. Longitudinal predictors of human papillomavirus vaccine initiation among adolescent girls in a high-risk geographic area
    Brewer NT, Gottlieb SL, Reiter PL, McRee AL, Liddon N, Markowitz L, Smith JS.
    Sex Transm Dis. 2011 Mar;38(3):197-204.

  266. Immunologic non-inferiority of a newly licensed inactivated trivalent influenza vaccine versus an established vaccine: a randomized study in US adults
    Campbell JD, Chambers CV, Brady RC, Caldwell MC, Bennett NL, Fourneau MA, Jain VK, Innis BL.
    Hum Vaccin. 2011 Jan 1;7(1).

  267. Correlates of receiving recommended adolescent vaccines among adolescent females in North Carolina
    Reiter PL, McRee AL, Gottlieb SL, Brewer NT.
    Hum Vaccin. 2011 Jan 1;7(1).

  268. Group B streptococcal vaccine for resource-poor countries
    Schrag SJ.
    Lancet. 2011 Mar 4.

  269. Human papillomavirus vaccine initiation among adolescent girls in high-risk communities
    Guerry SL, De Rosa CJ, Markowitz LE, Walker S, Liddon N, Kerndt PR, Gottlieb SL.
    Vaccine. 2011 Mar 9;29(12):2235-41.

  270. Mycobacterium bovis (Bacille Calmette-Guerin) bacteremia in immunocompetent neonates following vaccination
    Thamthitiwat S, Marin N, Baggett HC, Peruski LF, Kiatkulwiwat W, Panumatrasmee V, Varma JK, Nateniyom S, Akarasewi P, Maloney SA.
    Vaccine. 2011 Feb 17;29(9):1727-30.

  271. Injection site and risk of medically attended local reactions to acellular pertussis vaccine
    Jackson LA, Yu O, Nelson JC, Dominguez C, Peterson D, Baxter R, Hambidge SJ, Naleway AL, Belongia EA, Nordin JD, Baggs J.
    Pediatrics. 2011 Mar;127(3):e581-e587.

  272. Seasonal influenza vaccine coverage among pregnant women: Pregnancy Risk Assessment Monitoring System
    Ahluwalia IB, Singleton JA, Jamieson DJ, Rasmussen SA, Harrison L.
    J Womens Health (Larchmt). 2011 Mar 25.

  273. Do vaccination strategies implemented by nursing homes narrow the racial gap in receipt of influenza vaccination in the United States?
    Bardenheier B, Shefer A, Ahmed F, Remsburg R, Rowland Hogue CJ, Gravenstein S.
    J Am Geriatr Soc. 2011 Mar 25.

  274. Prospecting the influenza hemagglutinin to develop universal vaccines
    Donis RO, Cox NJ.
    Clin Infect Dis. 2011 Apr;52(8):1010-2.

  275. Barriers to early uptake of tetanus, diphtheria and acellular pertussis vaccine (Tdap) among adults-United States, 2005-2007
    Miller BL, Kretsinger K, Euler GL, Lu PJ, Ahmed F.
    Vaccine. 2011 Mar 31.

  276. The Vaccine Safety Datalink: A model for monitoring immunization safety
    Baggs J, Gee J, Lewis E, Fowler G, Benson P, Lieu T, Naleway A, Klein NP, Baxter R, Belongia E, Glanz J, Hambidge SJ, Jacobsen SJ, Jackson L, Nordin J, Weintraub E.
    Pediatrics. 2011 Apr 18.

  277. Highly pathogenic (H5N1) avian influenza induces an inflammatory T helper type 1 cytokine response in the chicken
    Karpala AJ, Bingham J, Schat KA, Chen LM, Donis RO, Lowenthal JW, Bean AG.
    J Interferon Cytokine Res. 2011 Apr;31(4):393-400.

  278. PAMPer and tRIGer: ligand-induced activation of RIG-I
    Bowzard JB, Davis WG, Jeisy-Scott V, Ranjan P, Gangappa S, Fujita T, Sambhara S.
    Trends Biochem Sci. 2011 Apr 14.

  279. Workplace efforts to promote influenza vaccination among healthcare personnel and their association with uptake during the 2009 pandemic influenza A (H1N1)
    Harris K, Maurer J, Black C, Euler G, Kadiyala S.
    Vaccine. 2011 Apr 5;29(16):2978-85.

  280. Rates and correlates of influenza vaccination among HIV-infected adults in the HIV Outpatient Study (HOPS), USA, 1999-2008
    Durham MD, Buchacz K, Armon C, Patel P, Wood K, Brooks JT.
    Prev Med. 2011 May 4.

  281. Prevalence and genetic diversity of candidate vaccine antigens among invasive Neisseria meningitidis isolates in the United States
    Wang X, Cohn A, Comanducci M, Andrew L, Zhao X, Macneil JR, Schmink S, Muzzi A, Bambini S, Rappuoli R, Pizza M, Murphy E, Hoiseth SK, Jansen KU, Anderson AS, Harrison LH, Clark TA, Messonnier NE, Mayer LW.
    Vaccine. 2011 May 12.

  282. Evaluation of a broadly protective Chlamydia-cholera combination vaccine candidate
    Eko FO, Okenu DN, Singh UP, He Q, Black C, Igietseme JU.
    Vaccine. 2011 May 12;29(21):3802-10.

  283. Towards validated assays for key immunological outcomes in malaria vaccine development
    Cavanagh DR, Dubois PM, Holtel A, Kisser A, Leroy O, Locke E, Moorthy VS, Remarque EJ, Shi YP.
    Vaccine. 2011 Apr 12;29(17):3093-5.

  284. Human papillomavirus vaccine coverage in the United States, National Health and Nutrition Examination Survey, 2007-2008
    Taylor LD, Hariri S, Sternberg M, Dunne EF, Markowitz LE.
    Prev Med. 2011 May 1;52(5):398-400.

  285. Understanding the role of human variation in vaccine adverse events: the Clinical Immunization Safety Assessment Network
    LaRussa PS, Edwards KM, Dekker CL, Klein NP, Halsey NA, Marchant C, Baxter R, Engler RJ, Kissner J, Slade BA.
    Pediatrics. 2011 May;127 Suppl 1:S65-73.

  286. Decline in diarrhea mortality and admissions after routine childhood rotavirus immunization in Brazil: a time-series analysis
    do Carmo GM, Yen C, Cortes J, Siqueira AA, de Oliveira WK, Cortez-Escalante JJ, Lopman B, Flannery B, de Oliveira LH, Hage Carmo E, Patel M.
    PLoS Med. 2011 Apr;8(4):e1001024.

  287. The need for innovative strategies to improve immunisation services in rural Zimbabwe
    Chadambuka A, Chimusoro A, Apollo T, Tshimanga M, Namusisi O, Luman ET.
    Disasters. 2011 May 31.

  288. Toward the development of a hepatitis E vaccine
    Kamili S.
    Virus Res. 2011 May 18.

  289. Evaluation of immunization rates and safety among children with inborn errors of metabolism
    Klein NP, Aukes L, Lee J, Fireman B, Shapira SK, Slade B, Baxter R, Summar M.
    Pediatrics. 2011 May;127(5):e1139-46.

  290. Confidence about vaccines in the United States: understanding parents' perceptions
    Kennedy A, Lavail K, Nowak G, Basket M, Landry S.
    Health Aff (Millwood). 2011 Jun;30(6):1151-9.

  291. Influenza vaccination coverage among pregnant women--National 2009 H1N1 Flu Survey (NHFS)
    Ding H, Santibanez TA, Jamieson DJ, Weinbaum CM, Euler GL, Grohskopf LA, Lu PJ, Singleton JA.
    Am J Obstet Gynecol. 2011 Jun;204(6 Suppl 1):S96-106.

  292. Immune correlates of protection against influenza: challenges for licensure of seasonal and pandemic influenza vaccines, Miami, FL, USA, March 1-3, 2010
    Haaheim LR, Katz JM.
    Influenza Other Respi Viruses. 2011 Jul;5(4):288-95.

  293. Varicella zoster virus DNA at inoculation sites and in saliva after Zostavax immunization
    Pierson DL, Mehta SK, Gilden D, Cohrs RJ, Nagel MA, Schmid DS, Tyring SK.
    J Infect Dis. 2011 Jun;203(11):1542-5.

  294. Detection of fecal shedding of rotavirus vaccine in infants following their first dose of pentavalent rotavirus vaccine
    Yen C, Jakob K, Esona MD, Peckham X, Rausch J, Hull JJ, Whittier S, Gentsch JR, Larussa P.
    Vaccine. 2011 May 31;29(24):4151-5.

  295. Should outbreak response immunization be recommended for measles outbreaks in middle- and low-income countries? An update
    Cairns KL, Perry RT, Ryman TK, Nandy RK, Grais RF.
    J Infect Dis. 2011 Jul;204 Suppl 1:S35-46.

  296. Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil
    Patel MM, Lopez-Collada VR, Bulhoes MM, De Oliveira LH, Bautista Marquez A, Flannery B, Esparza-Aguilar M, Montenegro Renoiner EI, Luna-Cruz ME, Sato HK, Hernandez-Hernandez Ldel C, Toledo-Cortina G, Ceron-Rodriguez M, Osnaya-Romero N, Martinez-Alcazar M, Aguinaga-Villasenor RG, Plascencia-Hernandez A, Fojaco-Gonzalez F, Hernandez-Peredo Rezk G, Gutierrez-Ramirez SF, Dorame-Castillo R, Tinajero-Pizano R, Mercado-Villegas B, Barbosa MR, Maluf EM, Ferreira LB, de Carvalho FM, dos Santos AR, Cesar ED, de Oliveira ME, Silva CL, de Los Angeles Cortes M, Ruiz Matus C, Tate J, Gargiullo P, Parashar UD.
    N Engl J Med. 2011 Jun 16;364(24):2283-92.

  297. Persistence of vaccine-induced measles antibody beyond age 12 months: a comparison of response to one and two doses of Edmonston-Zagreb measles vaccine among HIV-infected and uninfected children in Malawi
    Fowlkes A, Witte D, Beeler J, Audet S, Garcia P, Curns A, Yang C, Fudzulani R, Broadhead R, Bellini WJ, Cutts F, Helfand RF.
    J Infect Dis. 2011 Jul;204 Suppl 1:S149-57.

  298. Rubella epidemiology in Africa in the prevaccine era, 2002-2009
    Goodson JL, Masresha B, Dosseh A, Byabamazima C, Nshimirimana D, Cochi S, Reef S.
    J Infect Dis. 2011 Jul;204 Suppl 1:S215-25.

  299. Impact of a measles outbreak response immunization campaign: Maroua, Cameroon, 2009
    Goodson JL, Sosler S, Pasi O, Johnson T, Kobella M, Monono ME, Uzicanin A.
    J Infect Dis. 2011 Jul;204 Suppl 1:S252-9.

  300. Supplementary immunization activities to achieve measles elimination: experience of the European Region
    Khetsuriani N, Deshevoi S, Goel A, Spika J, Martin R, Emiroglu N.
    J Infect Dis. 2011 Jul;204 Suppl 1:S343-52.

  301. Guillain-Barre syndrome following influenza vaccination: causal or coincidental?
    Sejvar JJ, Pfeifer D, Schonberger LB.
    Curr Infect Dis Rep. 2011 Jun 17.

  302. Preplanned national measles vaccination campaign at the beginning of a measles outbreak--Sierra Leone, 2009-2010
    Sugerman DE, Fall A, Guigui MT, N'Dolie M, Balogun T, Wurie A, Goodson JL.
    J Infect Dis. 2011 Jul;204 Suppl 1:S260-9.

  303. Field effectiveness of live attenuated measles-containing vaccines: a review of published literature
    Uzicanin A, Zimmerman L.
    J Infect Dis. 2011 Jul;204 Suppl 1:S133-48.

  304. Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study
    Brotherton JM, Fridman M, May CL, Chappell G, Saville AM, Gertig DM.
    Lancet. 2011 Jun 18;377(9783):2085-92.

  305. HPV vaccine effect: is the glass half full or half empty?
    Saraiya M, Hariri S.
    Lancet. 2011 Jun 18;377(9783):2057-8.

  306. Novel pandemic A (H1N1) influenza vaccination among pregnant women: motivators and barriers
    SteelFisher GK, Blendon RJ, Bekheit MM, Mitchell EW, Williams J, Lubell K, Peugh J, DiSogra CA.
    Am J Obstet Gynecol. 2011 Jun;204(6 Suppl 1):S116-23.

  307. Poliovirus vaccines: past, present, and future
    Nathanson N, Kew OM.
    Arch Pediatr Adolesc Med. 2011 Jun;165(6):489-90.

  308. Impact of maternal immunization on influenza hospitalizations in infants
    Poehling KA, Szilagyi PG, Staat MA, Snively BM, Payne DC, Bridges CB, Chu SY, Light LS, Prill MM, Finelli L, Griffin MR, Edwards KM.
    Am J Obstet Gynecol. 2011 Jun;204(6 Suppl 1):S141-8.

  309. Increasing adolescent vaccination coverage: the challenges that remain
    Stokley S, Vogt T, Shefer A.
    Arch Pediatr Adolesc Med. 2011 Jun;165(6):568-70.

  310. Human papillomavirus vaccine uptake among 9- to 17-year-old girls: National Health Interview Survey, 2008
    Wong CA, Berkowitz Z, Dorell CG, Price RA, Lee J, Saraiya M.
    Cancer. 2011 Jun 20.

  311. Models of the impact of dengue vaccines: a review of current research and potential approaches
    Johansson MA, Hombach J, Cummings DA.
    Vaccine. 2011 Jun 20.

  312. Direct and indirect effects of rotavirus vaccination upon childhood hospitalizations in 3 US counties, 2006-2009
    Payne DC, Staat MA, Edwards KM, Szilagyi PG, Weinberg GA, Hall CB, Chappell J, Curns AT, Wikswo M, Tate JE, Lopman BA, Parashar UD.
    Clin Infect Dis. 2011 Jun 23.

  313. Impact of maternal immunization on influenza hospitalizations in infants
    Poehling KA, Szilagyi PG, Staat MA, Snively BM, Payne DC, Bridges CB, Chu SY, Light LS, Prill MM, Finelli L, Griffin MR, Edwards KM.
    Am J Obstet Gynecol. 2011 Jun;204(6 Suppl 1):S141-8.

  314. Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans
    Sow SO, Okoko BJ, Diallo A, Viviani S, Borrow R, Carlone G, Tapia M, Akinsola AK, Arduin P, Findlow H, Elie C, Haidara FC, Adegbola RA, Diop D, Parulekar V, Chaumont J, Martellet L, Diallo F, Idoko OT, Tang Y, Plikaytis BD, Kulkarni PS, Marchetti E, LaForce FM, Preziosi MP.
    N Engl J Med. 2011 Jun 16;364(24):2293-304.

  315. Preparing for the availability of a partially effective HIV vaccine: lessons from other licensed vaccines
    Chen RT, Hu DJ, Dunne E, Shaw M, Mullins J, Rerks-Ngarm S.
    Vaccine. 2011 Jul 8.

  316. Safety of adjuvanted pandemic influenza A (H1N1) 2009 vaccines
    DeStefano F, Vellozzi C, Schonberger LB, Chen RT.
    BMJ. 2011 ;343:d4159.

  317. Pandemic (H1N1) 2009 and Hajj pilgrims who received predeparture vaccination, Egypt
    Kandeel A, Deming M, Kereem EA, El-Refay S, Afifi S, Abukela M, Earhart K, El-Sayed N, El-Gabaly H.
    Emerg Infect Dis. 2011 ;17(7):1266-1268.

  318. Strategies to vaccinate against cancer of the cervix: feasibility of a school-based HPV vaccination program in Peru
    Penny M, Bartolini R, Mosqueira NR, Lamontagne DS, Mendoza MA, Ramos I, Winkler JL, Villafana J, Janmohamed A, Jumaan AO.
    Vaccine. 2011 Jul 12;29(31):5022-30.

  319. Near real-time vaccine safety surveillance with partially accrued data
    Greene SK, Kulldorff M, Yin R, Yih WK, Lieu TA, Weintraub ES, Lee GM.
    Pharmacoepidemiol Drug Saf. 2011 Jun;20(6):583-90.

  320. Laboratory characterization of measles virus infection in previously vaccinated and unvaccinated individuals
    Hickman CJ, Hyde TB, Sowers SB, Mercader S, McGrew M, Williams NJ, Beeler JA, Audet S, Kiehl B, Nandy R, Tamin A, Bellini WJ.
    J Infect Dis. 2011 Jul;204 Suppl 1:S549-58.

  321. Actinic varicella vaccine rash
    Theodoridou K, Papaevangelou V, Papadogeorgaki E, Quinlivan M, Theodoridou M, Kakourou T, Breuer J.
    Pediatr Infect Dis J. 2011 Jul 15.

  322. Hepatitis B vaccination coverage and documented seroprotection among matriculating healthcare students at an academic institution in the United States
    Tohme RA, Ribner B, Huey MJ, Spradling PR.
    Infect Control Hosp Epidemiol. 2011 Aug;32(8):818-21.

  323. Near elimination of varicella deaths in the US after implementation of the vaccination program
    Marin M, Zhang JX, Seward JF.
    Pediatrics. 2011 Jul 25.

  324. The major determinant of attenuation in mice of the Candid1 vaccine for Argentine hemorrhagic fever is located in the G2 glycoprotein transmembrane domain
    Albarino CG, Bird BH, Chakrabarti AK, Dodd KA, Flint M, Bergeron E, White DM, Nichol ST.
    J Virol. 2011 Jul 27.

  325. Thimerosal exposure in early life and neuropsychological outcomes 7-10 years later
    Barile JP, Kuperminc GP, Weintraub ES, Mink JW, Thompson WW.
    J Pediatr Psychol. 2011 Jul 23.

  326. Hepatitis B vaccination coverage among high-risk adults 18-49 years, U.S., 2009
    Lu PJ, Byrd KK, Murphy TV, Weinbaum C.
    Vaccine. 2011 Jul 20.

  327. Vaccination coverage among U.S. adolescents aged 13-17 years eligible for the Vaccines for Children program, 2009
    Lindley MC, Smith PJ, Rodewald LE.
    Public Health Rep. 2011 Jul-Aug;126 Suppl 2:124-34.

  328. H1N1 and seasonal influenza vaccine safety in the Vaccine Safety Datalink Project
    Lee GM, Greene SK, Weintraub ES, Baggs J, Kulldorff M, Fireman BH, Baxter R, Jacobsen SJ, Irving S, Daley MF, Yin R, Naleway A, Nordin JD, Li L, McCarthy N, Vellozzi C, Destefano F, Lieu TA.
    Am J Prev Med. 2011 Aug;41(2):121-8.

  329. Validity of parent-reported vaccination status for adolescents aged 13-17 years: National Immunization Survey-Teen, 2008
    Dorell CG, Jain N, Yankey D.
    Public Health Rep. 2011 Jul-Aug;126 Suppl 2:60-9.

  330. Monovalent type 1 oral poliovirus vaccine among infants in India: report of two randomized double-blind controlled clinical trials
    John TJ, Jain H, Ravishankar K, Amaresh A, Verma H, Deshpande J, Pallansch MA, Singh AP, Sreevatsava M, Burton A, Malankar P, Chatterjee A, Sutter RW.
    Vaccine. 2011 Aug 5;29(34):5793-801.

  331. Cellular immune responses to nine Mycobacterium tuberculosis vaccine candidates following intranasal vaccination
    Sable SB, Cheruvu M, Nandakumar S, Sharma S, Bandyopadhyay K, Kellar KL, Posey JE, Plikaytis BB, Amara RR, Shinnick TM.
    PLoS One. 2011 ;6(7):e22718.

  332. The epidemiologic evidence underlying recommendations for use of pneumococcal polysaccharide vaccine among American Indian and Alaska Native populations
    Said MA, O'Brien KL, Nuorti JP, Singleton R, Whitney CG, Hennessy TW.
    Vaccine. 2011 Jul 26;29(33):5355-62.

  333. Parental delay or refusal of vaccine doses, childhood vaccination coverage at 24 months of age, and the Health Belief Model
    Smith PJ, Humiston SG, Marcuse EK, Zhao Z, Dorell CG, Howes C, Hibbs B.
    Public Health Rep. 2011 Jul-Aug;126 Suppl 2:135-46.

  334. Vaccination coverage among U.S. children aged 19-35 months entitled by the Vaccines for Children program, 2009
    Smith PJ, Lindley MC, Rodewald LE.
    Public Health Rep. 2011 Jul-Aug;126 Suppl 2:109-23.

  335. Highlights of historical events leading to national surveillance of vaccination coverage in the United States
    Smith PJ, Wood D, Darden PM.
    Public Health Rep. 2011 Jul-Aug;126 Suppl 2:3-12.

  336. The cost-effectiveness of male HPV vaccination in the United States
    Chesson HW, Ekwueme DU, Saraiya M, Dunne EF, Markowitz LE.
    Vaccine. 2011 Aug 1.

  337. Paralytic poliomyelitis associated with Sabin monovalent and bivalent oral polio vaccines in Hungary
    Estivariz CF, Molnar Z, Venczel L, Kapusinszky B, Zingeser JA, Lipskaya GY, Kew OM, Berencsi G, Csohan A.
    Am J Epidemiol. 2011 Aug 1;174(3):316-25.

  338. Improving influenza vaccine virus selection: Report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010
    Ampofo WK, Baylor N, Cobey S, Cox NJ, Daves S, Edwards S, Ferguson N, Grohmann G, Hay A, Katz J, Kullabutr K, Lambert L, Levandowski R, Mishra AC, Monto A, Siqueira M, Tashiro M, Waddell AL, Wairagkar N, Wood J, Zambon M, Zhang W.
    Influenza Other Respi Viruses. 2011 Aug 8.

  339. Parents' acceptance of adolescent immunizations outside of the traditional medical home
    Clevenger LM, Pyrzanowski J, Curtis CR, Bull S, Crane LA, Barrow JC, Kempe A, Daley MF.
    J Adolesc Health. 2011 Aug;49(2):133-40.

  340. Student immunity requirements of health professional schools: vaccination and other means of fulfillment-United States, 2008
    Miller BL, Lindley MC, Ahmed F, Wortley PM.
    Infect Control Hosp Epidemiol. 2011 Sep;32(9):908-11.

  341. Methods for developing evidence-based recommendations by the Advisory Committee on Immunization Practices (ACIP) of the U.S. Centers for Disease Control and Prevention (CDC)
    Ahmed F, Temte JL, Campos-Outcalt D, Schunemann HJ.
    Vaccine. 2011 Aug 10.

  342. Cost-effectiveness of 2009 pandemic influenza A(H1N1) vaccination in the United States
    Prosser LA, Lavelle TA, Fiore AE, Bridges CB, Reed C, Jain S, Dunham KM, Meltzer MI.
    PLoS One. 2011 ;6(7):e22308.

  343. Human papillomavirus (HPV) 6, 11, 16, and 18 prevalence among females in the United States--National Health and Nutrition Examination Survey, 2003-2006: opportunity to measure HPV vaccine impact?
    Dunne EF, Sternberg M, Markowitz LE, McQuillan G, Swan D, Patel S, Unger ER.
    J Infect Dis. 2011 Aug;204(4):562-5.

  344. Novel chikungunya vaccine candidate with an IRES-based attenuation and host range alteration mechanism
    Plante K, Wang E, Partidos CD, Weger J, Gorchakov R, Tsetsarkin K, Borland EM, Powers AM, Seymour R, Stinchcomb DT, Osorio JE, Frolov I, Weaver SC.
    PLoS Pathog. 2011 Jul;7(7):e1002142.

  345. Parent-reported reasons for nonreceipt of recommended adolescent vaccinations, National Immunization Survey--Teen, 2009
    Dorell C, Yankey D, Strasser S.
    Clin Pediatr (Phila). 2011 Aug 19.

  346. Safety of trivalent inactivated influenza vaccine in children aged 24 to 59 months in the Vaccine Safety Datalink
    Glanz JM, Newcomer SR, Hambidge SJ, Daley MF, Narwaney KJ, Xu S, Lee GM, Baggs J, Klein NP, Nordin JD, Naleway AL, Belongia EA, Weintraub ES.
    Arch Pediatr Adolesc Med. 2011 Aug;165(8):749-55.

  347. Modeling the impact of RV144-like vaccines on HIV transmission
    Hankins CA, Glasser JW, Chen RT.
    Vaccine. 2011 Aug 18;29(36):6069-71.

  348. Influenza vaccine effectiveness in Wisconsin during the 2007-08 season: comparison of interim and final results
    Belongia EA, Kieke BA, Donahue JG, Coleman LA, Irving SA, Meece JK, Vandermause M, Lindstrom S, Gargiullo P, Shay DK.
    Vaccine. 2011 Sep 2;29(38):6558-63.

  349. Effectiveness of non-adjuvanted pandemic influenza A vaccines for preventing pandemic influenza acute respiratory illness visits in 4 U.S. communities
    Griffin MR, Monto AS, Belongia EA, Treanor JJ, Chen Q, Chen J, Talbot HK, Ohmit SE, Coleman LA, Lofthus G, Petrie JG, Meece JK, Hall CB, Williams JV, Gargiullo P, Berman L, Shay DK.
    PLoS One. 2011 ;6(8):e23085.

  350. Infant rotavirus vaccination may provide indirect protection to older children and adults in the United States
    Lopman BA, Curns AT, Yen C, Parashar UD.
    J Infect Dis. 2011 Oct;204(7):980-6.

  351. Design of future rabies biologics and antiviral drugs
    Smith TG, Wu X, Franka R, Rupprecht CE.
    Adv Virus Res. 2011 ;79:345-63.

  352. Effectiveness of pentavalent rotavirus vaccine against severe disease
    Staat MA, Payne DC, Donauer S, Weinberg GA, Edwards KM, Szilagyi PG, Griffin MR, Hall CB, Curns AT, Gentsch JR, Salisbury S, Fairbrother G, Parashar UD.
    Pediatrics. 2011 Aug;128(2):e267-e275.

  353. Risk of rheumatoid arthritis following vaccination with tetanus, influenza and hepatitis B vaccines among persons 15-59 years of age
    Ray P, Black S, Shinefield H, Dillon A, Carpenter D, Lewis E, Ross P, Chen RT, Klein NP, Baxter R.
    Vaccine. 2011 Sep 2;29(38):6592-6597.

  354. Pediatricians' attitudes about collaborations with other community vaccinators in the delivery of seasonal influenza vaccine
    Kempe A, Wortley P, O'Leary S, Crane LA, Daley MF, Stokley S, Babbel C, Dong F, Beaty B, Seewald L, Suh C, Dickinson LM.
    Acad Pediatr. 2011 Sep 5.

  355. Estimating effect of antiviral drug use during pandemic (H1N1) 2009 outbreak, United States
    Atkins CY, Patel A, Taylor TH, Biggerstaff M, Merlin TL, Dulin SM, Erickson BA, Borse RH, Hunkler R, Meltzer MI.
    Emerg Infect Dis. 2011 Sep;17(9):1591-8.

  356. Accelerating introduction of new vaccines: barriers to introduction and lessons learned from the recent Haemophilus influenzae type b vaccine experience
    Hajjeh R.
    Philos Trans R Soc Lond B Biol Sci. 2011 Oct 12;366(1579):2827-32.

  357. Reasons related to non-vaccination and under-vaccination of children in low and middle income countries: findings from a systematic review of the published literature, 1999-2009
    Rainey JJ, Watkins M, Ryman TK, Sandhu P, Bo A, Banerjee K.
    Vaccine. 2011 Sep 2.

  358. Immune response after rabies vaccine in a kidney transplant recipient
    Rodriguez-Romo R, Morales-Buenrostro LE, Lecuona L, Escalante-Santillan N, Velasco-Villa A, Kuzmin I, Rupprecht CE, De-Leo C, Ramirez J, Alberu J.
    Transpl Infect Dis. 2011 Aug 26.

  359. Compliance with recommendations and opportunities for vaccination at ages 11 to 12 years: evaluation of the 2009 National Immunization Survey-Teen
    Stokley S, Cohn A, Jain N, McCauley MM.
    Arch Pediatr Adolesc Med. 2011 Sep;165(9):813-8.

  360. Monitoring the safety of quadrivalent human papillomavirus vaccine: findings from the Vaccine Safety Datalink
    Gee J, Naleway A, Shui I, Baggs J, Yin R, Li R, Kulldorff M, Lewis E, Fireman B, Daley MF, Klein NP, Weintraub ES.
    Vaccine. 2011 Sep 7.

  361. Childhood diarrhea deaths after rotavirus vaccination in Mexico
    Richardson V, Parashar U, Patel M.
    N Engl J Med. 2011 Aug 25;365(8):772-3.

  362. Monovalent rotavirus vaccine provides protection against an emerging fully heterotypic G9P[4] rotavirus strain in Mexico
    Yen C, Figueroa JR, Uribe ES, Carmen-Hernandez LD, Tate JE, Parashar UD, Patel MM, Richardson Lopez-Collado V.
    J Infect Dis. 2011 Sep;204(5):783-6.

  363. Effect of expanded US recommendations for seasonal influenza vaccination: comparison of two pediatric emergency departments in the United States and Canada
    Hoen AG, Buckeridge DL, Charland KM, Mandl KD, Quach C, Brownstein JS.
    CMAJ. 2011 Sep 20;183(13):E1025-32.

  364. Adverse events after tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine administered to adults 65 years of age and older reported to the Vaccine Adverse Event Reporting System (VAERS), 2005-2010
    Moro PL, Yue X, Lewis P, Haber P, Broder K.
    Vaccine. 2011 Sep 13.

  365. Molecular studies of the Oka varicella vaccine
    Quinlivan M, Breuer J, Schmid DS.
    Expert Rev Vaccines. 2011 Sep;10(9):1321-36.

  366. Increases in vaccination coverage of healthcare personnel following institutional requirements for influenza vaccination: a national survey of US hospitals
    Miller BL, Ahmed F, Lindley MC, Wortley PM.
    Vaccine. 2011 Sep 21.

  367. Development of DENVax: A chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever
    Osorio JE, Huang CY, Kinney RM, Stinchcomb DT.
    Vaccine. 2011 Sep 23;29(42):7251-60.

  368. Next generation dengue vaccines: a review of candidates in preclinical development
    Schmitz J, Roehrig J, Barrett A, Hombach J.
    Vaccine. 2011 Sep 23;29(42):7276-84.

  369. Overview of the Clinical Consult Case Review of adverse events following immunization: Clinical Immunization Safety Assessment (CISA) network 2004-2009
    Williams SE, Klein NP, Halsey N, Dekker CL, Baxter RP, Marchant CD, Larussa PS, Sparks RC, Tokars JI, Pahud BA, Aukes L, Jakob K, Coronel S, Choi H, Slade BA, Edwards KM.
    Vaccine. 2011 Sep 16;29(40):6920-7.

  370. Measles elimination in the Americas: a comparison between countries with a one-dose and two-dose routine vaccination schedule
    Sever AE, Rainey JJ, Zell ER, Hennessey K, Uzicanin A, Castillo-Solorzano C, Dietz V.
    J Infect Dis. 2011 Sep;204 Suppl 2:S748-55.

  371. The impact of missed opportunities on seasonal influenza vaccination coverage for healthy young children
    Allred NJ, Poehling KA, Szilagyi PG, Zhang F, Edwards KM, Staat MA, Donauer S, Prill MM, Fairbrother G.
    J Public Health Manag Pract. 2011 Nov;17(6):560-564.

  372. Comparative immunogenicity and cross-clade protective efficacy of mammalian cell-grown inactivated and live attenuated H5N1 reassortant vaccines in ferrets
    Gustin KM, Maines TR, Belser JA, van Hoeven N, Lu X, Dong L, Isakova-Sivak I, Chen LM, Voeten JT, Heldens JG, van den Bosch H, Cox NJ, Tumpey TM, Klimov AI, Rudenko L, Donis RO, Katz JM.
    J Infect Dis. 2011 Sep 28.

  373. Haiti 2007-2008 national measles-rubella vaccination campaign: implications for rubella elimination
    Rainey JJ, Danovaro-Holliday MC, Magloire R, Kananda G, Lee CE, Chamouillet H, Lacapere F, Mung K, Luman ET.
    J Infect Dis. 2011 Sep;204 Suppl 2:S616-21.

  374. Alternative vaccination schedule preferences among parents of young children
    Dempsey AF, Schaffer S, Singer D, Butchart A, Davis M, Freed GL.
    Pediatrics. 2011 Oct 3.

  375. Rotavirus vaccine and health care utilization for diarrhea in U.S. children
    Cortes JE, Curns AT, Tate JE, Cortese MM, Patel MM, Zhou F, Parashar UD.
    N Engl J Med. 2011 Sep 22;365(12):1108-17.

  376. Failure-to-success ratios, transition probabilities and phase lengths for prophylactic vaccines versus other pharmaceuticals in the development pipeline
    Davis MM, Butchart AT, Wheeler JR, Coleman MS, Singer DC, Freed GL.
    Vaccine. 2011 Oct 12.

  377. Lessons from the US rotavirus vaccination program
    Glass RI, Patel M, Parashar U.
    JAMA. 2011 Oct 19;306(15):1701-2.

  378. Assessing the effect of pneumococcal conjugate vaccines: what is the value of routinely collected surveillance data?
    Grijalva CG, Moore MR, Griffin MR.
    Lancet Infect Dis. 2011 Oct;11(10):724-6.

  379. Haemophilus influenzae type b carriage among young children in metropolitan Atlanta in the context of vaccine shortage and booster dose deferral
    Thomas JD, Jackson ML, Sharma D, Mair R, Bach MC, Castillo D, Ejigiri OG, Satola S, Cohn AC, Jerris R, Jain S, Farley MM, Mayer LW, Messonnier NE.
    Clin Vaccine Immunol. 2011 Oct 19.

  380. Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37
    Barlow PG, Svoboda P, Mackellar A, Nash AA, York IA, Pohl J, Davidson DJ, Donis RO.
    PLoS One. 2011 ;6(10):e25333.

  381. Report of the 7th meeting on Evaluation of Pandemic Influenza Vaccines in Clinical Trials, World Health Organization, Geneva, 17-18 February 2011
    Girard MP, Katz JM, Pervikov Y, Hombach J, Tam JS.
    Vaccine. 2011 Oct 13;29(44):7579-86.

  382. Virus-like particle vaccine containing hemagglutinin confers protection against 2009 H1N1 pandemic influenza
    Hossain MJ, Bourgeois M, Quan FS, Lipatov AS, Song JM, Chen LM, Compans RW, York I, Kang SM, Donis RO.
    Clin Vaccine Immunol. 2011 Oct 26.

  383. From the CDC: new country-specific recommendations for pre-travel typhoid vaccination
    Johnson KJ, Gallagher NM, Mintz ED, Newton AE, Brunette GW, Kozarsky PE.
    J Travel Med. 2011 Nov;18(6):430-433.

  384. Safety and immunogenicity of LC16m8, an attenuated smallpox vaccine in vaccinia-naive adults
    Kennedy JS, Gurwith M, Dekker CL, Frey SE, Edwards KM, Kenner J, Lock M, Empig C, Morikawa S, Saijo M, Yokote H, Karem K, Damon I, Perlroth M, Greenberg RN.
    J Infect Dis. 2011 Nov;204(9):1395-402.

  385. Attitudes and practices of obstetrician-gynecologists regarding influenza vaccination in pregnancy
    Kissin DM, Power ML, Kahn EB, Williams JL, Jamieson DJ, Macfarlane K, Schulkin J, Zhang Y, Callaghan WM.
    Obstet Gynecol. 2011 Nov;118(5):1074-80.

  386. Wheezing lower respiratory disease and vaccination of premature infants
    Mullooly JP, Schuler R, Mesa J, Drew L, Destefano F.
    Vaccine. 2011 Oct 13;29(44):7611-7617.

  387. A multi-center, qualitative assessment of pediatrician and maternal perspectives on rotavirus vaccines and the detection of Porcine circovirus
    Payne DC, Humiston S, Opel D, Kennedy A, Wikswo M, Downing K, Klein EJ, Kobayashi A, Locke D, Albertin C, Chesley C, Staat MA.
    BMC Pediatr. 2011 ;11:83.

  388. Parent and adolescent perspectives about adolescent vaccine delivery: practical considerations for vaccine communication
    Rand CM, Humiston SG, Schaffer SJ, Albertin CS, Shone LP, Blumkin AK, Stokley S, Szilagyi PG.
    Vaccine. 2011 Oct 13;29(44):7651-8.

  389. Vaccines and neurologic disease
    Sejvar JJ.
    Semin Neurol. 2011 Jul;31(3):338-55.

  390. Acceptability of school requirements for human papillomavirus vaccine
    Smith JS, Brewer NT, Chang Y, Liddon N, Guerry S, Pettigrew E, Markowitz LE, Gottlieb SL.
    Hum Vaccin. 2011 Sep 1;7(9).

  391. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis
    Tate JE, Burton AH, Boschi-Pinto C, Steele AD, Duque J, Parashar UD.
    Lancet Infect Dis. 2011 Oct 24.

  392. Evaluation of hepatitis B vaccine immunogenicity among older adults during an outbreak response in assisted living facilities
    Tohme RA, Awosika-Olumo D, Nielsen C, Khuwaja S, Scott J, Xing J, Drobeniuc J, Hu DJ, Turner C, Wafeeg T, Sharapov U, Spradling PR.
    Vaccine. 2011 Oct 18.

  393. Safety of zoster vaccine in adults from a large managed care cohort: a Vaccine Safety Datalink Study
    Tseng HF, Liu A, Sy L, Marcy SM, Fireman B, Weintraub E, Baggs J, Weinmann S, Baxter R, Nordin J, Daley MF, Jackson L, Jacobsen SJ.
    J Intern Med. 2011 Oct 25.

  394. Novel formulations enhance the thermal stability of live-attenuated flavivirus vaccines
    Wiggan O, Livengood JA, Silengo SJ, Kinney RM, Osorio JE, Huang CY, Stinchcomb DT.
    Vaccine. 2011 Oct 6;29(43):7456-62.

  395. Improving immunogenicity and effectiveness of influenza vaccine in older adults
    Cao W, Kim JH, Chirkova T, Reber AJ, Biber R, Shay DK, Sambhara S.
    Expert Rev Vaccines. 2011 Nov;10(11):1529-37.

  396. Immunogenicity of hepatitis B vaccine among hemodialysis patients: effect of revaccination of non-responders and duration of protection
    Chaves SS, Daniels D, Cooper BW, Malo-Schlegel S, Macarthur S, Robbins KC, Kobetitsch JF, McDaniel A, D'Avella JF, Alter MJ.
    Vaccine. 2011 Oct 29.

  397. Chlamydia vaccines: recent developments and the role of adjuvants in future formulations
    Igietseme JU, Eko FO, Black CM.
    Expert Rev Vaccines. 2011 Nov;10(11):1585-96.

  398. Institutional requirements for influenza vaccination of healthcare personnel: results from a nationally representative survey of acute care hospitals--United States, 2011
    Miller BL, Ahmed F, Lindley MC, Wortley PM.
    Clin Infect Dis. 2011 Dec;53(11):1051-9.

  399. Causality assessment of serious neurologic adverse events following 2009 H1N1 vaccination
    Williams SE, Pahud BA, Vellozzi C, Donofrio PD, Dekker CL, Halsey N, Klein NP, Baxter RP, Marchant CD, Larussa PS, Barnett ED, Tokars JI, McGeeney BE, Sparks RC, Aukes LL, Jakob K, Coronel S, Sejvar JJ, Slade BA, Edwards KM.
    Vaccine. 2011 Oct 26;29(46):8302-8.

  400. From brain passage to cell adaptation: the road of human rabies vaccine development
    Wu X, Smith TG, Rupprecht CE.
    Expert Rev Vaccines. 2011 Nov;10(11):1597-608.

  401. Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6-9 months in Moradabad, India: a community-based, randomised controlled trial
    Estivariz CF, Jafari H, Sutter RW, John TJ, Jain V, Agarwal A, Verma H, Pallansch MA, Singh AP, Guirguis S, Awale J, Burton A, Bahl S, Chatterjee A, Aylward RB.
    Lancet Infect Dis. 2011 Nov 7.

  402. Progress in newborn hepatitis B vaccination by birth year cohorts-1998-2007, USA
    Zhao Z, Murphy TV, Jacques-Carroll L.
    Vaccine. 2011 Nov 4.

  403. Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
    Lehtinen M, Paavonen J, Wheeler CM, Jaisamrarn U, Garland SM, Castellsague X, Skinner SR, Apter D, Naud P, Salmeron J, Chow S, Kitchener H, Teixeira JC, Hedrick J, Limson G, Szarewski A, Romanowski B, Aoki FY, Schwarz TF, Poppe WA, De Carvalho NS, Germar MJ, Peters K, Mindel A, De Sutter P, Bosch FX, David M, Descamps D, Struyf F, Dubin G.
    Lancet Oncol. 2011 Nov 9.

  404. Direct costs of a single case of refugee-imported measles in Kentucky
    Coleman MS, Garbat-Welch L, Burke H, Weinberg M, Humbaugh K, Tindall A, Cambron J.
    Vaccine. 2011 Nov 11.

  405. Considerations for oral cholera vaccine use during outbreak after earthquake in Haiti, 2010-2011
    Date KA, Vicari A, Hyde TB, Mintz E, Danovaro-Holliday MC, Henry A, Tappero JW, Roels TH, Abrams J, Burkholder BT, Ruiz-Matus C, Andrus J, Dietz V.
    Emerg Infect Dis. 2011 ;17(11):2105-2112.

  406. Vaccination and risk of type 1 diabetes mellitus in active component U.S. military, 2002-2008
    Duderstadt SK, Rose CE, Real TM, Sabatier JF, Stewart B, Ma G, Yerubandi UD, Eick AA, Tokars JI, McNeil MM.
    Vaccine. 2011 Nov 7.

  407. US hospital requirements for pertussis vaccination of healthcare personnel, 2011
    Miller BL, Ahmed F, Lindley MC, Wortley PM.
    Infect Control Hosp Epidemiol. 2011 Dec;32(12):1209-12.

  408. Adolescent vaccination - coverage levels in the United States: 2006-2009
    Stokley S, Cohn A, Dorell C, Hariri S, Yankey D, Messonnier N, Wortley PM.
    Pediatrics. 2011 Nov 14.

  409. Adolescent vaccination - coverage levels in the United States: 2006-2009
    Stokley S, Cohn A, Dorell C, Hariri S, Yankey D, Messonnier N, Wortley PM.
    Pediatrics. 2011 Nov 14.

  410. Varicella in infants after implementation of the US varicella vaccination program
    Chaves SS, Lopez AS, Watson TL, Civen R, Watson B, Mascola L, Seward JF.
    Pediatrics. 2011 Nov 28.

  411. Compliance with recommended dosing intervals for HPV vaccination among females, 13-17 years, National Immunization Survey-Teen, 2008-2009
    Dorell CG, Stokley S, Yankey D, Markowitz LE.
    Vaccine. 2011 Nov 22.

  412. Magnitude of potential biases in a simulated case-control study of the effectiveness of influenza vaccination
    Ferdinands JM, Shay DK.
    Clin Infect Dis. 2011 Nov 17.

  413. Meningococcal conjugate vaccines: optimizing global impact
    Terranella A, Cohn A, Clark T.
    Infect Drug Resist. 2011 ;4:161-9.

  414. Rotavirus vaccines: update on global impact and future priorities
    Yen C, Tate JE, Patel MM, Cortese MM, Lopman B, Fleming J, Lewis K, Jiang B, Gentsch J, Steele D, Parashar UD.
    Hum Vaccin. 2011 Dec 1;7(12).

  415. Developing the next generation of vaccinologists
    Klein NP, Gidudu J, Qiang Y, Pahud B, Rowhani-Rahbar A, Baxter R, Dekker CL, Edwards KM, Halsey NA, Larussa P, Marchant C, Tokars JI, Destefano F.
    Vaccine. 2011 Nov 21;29(50):9296-7.

  416. Timing of adolescent meningococcal conjugate vaccination: attitudes and practices of pediatricians and family medicine physicians
    Allison MA, Cohn AC, Stokley S, Crane LA, O'Leary ST, Hurley LP, Babbel CI, Dong F, Gahm C, Temte JL, Kempe A.
    Am J Prev Med. 2011 Dec;41(6):581-7.

  417. DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials
    Ledgerwood JE, Wei CJ, Hu Z, Gordon IJ, Enama ME, Hendel CS, McTamney PM, Pearce MB, Yassine HM, Boyington JC, Bailer R, Tumpey TM, Koup RA, Mascola JR, Nabel GJ, Graham BS.
    Lancet Infect Dis. 2011 Dec;11(12):916-924.

  418. First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children
    RTS, S Clinical Trials Partnership.
    N Engl J Med. 2011 Nov 17;365(20):1863-75.

  419. Effects of a nationwide Hib vaccine shortage on vaccination coverage in the United States
    Santibanez TA, Shefer A, Briere EC, Cohn A, Groom AV.
    Vaccine. 2011 Nov 29.

  420. Validity of parental report of influenza vaccination in young children seeking medical care
    Brown C, Clayton-Boswell H, Chaves SS, Prill MM, Iwane MK, Szilagyi PG, Edwards KM, Staat MA, Weinberg GA, Fairbrother G, Hall CB, Zhu Y, Bridges CB.
    Vaccine. 2011 Nov 28;29(51):9488-9492.

  421. Prevention of antibiotic-nonsusceptible Streptococcus pneumoniae with conjugate vaccines
    Hampton LM, Farley MM, Schaffner W, Thomas A, Reingold A, Harrison LH, Lynfield R, Bennett NM, Petit S, Gershman K, Baumbach J, Beall B, Jorgensen J, Glennen A, Zell ER, Moore M.
    J Infect Dis. 2011 Dec 7.

  422. Expanding and improving urban outreach immunization in Patna, India
    Pradhan N, Ryman TK, Varkey S, Ranjan A, Gupta SK, Krishna G, Swetanki RP, Young R.
    Trop Med Int Health. 2011 Dec 14.

  423. Rural parents' vaccination-related attitudes and intention to vaccinate middle and high school children against influenza following educational influenza vaccination intervention
    Sales JM, Painter JE, Pazol K, Gargano LM, Orenstein W, Hughes JM, Diclemente RJ.
    Hum Vaccin. 2011 Nov 1;7(11).

  424. Safety, tolerability, and immunogenicity of inactivated trivalent seasonal influenza vaccine administered with a needle-free disposable-syringe jet injector
    Simon JK, Carter M, Pasetti MF, Sztein MB, Kotloff KL, Weniger BG, Campbell JD, Levine MM.
    Vaccine. 2011 Nov 28;29(51):9544-50.

  425. Use of human papillomavirus vaccines among young adult women in the United States: an analysis of the 2008 National Health Interview Survey
    Anhang Price R, Tiro JA, Saraiya M, Meissner H, Breen N.
    Cancer. 2011 15 Dec;117(24):5560-5568.

  426. Influenza vaccination coverage among US nursing home nursing assistants: the role of working conditions
    Groenewold M, Baron S, Tak S, Allred N.
    J Am Med Dir Assoc. 2012 Jan;13(1):85 e17-23.

  427. Community-based values for 2009 pandemic influenza A H1N1 illnesses and vaccination-related adverse events
    Lavelle TA, Meltzer MI, Gebremariam A, Lamarand K, Fiore AE, Prosser LA.
    PLoS One. 2011 ;6(12):e27777.

  428. Human papillomavirus vaccine and sexual behavior among adolescent and young women
    Liddon NC, Leichliter JS, Markowitz LE.
    Am J Prev Med. 2012 Jan;42(1):44-52.

  429. HPV vaccine implementation in STD clinics - STD Surveillance Network
    Meites E, Llata E, Hariri S, Zenilman J, Longfellow L, Schwebke J, Tabidze I, Mettenbrink C, Jenkins H, Guerry S, Pathela P, Asbel L, Stover JA, Bernstein K, Kerani RP, Dunne EF, Markowitz LE.
    Sex Transm Dis. 2012 Jan;39(1):32-34.

  430. Cancers that U.S. physicians believe the HPV vaccine prevents: findings from a physician survey, 2009
    Saraiya M, Rosser JI, Cooper CP.
    J Womens Health (Larchmt). 2012 Jan 4.

  431. Updated recommendations of the Advisory Committee on Immunization Practices for healthcare personnel vaccination: a necessary foundation for the essential work that remains to build successful programs
    Shefer A, Strikas R, Bridges CB.
    Infect Control Hosp Epidemiol. 2012 Jan;33(1):71-4.

  432. Early impact of the US Tdap vaccination program on pertussis trends
    Skoff TH, Cohn AC, Clark TA, Messonnier NE, Martin SW.
    Arch Pediatr Adolesc Med. 2012 Jan 2.

  433. No evidence of murine leukemia virus-related viruses in live attenuated human vaccines
    Switzer WM, Zheng H, Simmons G, Zhou Y, Tang S, Shankar A, Kapusinszky B, Delwart EL, Heneine W.
    PLoS One. 2011 ;6(12):e29223.

  434. Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine
    Reed C, Meltzer MI, Finelli L, Fiore A.
    Vaccine. 2012 Jan 4.

  435. Impact of vaccination against Haemophilus influenzae type b with and without a booster dose on meningitis in four South American countries
    Garcia S, Lagos R, Munoz A, Picon T, Rosa R, Alfonso A, Abriata G, Gentile A, Romanin V, Regueira M, Chiavetta L, Agudelo CI, Castaneda E, De la Hoz F, Higuera AB, Arce P, Cohen AL, Verani J, Zuber P, Gabastou JM, Pastor D, Flannery B, Andrus J.
    Vaccine. 2012 Jan 5;30(2):486-92.

  436. Vaccination coverage in Haiti: results from the 2009 national survey
    Rainey JJ, Lacapere F, Danovaro-Holliday MC, Mung K, Magloire R, Kananda G, Cadet JR, Lee CE, Chamouillet H, Luman E.
    Vaccine. 2012 Jan 3.

  437. Health-related quality of life in the anthrax vaccination program for workers in the laboratory response network
    Stewart B, Zhang Y, Rose Jr CE, Tokars JI, Martin SW, Franzke LH, McNeil MM.
    Vaccine. 2012 Jan 6.

  438. Invasive disease due to Haemophilus influenzae serotype b ten years after routine vaccination, South Africa, 2003-2009
    von Gottberg A, Cohen C, Whitelaw A, Chhagan M, Flannery B, Cohen AL, de Gouveia L, Plessis MD, Madhi SA, Klugman KP.
    Vaccine. 2012 Jan 11;30(3):565-571.

  439. Persistence of long-term immunity to hepatitis B among adolescents immunized at birth
    Chaves SS, Fischer G, Groeger J, Patel PR, Thompson ND, Teshale EH, Stevenson K, Yano VM, Armstrong GL, Samandari T, Kamili S, Drobeniuc J, Hu DJ.
    Vaccine. 2012 Jan 10.

  440. Human vaccines and their importance to public health
    Schuchat A.
    Procedia Vaccinol. 2011 ;5(1):120-126.

  441. Improved equity in measles vaccination from integrating insecticide-treated bednets in a vaccination campaign, Madagascar
    Goodson JL, Kulkarni MA, Vanden Eng JL, Wannemuehler KA, Cotte AH, Desrochers RE, Randriamanalina B, Luman ET.
    Trop Med Int Health. 2012 Jan 24.

  442. Hepatitis A vaccination coverage among adolescents in the United States
    Dorell CG, Yankey D, Byrd KK, Murphy TV.
    Pediatrics. 2012 Jan 23.

  443. Limited awareness of vaccines recommended for adolescents and other results from two national consumer health surveys in the United States
    Kennedy A, Stokley S, Curtis CR, Gust D.
    J Adolesc Health. 2012 Feb;50(2):198-200.

  444. Impact of more than a decade of pneumococcal conjugate vaccine use on carriage and invasive potential in Native American communities
    Scott JR, Millar EV, Lipsitch M, Moulton LH, Weatherholtz R, Perilla MJ, Jackson DM, Beall B, Craig MJ, Reid R, Santosham M, O'Brien KL.
    J Infect Dis. 2012 Jan;205(2):280-8.

  445. Randomized trial of type 1 and type 3 oral monovalent poliovirus vaccines in newborns in Africa
    Waggie Z, Geldenhuys H, Sutter RW, Jacks M, Mulenga H, Mahomed H, De Kock M, Hanekom W, Pallansch MA, Kahn AL, Burton AH, Sreevatsava M, Hussey G.
    J Infect Dis. 2012 Jan;205(2):228-36.

  446. Hepatitis A vaccination coverage among adolescents in the United States
    Dorell CG, Yankey D, Byrd KK, Murphy TV.
    Pediatrics. 2012 Jan 23.

  447. Recommended adult immunization schedule: United States, 2012
    Advisory Committee on Immunization Practices..
    Ann Intern Med. 2012 Jan 31.

  448. Human papillomavirus vaccination practices among providers in Indian Health Service, Tribal and Urban Indian healthcare facilities
    Jim CC, Wai-Yin Lee J, Groom AV, Espey DK, Saraiya M, Holve S, Bullock A, Howe J, Thierry J.
    J Womens Health (Larchmt). 2012 Feb 6.

  449. Needlestick injury surveillance during mass vaccination clinics: lessons learned and why more is needed - Tri-County (Denver Metropolitan) region, Colorado, 2009
    Williams NJ, Ghosh TS, Vogt RL.
    Am J Infect Control. 2012 Feb 2.

  450. Remaining issues and challenges for rotavirus vaccine in preventing global childhood diarrheal morbidity and mortality
    Tate JE, Patel MM, Cortese MM, Lopman BA, Gentsch JR, Fleming J, Steele AD, Parashar UD.
    Expert Rev Vaccines. 2012 Feb;11(2):211-20.

  451. A cluster of nonspecific adverse events in a military reserve unit following pandemic influenza A (H1N1) 2009 vaccination - possible stimulated reporting?
    McNeil MM, Arana J, Stewart B, Hartshorn M, Hrncir D, Wang H, Lamias M, Locke M, Stamper J, Tokars JI, Engler RJ.
    Vaccine. 2012 Feb 3.

  452. Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants
    Shui IM, Baggs J, Patel M, Parashar UD, Rett M, Belongia EA, Hambidge SJ, Glanz JM, Klein NP, Weintraub E.
    JAMA. 2012 Feb 8;307(6):598-604.

  453. Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants
    Shui IM, Baggs J, Patel M, Parashar UD, Rett M, Belongia EA, Hambidge SJ, Glanz JM, Klein NP, Weintraub E.
    JAMA. 2012 Feb 8;307(6):598-604.

  454. Feasibility of initiating and sustaining registry-based immunization recall in private practices
    Dombkowski KJ, Cowan AE, Harrington LB, Allred NJ, Hudson E, Clark SJ.
    Acad Pediatr. 2012 Feb 7.

  455. Contribution of Immunization Weeks toward improving coverage, access to services, and completion of recommended childhood vaccinations in Assam, India
    Ryman TK, Trakroo A, Ekka JB, Watkins M.
    Vaccine. 2012 Feb 7.

  456. Improving the quality of immunization delivery to an at-risk population: a comprehensive approach
    Fu LY, Weissman M, McLaren R, Thomas C, Campbell J, Mbafor J, Doshi U, Cora-Bramble D.
    Pediatrics. 2012 Feb;129(2):e496-503.

  457. The concept of vaccination failure
    Heininger U, Bachtiar NS, Bahri P, Dana A, Dodoo A, Gidudu J, Santos EM.
    Vaccine. 2012 Feb 8;30(7):1265-8.

  458. Intent to receive HPV vaccine and reasons for not vaccinating among unvaccinated adolescent and young women: findings from the 2006-2008 National Survey of Family Growth
    Liddon NC, Hood J, Leichliter JS.
    Vaccine. 2012 Feb 15.

  459. Human papillomavirus vaccination history among women with precancerous cervical lesions: disparities and barriers
    Mehta NR, Julian PJ, Meek JI, Sosa LE, Bilinski A, Hariri S, Markowitz LE, Hadler JL, Niccolai LM.
    Obstet Gynecol. 2012 Mar;119(3):575-81.

  460. Building on success--potential to improve coverage of multiple health interventions through integrated delivery with routine childhood vaccination
    Anand A, Luman ET, O'Connor PM.
    J Infect Dis. 2012 Mar;205 Suppl 1:S28-39.

  461. Support for seasonal influenza vaccination requirements among US healthcare personnel
    Maurer J, Harris KM, Black CL, Euler GL.
    Infect Control Hosp Epidemiol. 2012 Mar;33(3):213-21.

  462. Novel genetic variation identified at fixed loci in ORF62 of the Oka varicella vaccine and in a case of vaccine-associated herpes zoster
    Quinlivan ML, Jensen NJ, Radford KW, Schmid DS.
    J Clin Microbiol. 2012 Feb 29.

  463. Persistence of hepatitis A vaccine induced seropositivity in infants and young children by maternal antibody status: 10-year follow-up
    Sharapov UM, Bulkow LR, Negus SE, Spradling PR, Homan C, Drobeniuc J, Bruce M, Kamili S, Hu DJ, McMahon BJ.
    Hepatology. 2012 Feb 28.

  464. Impact of integration of hygiene kit distribution with routine immunizations on infant vaccine coverage and water treatment and handwashing practices of Kenyan mothers
    Briere EC, Ryman TK, Cartwright E, Russo ET, Wannemuehler KA, Nygren BL, Kola S, Sadumah I, Ochieng C, Watkins ML, Quick R.
    J Infect Dis. 2012 Mar;205 Suppl 1:S56-64.

  465. Bridging the gap between data and public health needs. In the heat of a signal: responding to a vaccine safety signal for febrile seizures after 2010-11 influenza vaccine in young children, United States
    Broder KR, Martin DB, Vellozzi C.
    Vaccine. 2012 Mar 2;30(11):2032-4.

  466. Febrile seizures after 2010-2011 influenza vaccine in young children, United States: a vaccine safety signal from the Vaccine Adverse Event Reporting System
    Leroy Z, Broder K, Menschik D, Shimabukuro T, Martin D.
    Vaccine. 2012 Mar 2;30(11):2020-3.

  467. Building on success: should other health services be integrated into the immunization platform?
    Luman ET, Dietz V, Andrus JK, Binkin N.
    J Infect Dis. 2012 Mar;205 Suppl 1:NP.

  468. Prenatal care providers and influenza prevention and treatment: lessons from the field
    Mersereau PW, Layton CM, Smith LR, Kendrick JS, Mitchell EW, Amoozegar JB, Williams JL.
    Matern Child Health J. 2012 Feb;16(2):479-85.

  469. Adherence to expanded influenza immunization recommendations among primary care providers
    O'Leary ST, Crane LA, Wortley P, Daley MF, Hurley LP, Dong F, Stokley S, Babbel CI, Seewald L, Gahm C, Dickinson LM, Kempe A.
    J Pediatr. 2012 Mar;160(3):480-486 e1.

  470. Integration of routine vaccination and hygiene interventions: a comparison of 2 strategies in Kenya
    Ryman TK, Briere EC, Cartwright E, Schlanger K, Wannemuehler KA, Russo ET, Kola S, Sadumah I, Nygren BL, Ochieng C, Quick R, Watkins ML.
    J Infect Dis. 2012 Mar;205 Suppl 1:S65-76.

  471. Use of the emergency Incident Command System for school-located mass influenza vaccination clinics
    Fishbane M, Kist A, Schieber RA.
    Pediatrics. 2012 Mar;129 Suppl 2:S101-6.

  472. Perspectives of allergists/immunologists on the 2009-2010 H1N1 vaccination effort
    Clark SJ, Cowan AE, Wortley PM.
    J Asthma. 2012 Mar;49(2):184-9.

  473. Evolution of the pediatric influenza vaccination program in the United States
    Neuzil KM, Fiore AE, Schieber RA.
    Pediatrics. 2012 Mar;129 Suppl 2:S51-3.

  474. Early experience conducting school-located vaccination programs for seasonal influenza
    Schieber RA, Kennedy A, Kahn EB.
    Pediatrics. 2012 Mar;129 Suppl 2:S68-74.

  475. Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010-2011
    Tse A, Tseng HF, Greene SK, Vellozzi C, Lee GM.
    Vaccine. 2012 Mar 2;30(11):2024-2031.

  476. Epilogue: School-located influenza vaccination during the 2009-2010 pandemic and beyond
    Vogt TM, Wortley PM.
    Pediatrics. 2012 Mar;129 Suppl 2:S107-9.

  477. Recurrent Guillain-Barre syndrome following vaccination
    Baxter R, Lewis N, Bakshi N, Vellozzi C, Klein NP.
    Clin Infect Dis. 2012 Mar;54(6):800-804.

  478. Inching toward a serogroup B meningococcal vaccine for infants
    Cohn AC, Messonnier NE.
    JAMA. 2012 Feb 8;307(6):614-5.

  479. Elicitation of anti-1918 influenza virus immunity early in life prevents morbidity and lower levels of lung infection by 2009 pandemic H1N1 influenza virus in aged mice
    Giles BM, Bissel SJ, Craigo JK, Dealmeida DR, Wiley CA, Tumpey TM, Ross TM.
    J Virol. 2012 Feb;86(3):1500-13.

  480. Cost-effectiveness of adult vaccination strategies using pneumococcal conjugate vaccine compared with pneumococcal polysaccharide vaccine
    Smith KJ, Wateska AR, Nowalk MP, Raymund M, Nuorti JP, Zimmerman RK.
    JAMA. 2012 Feb 22;307(8):804-12.

  481. Lack of interference by zoster vaccine with the immune response to yellow fever vaccine
    Stier DM, Weber IB, Staples JE.
    J Travel Med. 2012 Mar;19(2):122-3.

  482. The risk of Guillain-Barre syndrome associated with influenza A (H1N1) 2009 monovalent vaccine and 2009-2010 seasonal influenza vaccines: results from self-controlled analyses
    Tokars JI, Lewis P, Destefano F, Wise M, Viray M, Morgan O, Gargiullo P, Vellozzi C.
    Pharmacoepidemiol Drug Saf. 2012 Mar 8.

  483. Potential intussusception risk versus health benefits from rotavirus vaccination in Latin America
    Desai R, Parashar UD, Lopman B, Helena de Oliveira L, Clark AD, Sanderson CF, Tate JE, Matus CR, Andrus JK, Patel MM.
    Clin Infect Dis. 2012 Mar 19.

  484. Hepatitis B vaccination of susceptible elderly residents of long term care facilities during a hepatitis B outbreak
    Williams RE, Sena AC, Moorman AC, Moore ZS, Sharapov UM, Drobenuic J, Hu DJ, Wood HW, Xing J, Spradling PR.
    Vaccine. 2012 Mar 12.

  485. Expanding the recommendations for annual influenza vaccination to school-age children in the United States
    Fiore AE, Epperson S, Perrotta D, Bernstein H, Neuzil K.
    Pediatrics. 2012 Mar;129 Suppl 2:S54-62.

  486. Postlicensure safety surveillance for high-dose trivalent inactivated influenza vaccine in the Vaccine Adverse Event Reporting System, 1 July 2010-31 December 2010
    Moro PL, Arana J, Cano M, Menschik D, Yue X, Lewis P, Haber P, Martin D, Broder K.
    Clin Infect Dis. 2012 Mar 22.

  487. Attitudes of pediatricians and primary health center physicians in India concerning routine immunization, barriers to vaccination, and missed opportunities to vaccinate
    Gargano LM, Thacker N, Choudhury P, Weiss PS, Pazol K, Bahl S, Jafari HS, Arora M, Orenstein WA, Hughes JM, Omer SB.
    Pediatr Infect Dis J. 2012 Feb;31(2):e37-42.

  488. A comparison of parent and provider reported influenza vaccination status of adolescents
    Lu PJ, Dorell C, Yankey D, Santibanez TA, Singleton JA.
    Vaccine. 2012 Mar 20.

  489. Vaccination with Haemophilus influenzae type b conjugate vaccine reduces bacterial meningitis in Morocco
    Braikat M, Barkia A, Mdaghri NE, Rainey JJ, Cohen AL, Teleb N.
    Vaccine. 2012 Mar 28;30(15):2594-9.

  490. Measles-containing vaccines and febrile seizures in children age 4 to 6 years
    Klein NP, Lewis E, Baxter R, Weintraub E, Glanz J, Naleway A, Jackson LA, Nordin J, Lieu T, Belongia EA, Fireman B.
    Pediatrics. 2012 Apr 2.

  491. Baseline hepatitis B vaccination coverage among persons with diabetes before implementing a U.S. recommendation for vaccination
    Byrd KK, Lu PJ, Murphy TV.
    Vaccine. 2012 Mar 31.

  492. Measles-containing vaccines and febrile seizures in children age 4 to 6 years
    Klein NP, Lewis E, Baxter R, Weintraub E, Glanz J, Naleway A, Jackson LA, Nordin J, Lieu T, Belongia EA, Fireman B.
    Pediatrics. 2012 Apr 2.

  493. Pertussis control: time for something new?
    Clark TA, Messonnier NE, Hadler SC.
    Trends Microbiol. 2012 Apr 9.

  494. Comparative tuberculosis (TB) prevention effectiveness in children of Bacillus Calmette-Guerin (BCG) vaccines from different sources, Kazakhstan
    Favorov M, Ali M, Tursunbayeva A, Aitmagambetova I, Kilgore P, Ismailov S, Chorba T.
    PLoS One. 2012 ;7(3):e32567.

  495. Impact of preexisting adenovirus vector immunity on immunogenicity and protection conferred with an adenovirus-based H5N1 influenza vaccine
    Pandey A, Singh N, Vemula SV, Couetil L, Katz JM, Donis R, Sambhara S, Mittal SK.
    PLoS One. 2012 ;7(3):e33428.

  496. Improved equity in measles vaccination from integrating insecticide-treated bednets in a vaccination campaign, Madagascar
    Goodson JL, Kulkarni MA, Vanden Eng JL, Wannemuehler KA, Cotte AH, Desrochers RE, Randriamanalina B, Luman ET.
    Trop Med Int Health. 2012 Jan 24.

  497. Perspectives of pulmonologists on the 2009-2010 H1N1 vaccination effort
    Clark SJ, Cowan AE, Wortley PM.
    Pulm Med. 2012 ;2012:306207.

  498. Immunosenescence and challenges of vaccination against influenza in the aging population
    Reber AJ, Chirkova T, Kim JH, Cao W, Biber R, Shay DK, Sambhara S.
    Aging Dis. 2012 Feb;3(1):68-90.

  499. Immunization site pain: case definition and guidelines for collection, analysis, and presentation of immunization safety data
    Gidudu JF, Walco GA, Anna Taddio A, Zempsky WT, Halperin SA, Calugar A, Gibbs NA, Hennig R, Jovancevic M, Netterlid E, O'Connor T, Oleske JM, Varricchio F, Tsai TF, Seifert H, Schuind AE.
    Vaccine. 2012 Apr 17.

  500. Immunogenicity of one dose of Vero cell culture-derived Japanese encephalitis (JE) vaccine in adults previously vaccinated with mouse brain-derived JE vaccine
    Woolpert T, Staples JE, Faix DJ, Nett RJ, Kosoy OI, Biggerstaff BJ, Johnson BW, Sracic M, Fischer M.
    Vaccine. 2012 Apr 26;30(20):3090-6.

  501. Efficacy of pentavalent rotavirus vaccine in a high HIV prevalence population in Kenya
    Feikin DR, Laserson KF, Ojwando J, Nyambane G, Ssempijja V, Audi A, Nyakundi D, Oyieko J, Dallas MJ, Ciarlet M, Neuzil KM, Breiman RF.
    Vaccine. 2012 Apr 27;30 Suppl 1:A52-60.

  502. Does Tdap vaccination interfere with serodiagnosis of pertussis infection?
    Pawloski LC, Kirkland KB, Baughman AL, Martin MD, Talbot EA, Messonnier NE, Tondella ML.
    Clin Vaccine Immunol. 2012 Apr 25.

  503. Seasonal trivalent inactivated influenza vaccine protects against 1918 Spanish influenza virus in ferrets
    Pearce MB, Belser JA, Gustin KM, Pappas C, Houser KV, Sun X, Maines TR, Pantin-Jackwood MJ, Katz JM, Tumpey TM.
    J Virol. 2012 May 2.

  504. Analyses of health outcomes from the 5 sites participating in the Africa and Asia clinical efficacy trials of the oral pentavalent rotavirus vaccine
    Breiman RF, Zaman K, Armah G, Sow SO, Anh DD, Victor JC, Hille D, Ciarlet M, Neuzil KM.
    Vaccine. 2012 Apr 27;30 Suppl 1:A24-9.

  505. In the heat of a signal: responding to a vaccine safety signal for febrile seizures after 2010-11 influenza vaccine in young children, United States
    Broder KR, Martin DB, Vellozzi C.
    Vaccine. 2012 Mar 2;30(11):2032-4.

  506. Impact of rotavirus vaccine on diarrhea-associated disease burden among American Indian and Alaska Native children
    Desai R, Haberling D, Holman RC, Singleton RJ, Cheek JE, Groom AV, Steiner CA, Parashar UD, Esposito DH.
    Pediatrics. 2012 Apr;129(4):e907-13.

  507. Safety of the pentavalent rotavirus vaccine (PRV), RotaTeq(R), in Kenya, including among HIV-infected and HIV-exposed infants
    Laserson KF, Nyakundi D, Feikin DR, Nyambane G, Cook E, Oyieko J, Ojwando J, Rivers SB, Ciarlet M, Neuzil KM, Breiman RF.
    Vaccine. 2012 Apr 27;30 Suppl 1:A61-70.

  508. Uptake of pneumococcal polysaccharide vaccination among working-age adults with underlying medical conditions, United States, 2009
    Lu PJ, Nuorti JP.
    Am J Epidemiol. 2012 Apr 15;175(8):827-37.

  509. Reported adverse events in young women following quadrivalent human papillomavirus vaccination
    Naleway AL, Gold R, Drew L, Riedlinger K, Henninger ML, Gee J.
    J Womens Health (Larchmt). 2012 Apr;21(4):425-32.

  510. Influence of oral polio vaccines on performance of the monovalent and pentavalent rotavirus vaccines
    Patel M, Steele AD, Parashar UD.
    Vaccine. 2012 Apr 27;30 Suppl 1:A30-5.

  511. A rare event: a measles outbreak in a highly vaccinated two-dose population
    Seward JF, Orenstein WA.
    Clin Infect Dis. 2012 Apr 27.

  512. Research priorities regarding rotavirus vaccine and intussusception: a meeting summary
    Tate JE, Steele AD, Bines JE, Zuber PL, Parashar UD.
    Vaccine. 2012 Apr 27;30 Suppl 1:A179-84.

  513. Trends in intussusception hospitalizations among US infants before and after implementation of the rotavirus vaccination program, 2000-2009
    Yen C, Tate JE, Steiner CA, Cortese MM, Patel MM, Parashar UD.
    J Infect Dis. 2012 Apr 26.

  514. A dose-escalation safety and immunogenicity study of a new live attenuated human rotavirus vaccine (Rotavin-M1) in Vietnamese children
    Anh DD, Van Trang N, Thiem VD, Anh NT, Mao ND, Wang Y, Jiang B, Hien ND, Luan LT.
    Vaccine. 2012 27 Apr;30 Suppl 1:A114-A121.

  515. Immunogenicity of the pentavalent rotavirus vaccine in African infants
    Armah GE, Breiman RF, Tapia MD, Dallas MJ, Neuzil KM, Binka FN, Sow SO, Ojwando J, Ciarlet M, Steele AD.
    Vaccine. 2012 Apr 27;30 Suppl 1:A86-93.

  516. Middle school vaccination requirements and adolescent vaccination coverage
    Bugenske E, Stokley S, Kennedy A, Dorell C.
    Pediatrics. 2012 May 7.

  517. Effectiveness and cost of immunization recall at school-based health centers
    Kempe A, Barrow J, Stokley S, Saville A, Glazner JE, Suh C, Federico S, Abrams L, Seewald L, Beaty B, Daley MF, Dickinson LM.
    Pediatrics. 2012 May 7.

  518. Neonatal vaccine-strain varicella zoster virus infection 22 days after maternal post-partum vaccination
    Kluthe M, Herrera A, Blanca H, Leung J, Bialek SR, Schmid DS.
    Pediatr Infect Dis J. 2012 May 8.

  519. Effectiveness and net cost of reminder/recall for adolescent immunizations
    Suh CA, Saville A, Daley MF, Glazner JE, Barrow J, Stokley S, Dong F, Beaty B, Dickinson LM, Kempe A.
    Pediatrics. 2012 May 7.

  520. Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011-2030
    Atherly DE, Lewis KD, Tate J, Parashar UD, Rheingans RD.
    Vaccine. 2012 Apr 27;30 Suppl 1:A7-A14.

  521. Systematic review of regional and temporal trends in global rotavirus strain diversity in the pre rotavirus vaccine era: insights for understanding the impact of rotavirus vaccination programs
    Banyai K, Laszlo B, Duque J, Steele AD, Nelson EA, Gentsch JR, Parashar UD.
    Vaccine. 2012 Apr 27;30 Suppl 1:A122-30.

  522. Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data
    Gershman MD, Staples JE, Bentsi-Enchill AD, Breugelmans JG, Brito GS, Bastoscamacho LA, Cottin P, Domingo C, Durbin A, Gascon J, Guenaneche F, Hayes EB, Jelenik Z, Khromava A, Martins RD, Wilson MM, Massy N, Nasidi A, Niedrig M, Sherwat A, Tsai T, Vilella A, Wilson ME, Kohl KS.
    Vaccine. 2012 May 3.

  523. Parental and societal values for the risks and benefits of childhood combination vaccines
    Gidengil C, Lieu TA, Payne K, Rusinak D, Messonnier M, Prosser LA.
    Vaccine. 2012 May 14;30(23):3445-52.

  524. Rotavirus vaccines for children in developing countries: understanding the science, maximizing the impact, and sustaining the effort
    Neuzil KM, Parashar UD, Steele AD.
    Vaccine. 2012 Apr 27;30 Suppl 1:A1-2.

  525. Workshop on intussusception in African countries - meeting report
    Steele AD, Patel M, Cunliffe NA, Bresee JS, Borgstein E, Parashar UD.
    Vaccine. 2012 Apr 27;30 Suppl 1:A185-9.

  526. Secondary efficacy endpoints of the pentavalent rotavirus vaccine against gastroenteritis in sub-Saharan Africa
    Tapia MD, Armah G, Breiman RF, Dallas MJ, Lewis KD, Sow SO, Rivers SB, Levine MM, Laserson KF, Feikin DR, Victor JC, Ciarlet M, Neuzil KM, Steele AD.
    Vaccine. 2012 Apr 27;30 Suppl 1:A79-85.

  527. Middle school vaccination requirements and adolescent vaccination coverage
    Bugenske E, Stokley S, Kennedy A, Dorell C.
    Pediatrics. 2012 May 7.

  528. Effectiveness and cost of immunization recall at school-based health centers
    Kempe A, Barrow J, Stokley S, Saville A, Glazner JE, Suh C, Federico S, Abrams L, Seewald L, Beaty B, Daley MF, Dickinson LM.
    Pediatrics. 2012 May 7.

  529. Effectiveness and net cost of reminder/recall for adolescent immunizations
    Suh CA, Saville A, Daley MF, Glazner JE, Barrow J, Stokley S, Dong F, Beaty B, Dickinson LM, Kempe A.
    Pediatrics. 2012 May 7.

  530. Analysis of variola and vaccinia neutralization assays for smallpox vaccines
    Hughes CM, Newman FK, Davidson WB, Olson VA, Smith SK, Holman RC, Yan L, Frey SE, Belshe RB, Karem KL, Damon IK.
    Clin Vaccine Immunol. 2012 May 16.

  531. Completion of the human papillomavirus vaccine series among insured females between 2006 and 2009
    Hirth JM, Tan A, Wilkinson GS, Berenson AB.
    Cancer. 2012 Apr 27.

  532. Effects of immunizing school children with 2009 influenza A (H1N1) monovalent vaccine on absenteeism among students and teachers in Maine
    Graitcer SB, Dube NL, Basurto-Davila R, Smith PF, Ferdinands J, Thompson M, Uzicanin A, Gargiullo P, Chaves SS, Robinson S, Sears S, Tipton M, Monto AS, Mills D, Shay DK.
    Vaccine. 2012 May 17.

  533. Trends in vaccination coverage disparities among children, United States, 2001-2010
    Zhao Z, Smith PJ.
    Vaccine. 2012 May 15.

  534. Serologic testing for protection against hepatitis B virus infection among students at a health sciences university in the United States
    Spradling PR, Williams RE, Xing J, Soyemi K, Towers J.
    Infect Control Hosp Epidemiol. 2012 Jul;33(7):732-6.

  535. Effectively introducing a new meningococcal A conjugate vaccine in Africa: the Burkina Faso experience
    Djingarey MH, Barry R, Bonkoungou M, Tiendrebeogo S, Sebgo R, Kandolo D, Lingani C, Preziosi MP, Zuber PL, Perea W, Hugonnet S, Dellepiane de Rey Tolve N, Tevi-Benissan C, Clark TA, Mayer LW, Novak R, Messonier NE, Berlier M, Toboe D, Nshimirimana D, Mihigo R, Aguado T, Diomande F, Kristiansen PA, Caugant DA, Laforce FM.
    Vaccine. 2012 Apr 30;30 Suppl 2:B40-5.

  536. Single-dose immunization with virus replicon particles confers rapid robust protection against Rift Valley fever virus challenge
    Dodd KA, Bird BH, Metcalfe MG, Nichol ST, Albarino CG.
    J Virol. 2012 Apr;86(8):4204-12.

  537. Measles outbreak in Burkina Faso, 2009: a case-control study to determine risk factors and estimate vaccine effectiveness
    Kidd S, Ouedraogo B, Kambire C, Kambou JL, McLean H, Kutty PK, Ndiaye S, Fall A, Alleman M, Wannemuehler K, Masresha B, Goodson JL, Uzicanin A.
    Vaccine. 2012 May 28.

  538. Association between obesity and vulnerability and serologic response to influenza vaccination in older adults
    Talbot HK, Coleman LA, Crimin K, Zhu Y, Rock MT, Meece J, Shay DK, Belongia EA, Griffin MR.
    Vaccine. 2012 Jun 6;30(26):3937-43.

  539. Timing of hepatitis B vaccination and impact of non-simultaneous vaccination with DTP vaccine following introduction of a hepatitis B birth dose in the Philippines
    Wallace AS, Sobel H, Ryman TK, Mantaring Iii JB, Silvestre M, Thorley M, Ducusin J, Nyunt US.
    J Public Health Policy. 2012 Jun 7.

  540. Patterns in influenza antiviral medication use before and during the 2009 H1N1 pandemic, Vaccine Safety Datalink Project, 2000-2010
    Greene SK, Shay DK, Yin R, McCarthy NL, Baxter R, Jackson ML, Jacobsen SJ, Nordin JD, Irving SA, Naleway AL, Glanz JM, Lieu TA.
    Influenza Other Respi Viruses. 2012 Jun 11.

  541. Cost comparison of 2 mass vaccination campaigns against influenza A H1N1 in New York City
    Kansagra SM, McGinty MD, Morgenthau BM, Marquez ML, Rosselli-Fraschilla A, Zucker JR, Farley TA.
    Am J Public Health. 2012 Jul;102(7):1378-83.

  542. 2009 pandemic influenza A vaccination of pregnant women-King County, Washington State, 2009-2010
    Kay MK, Koelemay KG, Kwan-Gett TS, Cadwell BL, Duchin JS.
    Am J Public Health. 2012 Jun;102 Suppl 3:S368-74.

  543. Broad neutralization of wild-type dengue virus isolates following immunization in monkeys with a tetravalent dengue vaccine based on chimeric yellow fever 17D/dengue viruses
    Barban V, Munoz-Jordan JL, Santiago GA, Mantel N, Girerd Y, Gulia S, Claude JB, Lang J.
    Virology. 2012 Aug 1;429(2):91-8.

  544. Effectiveness of 1 dose of 2009 influenza A (H1N1) vaccine at preventing hospitalization with pandemic H1N1 influenza in children aged 7 months-9 years
    Hadler JL, Baker TN, Papadouka V, France AM, Zimmerman C, Livingston KA, Zucker JR.
    J Infect Dis. 2012 Jul;206(1):49-55.

  545. Risk of confirmed Guillain-Barre syndrome following receipt of monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the Vaccine Safety Datalink Project, 2009-2010
    Greene SK, Rett M, Weintraub ES, Li L, Yin R, Amato AA, Ho DT, Sheikh SI, Fireman BH, Daley MF, Belongia EA, Jacobsen SJ, Baxter R, Lieu TA, Kulldorff M, Vellozzi C, Lee GM.
    Am J Epidemiol. 2012 Jun 1;175(11):1100-9.

  546. Provider perceptions of barriers and facilitators of HPV vaccination in a high-risk community
    Javanbakht M, Stahlman S, Walker S, Gottlieb S, Markowitz L, Liddon N, Plant A, Guerry S.
    Vaccine. 2012 Jun 22;30(30):4511-6.

  547. Increased immunogenicity of avian influenza DNA vaccine delivered to the skin using a microneedle patch
    Kim YC, Song JM, Lipatov AS, Choi SO, Lee JW, Donis RO, Compans RW, Kang SM, Prausnitz MR.
    Eur J Pharm Biopharm. 2012 Jun;81(2):239-47.

  548. Guillain-Barre syndrome during the 2009-2010 H1N1 influenza vaccination campaign: population-based surveillance among 45 million Americans
    Wise ME, Viray M, Sejvar JJ, Lewis P, Baughman AL, Connor W, Danila R, Giambrone GP, Hale C, Hogan BC, Meek JI, Murphree R, Oh JY, Reingold A, Tellman N, Conner SM, Singleton JA, Lu PJ, Destefano F, Fridkin SK, Vellozzi C, Morgan OW.
    Am J Epidemiol. 2012 Jun 1;175(11):1110-9.

  549. Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women
    Zheteyeva YA, Moro PL, Tepper NK, Rasmussen SA, Barash FE, Revzina NV, Kissin D, Lewis PW, Yue X, Haber P, Tokars JI, Vellozzi C, Broder KR.
    Am J Obstet Gynecol. 2012 Jul;207(1):59 e1-7.

  550. Post-licensure experience with rotavirus vaccination in high and middle income countries; 2006 to 2011
    Lopman BA, Payne DC, Tate JE, Patel MM, Cortese MM, Parashar UD.
    Curr Opin Virol. 2012 Jun 29.

  551. Influenza vaccination in the 2009-2010 pandemic season: the experience of primary care physicians
    O'Leary ST, Stokley S, Crane LA, Allison MA, Hurley LP, Wortley P, Babbel CI, Beaty BL, Gahm C, Kempe A.
    Prev Med. 2012 Jul;55(1):68-71.

  552. Fulfilling the promise of rotavirus vaccines: how far have we come since licensure?
    Patel MM, Glass R, Desai R, Tate JE, Parashar UD.
    Lancet Infect Dis. 2012 Jul;12(7):561-70.

  553. A genome-wide association study of host genetic determinants of the antibody response to Anthrax Vaccine Adsorbed
    Pajewski NM, Shrestha S, Quinn CP, Parker SD, Wiener H, Aissani B, McKinney BA, Poland GA, Edberg JC, Kimberly RP, Tang J, Kaslow RA.
    Vaccine. 2012 Jul 6;30(32):4778-84.

  554. Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data
    Novak RT, Kambou JL, Diomande FV, Tarbangdo TF, Ouedraogo-Traore R, Sangare L, Lingani C, Martin SW, Hatcher C, Mayer LW, Laforce FM, Avokey F, Djingarey MH, Messonnier NE, Tiendrebeogo SR, Clark TA.
    Lancet Infect Dis. 2012 Jul 17.

  555. Assessing the interest to participate in a dengue vaccine efficacy trial among residents of Puerto Rico
    Guerra CL, Rodriguez-Acosta R, Soto-Gomez E, Zielinski-Gutierrez E, Pena-Orellana M, Santiago L, Rivera R, Cruz RR, Ramirez V, Tomashek K, Dayan G.
    Hum Vaccin Immunother. 2012 Jul 1;8(7).

  556. Frequency of alternative immunization schedule use in a metropolitan area
    Robison SG, Groom H, Young C.
    Pediatrics. 2012 Jul;130(1):32-8.

  557. Health-related quality of life in the CDC Human Anthrax Vaccine Adsorbed Clinical Trial
    Stewart B, Rose CE, Tokars JI, Martin SW, Keitel WA, Keyserling HL, Babcock J, Parker SD, Jacobson RM, Poland GA, McNeil MM.
    Vaccine. 2012 Jul 16.

  558. A varicella outbreak in a school with high one-dose vaccination coverage, Beijing, China
    Lu L, Suo L, Li J, Zhai L, Zheng Q, Pang X, Bialek SR, Wang C.
    Vaccine. 2012 Jul 20;30(34):5094-8.

  559. Antibody persistence in mothers one year after pneumococcal immunization in pregnancy
    Schlaudecker EP, Steinhoff MC, Omer SB, Roy E, Arifeen SE, Dodd CN, Altaye M, Raqib R, Breiman RF, Zaman K.
    Vaccine. 2012 Jul 20;30(34):5063-6.

  560. A qualitative analysis of vaccine safety perceptions and concerns among caretakers in Uganda
    Braka F, Asiimwe D, Soud F, Lewis RF, Makumbi I, Gust D.
    Matern Child Health J. 2012 Jul;16(5):1045-52.

  561. Knowledge, attitude, and practices about the seasonal influenza vaccination among healthcare workers in Srinagar, India
    Bali NK, Ashraf M, Ahmad F, Khan UH, Widdowson MA, Lal RB, Koul PA.
    Influenza Other Respi Viruses. 2012 Aug 2.

  562. Haemophilus influenzae type B disease and vaccine booster dose deferral, United States, 1998-2009
    Briere EC, Jackson M, Shah SG, Cohn AC, Anderson RD, Macneil JR, Coronado FM, Mayer LW, Clark TA, Messonnier NE.
    Pediatrics. 2012 Aug 6.

  563. An assessment of the screening method to evaluate vaccine effectiveness: the case of 7-valent pneumococcal conjugate vaccine in the United States
    Cohen AL, Taylor T, Farley MM, Schaffner W, Lesher LJ, Gershman KA, Bennett NM, Reingold A, Thomas A, Baumbach J, Harrison LH, Petit S, Beall B, Zell E, Moore M.
    PLoS One. 2012 ;7(8):e41785.

  564. Variation in adult vaccination policies across Europe: an overview from VENICE network on vaccine recommendations, funding and coverage
    Kanitz EE, Wu LA, Giambi C, Strikas RA, Levy-Bruhl D, Stefanoff P, Mereckiene J, Appelgren E, D'Ancona F.
    Vaccine. 2012 Jul 27;30(35):5222-8.

  565. Estimating the effectiveness of acellular pertussis vaccines
    Misegades LK, Martin SW, Messonnier NE, Clark TA.
    Clin Infect Dis. 2012 Aug 7.

  566. Rotavirus vaccination programmes
    Patel MM.
    BMJ. 2012 ;345:e5286.

  567. Parental views of school-located delivery of adolescent vaccines
    Kelminson K, Saville A, Seewald L, Stokley S, Dickinson LM, Daley MF, Suh C, Kempe A.
    J Adolesc Health. 2012 Aug;51(2):190-6.

  568. Understanding reduced rotavirus vaccine efficacy in low socio-economic settings
    Lopman BA, Pitzer VE, Sarkar R, Gladstone B, Patel M, Glasser J, Gambhir M, Atchison C, Grenfell BT, Edmunds WJ, Kang G, Parashar UD.
    PLoS One. 2012 ;7(8):e41720.

  569. Challenges in confirming a varicella outbreak in the two-dose vaccine era
    Mahamud A, Wiseman R, Grytdal S, Basham C, Asghar J, Dang T, Leung J, Lopez A, Schmid DS, Bialek SR.
    Vaccine. 2012 Aug 7.

  570. Persistence of hepatitis A vaccine induced seropositivity in infants and young children by maternal antibody status: 10-year follow-up
    Sharapov UM, Bulkow LR, Negus SE, Spradling PR, Homan C, Drobeniuc J, Bruce M, Kamili S, Hu DJ, McMahon BJ.
    Hepatology. 2012 ;56(2):516-522.

  571. Progressive vaccinia: case description and laboratory-guided therapy with vaccinia immune globulin, ST-246 and CMX001
    Lederman ER, Davidson W, Groff HL, Smith SK, Warkentien T, Li Y, Wilkins KA, Karem KL, Akondy RS, Ahmed R, Frace M, Shieh WJ, Zaki S, Hruby DE, Painter WP, Bergman KL, Cohen JI, Damon IK.
    J Infect Dis. 2012 Aug 16.

  572. H1N1 and seasonal influenza vaccination of U.S. healthcare personnel, 2010
    Lu PJ, Ding H, Black CL.
    Am J Prev Med. 2012 Sep;43(3):282-92.

  573. 7-valent pneumococcal conjugate vaccine and otitis media: effectiveness of a 2-dose versus 3-dose primary series
    Stoecker C, Hampton LM, Moore MR.
    Vaccine. 2012 Aug 17.

  574. Potential intussusception risk versus benefits of rotavirus vaccination in the United States
    Desai R, Cortese MM, Meltzer MI, Shankar M, Tate JE, Yen C, Patel MM, Parashar UD.
    Pediatr Infect Dis J. 2012 Aug 27.

  575. A three dose intramuscular schedule of anthrax vaccine adsorbed generates sustained humoral and cellular immune responses to protective antigen and provides long term protection against inhalation anthrax in rhesus macaques
    Quinn CP, Sabourin CL, Niemuth NA, Li H, Semenova VA, Rudge TL, Mayfield HJ, Schiffer J, Mittler RS, Ibegbu CC, Wrammert J, Ahmed R, Brys AM, Hunt RE, Levesque D, Estep JE, Barnewall RE, Robinson DM, Plikaytis BD, Marano N.
    Clin Vaccine Immunol. 2012 Aug 29.

  576. Health-related quality of life in the CDC Anthrax Vaccine Adsorbed Human Clinical Trial
    Stewart B, Rose CE, Tokars JI, Martin SW, Keitel WA, Keyserling HL, Babcock J, Parker SD, Jacobson RM, Poland GA, McNeil MM.
    Vaccine. 2012 Aug 31;30(40):5875-9.

  577. The impact of new vaccine introduction on immunization and health systems: a review of the published literature
    Hyde T, Dentz H, Wang S, Burchett H, Mounier-Jack S, Mantel C.
    Vaccine. 2012 Aug 28.

  578. Benefits of influenza vaccination during pregnancy for pregnant women
    Jamieson DJ, Kissin DM, Bridges CB, Rasmussen SA.
    Am J Obstet Gynecol. 2012 Sep;207(3 Suppl):S17-20.

  579. Involvement of endocrinologists in the 2009 to 2010 H1N1 vaccination effort
    Clark SJ, Cowan AE, Wortley PM.
    Endocr Pract. 2012 Jul 1;18(4):464-71.

  580. Algorithm to assess causality after individual adverse events following immunizations
    Halsey NA, Edwards KM, Dekker CL, Klein NP, Baxter R, Larussa P, Marchant C, Slade B, Vellozzi C.
    Vaccine. 2012 Aug 24;30(39):5791-5798.

  581. Monitoring seasonal influenza vaccination coverage among pregnant women in the United States
    Kennedy ED, Ahluwalia IB, Ding H, Lu PJ, Singleton JA, Bridges CB.
    Am J Obstet Gynecol. 2012 Sep;207(3 Suppl):S9-S16.

  582. Duration of protection of pentavalent rotavirus vaccination in Nicaragua
    Patel M, Pedreira C, De Oliveira LH, Umana J, Tate J, Lopman B, Sanchez E, Reyes M, Mercado J, Gonzalez A, Perez MC, Balmaceda A, Andrus J, Parashar U.
    Pediatrics. 2012 Aug;130(2):e365-72.

  583. Perceptions matter: beliefs about influenza vaccine and vaccination behavior among elderly white, black and Hispanic Americans
    Wooten KG, Wortley PM, Singleton JA, Euler GL.
    Vaccine. 2012 Aug 30.

  584. Medical exemptions to school immunization requirements in the United States--association of state policies with medical exemption rates (2004-2011)
    Stadlin S, Bednarczyk RA, Omer SB.
    J Infect Dis. 2012 Aug 29.

  585. Compared to subcutaneous tenofovir, oral tenofovir disoproxyl fumarate administration preferentially concentrates the drug into gut-associated lymphoid cells in simian immunodeficiency virus-infected macaques
    Van Rompay KK, Babusis D, Abbott Z, Geng Y, Jayashankar K, Johnson JA, Lipscomb J, Heneine W, Abel K, Ray AS.
    Antimicrob Agents Chemother. 2012 Sep;56(9):4980-4.

  586. Strategies to alleviate original antigenic sin responses to influenza viruses
    Kim JH, Davis WG, Sambhara S, Jacob J.
    Proc Natl Acad Sci U S A. 2012 Aug 21;109(34):13751-6.

  587. Vaccine administration decision making: the case of yellow fever vaccine
    Lown BA, Chen LH, Wilson ME, Sisson E, Gershman M, Yanni E, Jentes ES, Hochberg NS, Hamer DH, Barnett ED.
    Clin Infect Dis. 2012 Sep;55(6):837-43.

  588. Prolonged tenofovir treatment of macaques infected with K65R reverse transcriptase mutants of SIV results in the development of antiviral immune responses that control virus replication after drug withdrawal
    Van Rompay KK, Trott KA, Jayashankar K, Geng Y, Labranche CC, Johnson JA, Landucci G, Lipscomb J, Tarara RP, Canfield DR, Heneine W, Forthal DN, Montefiori D, Abel K.
    Retrovirology. 2012 ;9:57.

  589. Genetic variation in the Plasmodium falciparum circumsporozoite protein in India and its relevance to RTS,S malaria vaccine
    Zeeshan M, Alam MT, Vinayak S, Bora H, Tyagi RK, Alam MS, Choudhary V, Mittra P, Lumb V, Bharti PK, Udhayakumar V, Singh N, Jain V, Singh PP, Sharma YD.
    PLoS One. 2012 ;7(8):e43430.

  590. The safety of adjuvants in influenza vaccines during pregnancy: what do we know and why do we need them?
    Jamieson DJ, Rasmussen SA.
    Am J Obstet Gynecol. 2012 Sep;207(3):145-6.

  591. Safety of seasonal influenza and influenza A (H1N1) 2009 monovalent vaccines in pregnancy
    Moro PL, Tepper NK, Grohskopf LA, Vellozzi C, Broder K.
    Expert Rev Vaccines. 2012 Aug;11(8):911-21.

  592. Improving influenza vaccines
    Sambhara S, Rappuoli R.
    Expert Rev Vaccines. 2012 Aug;11(8):871-2.

  593. The 13-valent pneumococcal conjugate vaccine for invasive pneumococcal disease in Alaska Native children: results of a clinical trial
    Singleton R, Wenger J, Klejka JA, Bulkow LR, Thompson A, Sarkozy D, Emini EA, Gruber WC, Scott DA.
    Pediatr Infect Dis J. 2012 Sep 20.

  594. Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains
    Treanor JJ, Talbot HK, Ohmit SE, Coleman LA, Thompson MG, Cheng PY, Petrie JG, Lofthus G, Meece JK, Williams JV, Berman L, Breese Hall C, Monto AS, Griffin MR, Belongia E, Shay DK.
    Clin Infect Dis. 2012 Oct;55(7):951-959.

  595. Anthrax vaccine-induced antibodies provide cross-species prediction of survival to aerosol challenge
    Fay MP, Follmann DA, Lynn F, Schiffer JM, Stark GV, Kohberger R, Quinn CP, Nuzum EO.
    Sci Transl Med. 2012 Sep 12;4(151):151ra126.

  596. Physician attitudes regarding school-located vaccinations
    McCormick EV, Durfee J, Vogt TM, Daley MF, Hambidge SJ, Shlay J.
    Pediatrics. 2012 Oct 1.

  597. Report on the international workshop on alternative methods for human and veterinary rabies vaccine testing: state of the science and planning the way forward
    Stokes W, McFarland R, Kulpa-Eddy J, Gatewood D, Levis R, Halder M, Pulle G, Kojima H, Casey W, Gaydamaka A, Miller T, Brown K, Lewis C, Chapsal JM, Bruckner L, Gairola S, Kamphuis E, Rupprecht CE, Wunderli P, McElhinney L, De Mattia F, Gamoh K, Hill R, Reed D, Doelling V, Johnson N, Allen D, Rinckel L, Jones B.
    Biologicals. 2012 Sep;40(5):369-81.

  598. Effectiveness of 1 dose of influenza A (H1N1) 2009 monovalent vaccines in preventing reverse-transcription polymerase chain reaction-confirmed H1N1 infection among school-aged children in Maine
    Uzicanin A, Thompson M, Smith P, Chaves SS, Foster L, Dube N, Graitcer S, Jackson R, Ferdinands J, Gargiullo P, Mills D, Monto AS, Shay DK.
    J Infect Dis. 2012 Oct;206(7):1059-1068.

  599. Adverse events following a third dose of measles, mumps, and rubella vaccine in a mumps outbreak
    Abedi GR, Mutuc JD, Lawler J, Leroy ZC, Hudson JM, Blog DS, Schulte CR, Rausch-Phung E, Ogbuanu IU, Gallagher K, Kutty PK.
    Vaccine. 2012 Oct 3.

  600. Immunogenicity and safety of a new meningococcal A conjugate vaccine in Indian children aged 2-10 years: a phase II/III double-blind randomized controlled trial
    Hirve S, Bavdekar A, Pandit A, Juvekar S, Patil M, Preziosi MP, Tang Y, Marchetti E, Martellet L, Findlow H, Elie C, Parulekar V, Plikaytis B, Borrow R, Carlone G, Kulkarni PS, Goel A, Suresh K, Beri S, Kapre S, Jadhav S, Preaud JM, Viviani S, Laforce FM.
    Vaccine. 2012 Oct 5;30(45):6456-60.

  601. WHO recommendations for the viruses to be used in the 2012 Southern Hemisphere influenza vaccine: epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from February to September 2011
    Klimov AI, Garten R, Russell C, Barr IG, Besselaar TG, Daniels R, Engelhardt OG, Grohmann G, Itamura S, Kelso A, McCauley J, Odagiri T, Smith D, Tashiro M, Xu X, Webby R, Wang D, Ye Z, Yuelong S, Zhang W, Cox N.
    Vaccine. 2012 Oct 5;30(45):6461-71.

  602. Monitoring of rotavirus vaccination in Morocco: establishing the baseline burden of rotavirus disease
    Benhafid M, Rguig A, Trivedi T, Elqazoui M, Teleb N, Mouane N, Maltouf AF, Parashar U, Patel M, Aouad RE.
    Vaccine. 2012 Oct 12;30(46):6515-20.

  603. Reducing the global burden of congenital rubella syndrome
    Reef SE, Chu SY, Cochi SL, Kezaala R, van den Ent M, Gay A, de Quadros C, Strebel PM.
    Lancet. 2012 Sep 29;380(9848):1145-6.

  604. Symptomatic infection and detection of vaccine and vaccine-reassortant rotavirus strains in 5 children: a case series
    Boom JA, Sahni LC, Payne DC, Gautam R, Lyde F, Mijatovic-Rustempasic S, Bowen MD, Tate JE, Rench MA, Gentsch JR, Parashar UD, Baker CJ.
    J Infect Dis. 2012 Oct;206(8):1275-9.

  605. Varicella vaccine uptake in Shandong Province, China
    Xu A, Xu Q, Fang X, Bialek S, Wang C.
    Hum Vaccin Immunother. 2012 Sep 1;8(9).

  606. Pneumococcal carriage and invasive disease in children before introduction of the 13-valent conjugate vaccine: comparison with the pre-7-valent conjugate vaccine era
    Sharma D, Baughman W, Holst A, Thomas S, Jackson D, Carvalho MD, Beall B, Satola S, Jerris R, Jain S, Farley MM, Nuorti JP.
    Pediatr Infect Dis J. 2012 Oct 17.

  607. Decline in gastroenteritis-related triage calls after rotavirus vaccine licensure
    Williams DJ, Edwards KM, Payne DC, Manning J, Parashar UD, Lopman BA.
    Pediatrics. 2012 Oct;130(4):e872-8.

  608. Removing the age restrictions for rotavirus vaccination: a benefit-risk modeling analysis
    Patel MM, Clark AD, Sanderson CF, Tate J, Parashar UD.
    PLoS Med. 2012 Oct;9(10):e1001330.

  609. Detection of anti-yellow fever virus immunoglobulin M antibodies at 3-4 years following yellow fever vaccination
    Gibney KB, Edupuganti S, Panella AJ, Kosoy OI, Delorey MJ, Lanciotti RS, Mulligan MJ, Fischer M, Staples JE.
    Am J Trop Med Hyg. 2012 Oct 29.

  610. Impact of a third dose of measles-mumps-rubella vaccine on a mumps outbreak
    Ogbuanu IU, Kutty PK, Hudson JM, Blog D, Abedi GR, Goodell S, Lawler J, McLean HQ, Pollock L, Rausch-Phung E, Schulte C, Valure B, Armstrong GL, Gallagher K.
    Pediatrics. 2012 Nov 5.

  611. Impact of human papillomavirus (HPV) vaccination on HPV 16/18-related prevalence in precancerous cervical lesions
    Powell SE, Hariri S, Steinau M, Bauer HM, Bennett NM, Bloch KC, Niccolai LM, Schafer S, Unger ER, Markowitz LE.
    Vaccine. 2012 Nov 5.

  612. The genetic match between vaccine strains and circulating seasonal influenza A viruses in Vietnam, 2001-2009
    Vuong CD, Hoang PM, Nguyen HL, Nguyen HT, Nguyen TC, Le TT, Dennis DT, Kapella BK, Kile JC, Le MQ.
    Influenza Other Respi Viruses. 2012 Nov 8.

  613. Vaccination coverage among American Indian and Alaska Native children, 2006-2010
    Groom AV, Santibanez TA, Bryan RT.
    Pediatrics. 2012 Nov 19.

  614. Influenza virus h5 DNA vaccination is immunogenic by intramuscular and intradermal routes in humans
    Ledgerwood JE, Hu Z, Gordon IJ, Yamshchikov G, Enama ME, Plummer S, Bailer R, Pearce MB, Tumpey TM, Koup RA, Mascola JR, Nabel GJ, Graham BS.
    Clin Vaccine Immunol. 2012 Nov;19(11):1792-7.

  615. Dose sparing and enhanced immunogenicity of inactivated rotavirus vaccine administered by skin vaccination using a microneedle patch
    Moon S, Wang Y, Edens C, Gentsch JR, Prausnitz MR, Jiang B.
    Vaccine. 2012 Nov 19.

  616. Long-term immune responses to Coxiella burnetii after vaccination
    Kersh GJ, Fitzpatrick KA, Self JS, Biggerstaff BJ, Massung RF.
    Clin Vaccine Immunol. 2012 Nov 28.

  617. Rules and tools that improved Vaccines for Children vaccine-ordering practices in Oregon: a 2010 pilot project
    Hewett R, Vancuren A, Trocio L, Beaudrault S, Gund A, Luther M, Groom H.
    J Public Health Manag Pract. 2013 Jan;19(1):9-15.

  618. Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010
    Misegades LK, Winter K, Harriman K, Talarico J, Messonnier NE, Clark TA, Martin SW.
    JAMA. 2012 Nov 28;308(20):2126-32.

  619. More evidence for use of pneumococcal conjugate vaccines
    Whitney CG.
    Lancet. 2012 Nov 15.

  620. Long-term immunogenicity of hepatitis A vaccine in Alaska 17 years after initial childhood series
    Raczniak GA, Bulkow L, Bruce MG, Zanis C, Baum R, Snowball M, Byrd KK, Sharapov UM, Hennessy TW, McMahon BJ.
    J Infect Dis. 2012 Nov 29.

  621. A randomized, double-blind, controlled trial of the 17D yellow fever virus vaccine given in combination with immune globulin or placebo: comparative viremia and immunogenicity
    Edupuganti S, Eidex RB, Keyserling H, Akondy RS, Lanciotti R, Orenstein W, Del Rio C, Pan Y, Querec T, Lipman H, Barrett A, Ahmed R, Teuwen D, Cetron M, Mulligan MJ.
    Am J Trop Med Hyg. 2012 Dec 3.

  622. Pandemic H1N1 influenza surveillance in Haiti, July-December 2009
    Fitter DL, Freeman NM, Buteau J, Magloire R, Sessions WM, Guo L, Katz MA, Boncy J.
    Influenza Other Respi Viruses. 2012 Nov 30.

  623. The potential economic value of a human norovirus vaccine for the United States
    Bartsch SM, Lopman BA, Hall AJ, Parashar UD, Lee BY.
    Vaccine. 2012 Nov 19;30(49):7097-104.

  624. Monitoring HPV vaccine impact: early results and ongoing challenges
    Hariri S, Markowitz L.
    J Infect Dis. 2012 Dec;206(11):1633-5.

  625. Human papillomavirus vaccine practices in the USA: do primary care providers use sexual history and cervical cancer screening results to make HPV vaccine recommendations?
    Kepka D, Berkowitz Z, Yabroff KR, Roland K, Saraiya M.
    Sex Transm Infect. 2012 Oct;88(6):433-5.

  626. Human papillomavirus vaccine introduction - the first five years
    Markowitz LE, Tsu V, Deeks SL, Cubie H, Wang SA, Vicari AS, Brotherton JM.
    Vaccine. 2012 Nov 20;30 Suppl 5:F139-48.

  627. Validity of vaccination cards and parental recall to estimate vaccination coverage: a systematic review of the literature
    Miles M, Ryman TK, Dietz V, Zell E, Luman ET.
    Vaccine. 2012 Nov 26.

  628. Causality assessment of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS)
    Loughlin AM, Marchant CD, Adams W, Barnett E, Baxter R, Black S, Casey C, Dekker C, Edwards KM, Klein J, Klein NP, Larussa P, Sparks R, Jakob K.
    Vaccine. 2012 Nov 26;30(50):7253-9.

  629. No risk of Guillain-Barre syndrome found after meningococcal conjugate vaccination in two large cohort studies
    Yih WK, Weintraub E, Kulldorff M.
    Pharmacoepidemiol Drug Saf. 2012 Dec;21(12):1359-60.

  630. The rotavirus experience in Mexico: discovery to control
    Patel MM, Parashar UD, Santosham M, Richardson V.
    Clin Infect Dis. 2012 Dec 27.

  631. Contribution of dendritic cells to measles virus induced immunosuppression
    Coughlin MM, Bellini WJ, Rota PA.
    Rev Med Virol. 2012 Dec 20.

  632. Influenza vaccination guidelines and vaccine sales in southeast Asia: 2008-2011
    Gupta V, Dawood FS, Muangchana C, Lan PT, Xeuatvongsa A, Sovann L, Olveda R, Cutter J, Oo KY, Ratih TS, Kheong CC, Kapella BK, Kitsutani P, Corwin A, Olsen SJ.
    PLoS One. 2012 ;7(12):e52842.

  633. Trivalent inactivated influenza vaccine and spontaneous abortion
    Irving SA, Kieke BA, Donahue JG, Mascola MA, Baggs J, Destefano F, Cheetham TC, Jackson LA, Naleway AL, Glanz JM, Nordin JD, Belongia EA.
    Obstet Gynecol. 2013 Jan;121(1):159-165.

  634. Seroprotection after recombinant hepatitis B vaccination among newborn infants: a review
    Schillie SF, Murphy TV.
    Vaccine. 2012 Dec 17.

  635. The feasibility of using mobile-phone based SMS reminders and conditional cash transfers to improve timely immunization in rural Kenya
    Wakadha H, Chandir S, Were EV, Rubin A, Obor D, Levine OS, Gibson DG, Odhiambo F, Laserson KF, Feikin DR.
    Vaccine. 2012 Dec 12.

  636. A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants
    RTS .
    N Engl J Med. 2012 Dec 13;367(24):2284-95.

  637. The first National Adult Immunization Summit 2012: implementing change through action
    Shen AK, Bridges CB, Tan L.
    Vaccine. 2013 Jan 2;31(2):279-84.

  638. Risk of fetal death after pandemic influenza virus infection or vaccination
    Haberg SE, Trogstad L, Gunnes N, Wilcox AJ, Gjessing HK, Samuelsen SO, Skrondal A, Cappelen I, Engeland A, Aavitsland P, Madsen S, Buajordet I, Furu K, Nafstad P, Vollset SE, Feiring B, Nokleby H, Magnus P, Stoltenberg C.
    N Engl J Med. 2013 Jan 16.

  639. Uptake of oral rotavirus vaccine and timeliness of routine immunization in Brazil's national immunization program
    Flannery B, Samad S, de Moraes JC, Tate JE, Danovaro-Holliday MC, de Oliveira LH, Rainey JJ.
    Vaccine. 2013 Jan 10.

  640. Immune response of hepatitis B vaccine among persons with diabetes: a systematic review of the literature
    Schillie SF, Spradling PR, Murphy TV.
    Diabetes Care. 2012 Dec;35(12):2690-7.

  641. A randomized trial of one versus two doses of influenza vaccine after allogeneic transplantation
    Karras NA, Weeres M, Sessions W, Xu X, Defor T, Young JA, Stefanski H, Brunstein C, Cooley S, Miller JS, Blazar BR, Wagner JE, Verneris MR.
    Biol Blood Marrow Transplant. 2013 Jan;19(1):109-16.

  642. Clinical assessment of serious adverse events in children receiving 2009 H1N1 vaccination
    Pahud BA, Williams SE, Dekker CL, Halsey N, Larussa P, Baxter RP, Klein NP, Marchant CD, Sparks RC, Jakob K, Aukes L, Swope S, Barnett E, Lewis P, Berger M, Dreskin SC, Donofrio PD, Sejvar JJ, Slade BA, Gidudu J, Vellozzi C, Edwards KM.
    Pediatr Infect Dis J. 2013 Feb;32(2):163-168.

  643. Estimation of the impact of a Japanese encephalitis immunization program with live, attenuated SA 14-14-2 vaccine in Nepal
    Upreti SR, Janusz K, Schluter WW, Bichha RP, Shakya G, Biggerstaff BJ, Shrestha MM, Sedai TR, Fischer M, Gibbons RV, Shrestha S, Hills SL.
    Am J Trop Med Hyg. 2013 Jan 28.

  644. Cost-effectiveness of hepatitis B vaccination in adults with diagnosed diabetes
    Hoerger TJ, Schillie S, Wittenborn JS, Bradley CL, Zhou F, Byrd K, Murphy TV.
    Diabetes Care. 2013 Jan;36(1):63-9.

  645. Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity
    Kristiansen PA, Diomande F, Ba AK, Sanou I, Ouedraogo AS, Ouedraogo R, Sangare L, Kandolo D, Ake F, Saga IM, Clark TA, Misegades L, Martin SW, Thomas JD, Tiendrebeogo SR, Hassan-King M, Djingarey MH, Messonnier NE, Preziosi MP, Laforce FM, Caugant DA.
    Clin Infect Dis. 2013 Feb;56(3):354-63.

  646. Associated factors for recommending HBV vaccination to children among Georgian health care workers
    Butsashvili M, Kamkamidze G, Topuridze M, Morse D, Triner W, Dehovitz J, Nelson K, McNutt LA.
    BMC Infect Dis. 2012 ;12:362.

  647. Safety of a tetanus-diphtheria-acellular pertussis vaccine when used off-label in an elderly population
    Tseng HF, Sy LS, Qian L, Marcy SM, Jackson LA, Glanz J, Nordin J, Baxter R, Naleway A, Donahue J, Weintraub E, Jacobsen SJ.
    Clin Infect Dis. 2013 Feb;56(3):315-321.

  648. Investigation of an outbreak of hypersensitivity-type reactions during the 2004 national measles-mumps-rubella vaccination campaign in Brazil
    Freitas DR, Moura E, Araujo G, Cardoso A, Scheidt P, Ferraz E, Madalosso G, Chen RT, Hatch DL.
    Vaccine. 2013 Jan 30;31(6):950-4.

  649. Narcolepsy as an adverse event following immunization: case definition and guidelines for data collection, analysis and presentation
    Poli F, Overeem S, Lammers GJ, Plazzi G, Lecendreux M, Bassetti CL, Dauvilliers Y, Keene D, Khatami R, Li Y, Mayer G, Nohynek H, Pahud B, Paiva T, Partinen M, Scammell TE, Shimabukuro T, Sturkenboom M, van Dinther K, Wiznitzer M, Bonhoeffer J.
    Vaccine. 2013 Jan 30;31(6):994-1007.

  650. Immunity to hepatitis B virus infection two decades after implementation of universal infant hepatitis B vaccination: the association of detectable residual antibody and response to a single hepatitis B vaccine challenge dose
    Spradling PR, Xing J, Williams R, Masunu-Faleafaga Y, Dulski T, Mahamud A, Drobeniuc J, Teshale EH.
    Clin Vaccine Immunol. 2013 Feb 13.

  651. Trends in national rotavirus activity before and after introduction of rotavirus vaccine into the National Immunization Program in the United States, 2000-2012
    Tate JE, Haynes A, Payne DC, Cortese MM, Lopman BA, Patel MM, Parashar UD.
    Pediatr Infect Dis J. 2013 Feb 19.

  652. Influenza A (H1N1) 2009 monovalent and seasonal influenza vaccination among adults 25 to 64 years of age with high-risk conditions-United States, 2010
    Lu PJ, Gonzalez-Feliciano A, Ding H, Bryan LN, Yankey D, Monsell EA, Greby SM, Euler GL.
    Am J Infect Control. 2013 Feb 15.

  653. Adoption of rotavirus vaccine by U.S. physicians: progress and challenges
    O'Leary ST, Parashar UD, Crane LA, Allison MA, Stokley S, Beaty BL, Brtnikova M, Hurley LP, Kempe A.
    Am J Prev Med. 2013 Jan;44(1):56-62.

  654. Progress with rotavirus vaccines: summary of the Tenth International Rotavirus Symposium
    Parashar U, Steele D, Neuzil K, Quadros C, Tharmaphornpilas P, Serhan F, Santosham M, Patel M, Glass R.
    Expert Rev Vaccines. 2013 Feb;12(2):113-7.

  655. Effects of vaccine program against pandemic influenza A(H1N1) virus, United States, 2009-2010
    Borse RH, Shrestha SS, Fiore AE, Atkins CY, Singleton JA, Furlow C, Meltzer MI.
    Emerg Infect Dis. 2013 ;19(3):439-448.

  656. The impact of vaccination among American Indians--progress and challenges
    Groom AV.
    S D Med. 2013 ;Spec no:90-5.[Request a copy via DocExpress]

  657. Vaccination site and risk of local reactions in children 1 through 6 years of age
    Jackson LA, Peterson D, Nelson JC, Marcy SM, Naleway AL, Nordin JD, Donahue JG, Hambidge SJ, Balsbaugh C, Baxter R, Marsh T, Madziwa L, Weintraub E.
    Pediatrics. 2013 Feb;131(2):283-9.

  658. The state of immunization 2013: we are the world
    Schuchat A.
    S D Med. 2013 ;Spec no:27-32.

  659. Effect of rotavirus vaccine on diarrhea mortality in different socioeconomic regions of Mexico
    Gastanaduy PA, Sanchez-Uribe E, Esparza-Aguilar M, Desai R, Parashar UD, Patel M, Richardson V.
    Pediatrics. 2013 Mar 4.

  660. Structures, roles, and procedures of state advisory committees on immunization
    Dolen V, Talkington K, Bhatt A, Rodewald L.
    J Public Health Manag Pract. 2013 Feb 27.

  661. Factors that influence parental vaccination decisions for adolescents, 13 to 17 years old: National Immunization Survey-Teen, 2010
    Dorell C, Yankey D, Kennedy A, Stokley S.
    Clin Pediatr (Phila). 2013 Feb;52(2):162-70.

  662. Travel characteristics and yellow fever vaccine usage among US Global TravEpiNet travelers visiting countries with risk of yellow fever virus transmission, 2009-2011
    Jentes ES, Han P, Gershman MD, Rao SR, Larocque RC, Staples JE, Ryan ET.
    Am J Trop Med Hyg. 2013 Mar 4.

  663. Safety of meningococcal polysaccharide-protein conjugate vaccine in pregnancy: a review of the Vaccine Adverse Event Reporting System
    Zheteyeva Y, Moro P, Yue X, Broder K.
    Am J Obstet Gynecol. 2013 Feb 20.

  664. Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years old, 2009-2011
    Payne DC, Boom JA, Staat MA, Edwards KM, Szilagyi PG, Klein EJ, Selvarangan R, Azimi PH, Harrison C, Moffatt M, Johnston SH, Sahni LC, Baker CJ, Rench MA, Donauer S, McNeal M, Chappell J, Weinberg GA, Tasslimi A, Tate JE, Wikswo M, Curns AT, Sulemana I, Mijatovic-Rustempasic S, Esona MD, Bowen MD, Gentsch JR, Parashar UD.
    Clin Infect Dis. 2013 Mar 13.

  665. Duration of protection against hepatitis A for the current two-dose vaccine compared to a three-dose vaccine schedule in children
    Raczniak GA, Thomas T, Bulkow L, Negus S, Zanis C, Bruce MG, Spradling PR, Teshale EH, McMahon BJ.
    Vaccine. 2013 Mar 4.

  666. Waning immunity to pertussis following 5 doses of DTaP
    Tartof SY, Lewis M, Kenyon C, White K, Osborn A, Liko J, Zell E, Martin S, Messonnier NE, Clark TA, Skoff TH.
    Pediatrics. 2013 Mar 11.

  667. Waning immunity to pertussis following 5 doses of DTaP
    Tartof SY, Lewis M, Kenyon C, White K, Osborn A, Liko J, Zell E, Martin S, Messonnier NE, Clark TA, Skoff TH.
    Pediatrics. 2013 Mar 11.

  668. Human papillomavirus vaccine initiation and awareness: U.S. young men in the 2010 National Health Interview Survey
    Lu PJ, Williams WW, Li J, Dorell C, Yankey D, Kepka D, Dunne EF.
    Am J Prev Med. 2013 Apr;44(4):330-8.

  669. Infection and treatment immunizations for successful parasite vaccines
    Mutapi F, Billingsley PF, Secor WE.
    Trends Parasitol. 2013 Mar;29(3):135-41.

  670. Physicians' confidence in vaccine safety studies
    O'Leary ST, Allison MA, Stokley S, Crane LA, Hurley LP, Beaty B, Kempe A.
    Prev Med. 2013 Mar;56(3-4):231-3.

  671. Increasing exposure to antibody-stimulating proteins and polysaccharides in vaccines is not associated with risk of autism
    DeStefano F, Price C, Weintraub E.
    J Pediatr. 2013 .

  672. Hepatitis A vaccination coverage among adults 18-49 years traveling to a country of high or intermediate endemicity, United States
    Lu PJ, Byrd KK, Murphy TV.
    Vaccine. 2013 Mar 20.

  673. Increasing exposure to antibody-stimulating proteins and polysaccharides in vaccines is not associated with risk of autism
    DeStefano F, Price CS, Weintraub ES.
    J Pediatr. 2013 .

  674. Factors associated with receipt of 2009 pandemic influenza A (H1N1) monovalent and seasonal influenza vaccination among school-aged children: Maricopa County, Arizona, 2009-2010 influenza season
    Baty SA, Ayala A, Odish M, Cadwell BL, Schumacher M, Sunenshine RH.
    J Public Health Manag Pract. 2013 Apr 1.

  675. U.S. postlicensure safety surveillance for adolescent and adult tetanus, diphtheria and acellular pertussis vaccines: 2005-2007
    Chang S, O'Connor PM, Slade BA, Woo EJ.
    Vaccine. 2013 Feb 27;31(10):1447-52.

  676. A population-based cohort study of undervaccination in 8 managed care organizations across the United States
    Glanz JM, Newcomer SR, Narwaney KJ, Hambidge SJ, Daley MF, Wagner NM, McClure DL, Xu S, Rowhani-Rahbar A, Lee GM, Nelson JC, Donahue JG, Naleway AL, Nordin JD, Lugg MM, Weintraub ES.
    JAMA Pediatr. 2013 Mar 1;167(3):274-81.

  677. Combined effects of antenatal receipt of influenza vaccine by mothers and pneumococcal conjugate vaccine receipt by infants: results from a randomized, blinded, controlled trial
    Omer SB, Zaman K, Roy E, Arifeen SE, Raqib R, Noory L, Seib K, Breiman RF, Steinhoff MC.
    J Infect Dis. 2013 Apr;207(7):1144-7.

  678. Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011-2030
    Atherly DE, Lewis KD, Tate J, Parashar UD, Rheingans RD.
    Vaccine. 2012 Apr 27;30 Suppl 1:A7-14.

  679. Discussing vaccination with concerned patients: an evidence-based resource for healthcare providers
    Blendell RL, Fehr JL.
    J Perinat Neonatal Nurs. 2012 Jul-Sep;26(3):230-41.

  680. Unvaccinated children in years of increasing coverage: how many and who are they? Evidence from 96 low- and middle-income countries
    Bosch-Capblanch X, Banerjee K, Burton A.
    Trop Med Int Health. 2012 Jun;17(6):697-710.

  681. What is health equity: and how does a life-course approach take us further toward it?
    Braveman P.
    Matern Child Health J. 2013 Feb 10.

  682. Hepatitis A vaccination coverage among adolescents in the United States
    Dorell CG, Yankey D, Byrd KK, Murphy TV.
    Pediatrics. 2012 Feb;129(2):213-21.

  683. Vaccination coverage among American Indian and Alaska Native children, 2006-2010
    Groom AV, Santibanez TA, Bryan RT.
    Pediatrics. 2012 Dec;130(6):e1592-9.

  684. Compulsory vaccination, the Constitution, and the hepatitis B mandate for infants and young children
    Hollan M.
    Yale J Health Policy Law Ethics. 2012 Winter;12(1):39-86.[Request a copy via DocExpress]

  685. Health equity: the challenge
    Marmot M.
    Aust N Z J Public Health. 2012 Dec;36(6):513-4.

  686. Inequity in childhood immunization in India: a systematic review
    Mathew JL.
    Indian Pediatr. 2012 Mar;49(3):203-23.

  687. Measles: the burden of preventable deaths
    Orenstein WA, Hinman AR.
    Lancet. 2012 Jun 9;379(9832):2130-1.

  688. Factors associated with differential uptake of seasonal influenza immunizations among underserved communities during the 2009-2010 influenza season
    Vlahov D, Bond KT, Jones KC, Ompad DC.
    J Community Health. 2012 Apr;37(2):282-7.

  689. Trends in vaccination coverage disparities among children, United States, 2001-2010
    Zhao Z, Smith PJ.
    Vaccine. 2013 Mar 22.

  690. Vaccination for typhoid fever in sub-Saharan Africa
    Slayton RB, Date KA, Mintz ED.
    Hum Vaccin Immunother. 2013 Apr 1;9(4).

  691. Unintentional transfer of vaccinia virus associated with smallpox vaccines: ACAM2000 (R) compared with Dryvax (R)
    Tack DM, Karem KL, Montgomery JR, Collins L, Bryant-Genevier MG, Tiernan R, Cano M, Lewis P, Engler RJ, Damon IK, Reynolds MG.
    Hum Vaccin Immunother. 2013 Apr 9;9(7).

  692. A survey of US travelers to Asia to assess compliance with recommendations for the use of Japanese encephalitis vaccine
    Duffy MR, Reed C, Edelson PJ, Blumensaadt S, Crocker K, Griggs A, Biggerstaff BJ, Delorey MJ, Hayes EB, Fischer M.
    J Travel Med. 2013 May;20(3):165-70.

  693. Differential profiles and inhibitory effect on rotavirus vaccines of non-antibody components in breast milk from mothers in developing and developed countries
    Moon SS, Tate JE, Ray P, Dennehy PH, Archary D, Coutsoudis A, Bland R, Newell ML, Glass RI, Parashar U, Jiang B.
    Pediatr Infect Dis J. 2013 Apr 11.

  694. Enterovirus 71 encephalitis: a new vaccine on the horizon?
    Pallansch MA, Oberste MS.
    Lancet. 2013 March;381(9871):976-977.

  695. A systematic review of anti-rotavirus serum IgA antibody titer as a potential correlate of rotavirus vaccine efficacy
    Patel M, Glass R, Jiang B, Santosham M, Lopman B, Parashar U.
    J Infect Dis. 2013 Apr 17.

  696. Vitamin D is not associated with serologic response to influenza vaccine in adults over 50 years old
    Sundaram ME, Talbot HK, Zhu Y, Griffin MR, Spencer S, Shay DK, Coleman LA.
    Vaccine. 2013 Apr 12;31(16):2057-61.

  697. Adolescents' perspectives on vaccination outside the traditional medical home: a survey of urban middle and high school students
    Pyrzanowski J, Curtis CR, Crane LA, Barrow J, Beaty B, Kempe A, Daley MF.
    Clin Pediatr (Phila). 2013 Apr;52(4):329-37.

  698. Cincinnati pediatricians' measured and reported immunizing behavior for children during the national shortages of pneumococcal conjugate vaccine
    Fairbrother G, Donauer S, Staat MA, Broder K, Salisbury S, Morrow AL, Tabangin ME, Altaye M, Holloway M, Schwartz B.
    Vaccine. 2013 Apr 19;31(17):2177-83.

  699. Who is unlikely to report adverse events after vaccinations to the vaccine adverse event reporting system (VAERS)?
    McNeil MM, Li R, Pickering S, Real TM, Smith PJ, Pemberton MR.
    Vaccine. 2013 Apr 15.

  700. The role of the GAVI Alliance in improving childhood hepatitis B vaccination in China: successes, lessons learned, and future global challenges
    Averhoff F, Kolwaite A, Ward JW.
    Vaccine. 2013 Apr 24.

  701. Effectiveness of monovalent 2009 pandemic influenza A virus subtype H1N1 and 2010-2011 trivalent inactivated influenza vaccines in Wisconsin during the 2010-2011 influenza season
    Bateman AC, Kieke BA, Irving SA, Meece JK, Shay DK, Belongia EA.
    J Infect Dis. 2013 Apr 15;207(8):1262-9.

  702. The case test-negative design for studies of the effectiveness of seasonal influenza vaccine
    Foppa IM, Haber M, Ferdinands JM, Shay DK.
    Vaccine. 2013 Apr 23.

  703. Factors associated with human papillomavirus vaccination among young adult women in the United States
    Williams WW, Lu PJ, Saraiya M, Yankey D, Dorell C, Rodriguez JL, Kepka D, Markowitz LE.
    Vaccine. 2013 Apr 30.

  704. Modeling the impact of quadrivalent HPV vaccination on the incidence of Pap test abnormalities in the United States
    Chesson HW, Flagg EW, Koutsky L, Hsu K, Unger ER, Shlay JC, Kerndt P, Ghanem KG, Zenilman JM, Hagensee M, Weinstock H, Datta SD.
    Vaccine. 2013 May 9.

  705. Desirability and feasibility of a vaccine against cytomegalovirus
    Griffiths P, Plotkin S, Mocarski E, Pass R, Schleiss M, Krause P, Bialek S.
    Vaccine. 2013 Apr 18;31 Suppl 2:B197-203.

  706. The estimated mortality impact of vaccinations forecast to be administered during 2011-2020 in 73 countries supported by the GAVI Alliance
    Lee LA, Franzel L, Atwell J, Datta SD, Friberg IK, Goldie SJ, Reef SE, Schwalbe N, Simons E, Strebel PM, Sweet S, Suraratdecha C, Tam Y, Vynnycky E, Walker N, Walker DG, Hansen PM.
    Vaccine. 2013 Apr 18;31 Suppl 2:B61-72.

  707. Identifying optimal vaccination strategies for serogroup A Neisseria meningitidis conjugate vaccine in the African meningitis belt
    Tartof S, Cohn A, Tarbangdo F, Djingarey MH, Messonnier N, Clark TA, Kambou JL, Novak R, Diomande FV, Medah I, Jackson ML.
    PLoS One. 2013 ;8(5):e63605.

  708. Enabling implementation of the Global Vaccine Action Plan: developing investment cases to achieve targets for measles and rubella prevention
    Thompson KM, Strebel PM, Dabbagh A, Cherian T, Cochi SL.
    Vaccine. 2013 Apr 18;31 Suppl 2:B149-56.

  709. New vaccine introductions: assessing the impact and the opportunities for immunization and health systems strengthening
    Wang SA, Hyde TB, Mounier-Jack S, Brenzel L, Favin M, Gordon WS, Shearer JC, Mantel CF, Arora N, Durrheim D.
    Vaccine. 2013 Apr 18;31 Suppl 2:B122-8.

  710. Trends in compliance with two-dose influenza vaccine recommendations among children aged 6 months through 8 years
    Pabst LJ, Chaves SS, Weinbaum C.
    Vaccine. 2013 May 15.

  711. Influenza vaccine effectiveness in the community and the household
    Ohmit SE, Petrie JG, Malosh RE, Cowling BJ, Thompson MG, Shay DK, Monto AS.
    Clin Infect Dis. 2013 May;56(10):1363-9.

  712. Assessing parents' knowledge and attitudes towards seasonal influenza vaccination of children before and after a seasonal influenza vaccination effectiveness study in low-income urban and rural Kenya, 2010--2011
    Oria PA, Arunga G, Lebo E, Wong JM, Emukule G, Muthoka P, Otieno N, Mutonga D, Breiman RF, Katz MA.
    BMC Public Health. 2013 Apr 25;13(1):391.

  713. Varicella immunity in vaccinated healthcare workers
    Behrman A, Lopez AS, Chaves SS, Watson BM, Schmid DS.
    J Clin Virol. 2013 Jun;57(2):109-14.

  714. Differences in adult influenza vaccine-seeking behavior: the roles of race and attitudes
    Groom HC, Zhang F, Fisher AK, Wortley PM.
    J Public Health Manag Pract. 2013 May 24.

  715. Association between Guillain-Barre syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis
    Salmon DA, Proschan M, Forshee R, Gargiullo P, Bleser W, Burwen DR, Cunningham F, Garman P, Greene SK, Lee GM, Vellozzi C, Yih WK, Gellin B, Lurie N.
    Lancet. 2013 Apr 27;381(9876):1461-8.

  716. Broadly protective adenovirus-based multivalent vaccines against highly pathogenic avian influenza viruses for pandemic preparedness
    Vemula SV, Ahi YS, Swaim AM, Katz JM, Donis R, Sambhara S, Mittal SK.
    PLoS One. 2013 ;8(4):e62496.

  717. Religious exemptions for immunization and risk of pertussis in New York State, 2000-2011
    Imdad A, Tserenpuntsag B, Blog DS, Halsey NA, Easton DE, Shaw J.
    Pediatrics. 2013 Jun 3.

  718. Inactivated influenza vaccines for prevention of community-acquired pneumonia: the limits of using nonspecific outcomes in vaccine effectiveness studies
    Ferdinands JM, Gargiullo P, Haber M, Moore M, Belongia EA, Shay DK.
    Epidemiology. 2013 Jul;24(4):530-7.

  719. Genetic and phenotypic characterization of manufacturing seeds for a tetravalent dengue vaccine (DENVax)
    Huang CY, Kinney RM, Livengood JA, Bolling B, Arguello JJ, Luy BE, Silengo SJ, Boroughs KL, Stovall JL, Kalanidhi AP, Brault AC, Osorio JE, Stinchcomb DT.
    PLoS Negl Trop Dis. 2013 May;7(5):e2243.

  720. Sick-visit immunizations and delayed well-baby visits
    Robison SG.
    Pediatrics. 2013 Jun 3.

  721. Poliovirus vaccination options for achieving eradication and securing the endgame
    Estivariz CF, Pallansch MA, Anand A, Wassilak SG, Sutter RW, Wenger JD, Orenstein WA.
    Curr Opin Virol. 2013 Jun 8.

  722. Does a monovalent inactivated rotavirus vaccine induce heterotypic immunity?: Evidence from animal studies
    Jiang B, Wang Y, Glass RI.
    Hum Vaccin Immunother. 2013 Jun 6;9(8).

  723. Prevalence of anogenital warts among participants in private health plans in the United States, 2003-2010: potential impact of human papillomavirus vaccination
    Flagg EW, Schwartz R, Weinstock H.
    Am J Public Health. 2013 Jun 13.

  724. Influenza illness and hospitalizations averted by influenza vaccination in the United States, 2005-2011
    Kostova D, Reed C, Finelli L, Cheng P, Gargiullo P, Shay D, Singleton J, Meltzer M, Lu P, Bresee J.
    PLoS One. 2013 .

  725. Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010
    Markowitz LE, Hariri S, Lin C, Dunne EF, Steinau M, McQuillan G, Unger ER.
    J Infect Dis. 2013 Jun 19.

  726. Long-term safety assessment of live attenuated tetravalent dengue vaccines: deliberations from a WHO technical consultation
    Bentsi-Enchill AD, Schmitz J, Edelman R, Durbin A, Roehrig JT, Smith PG, Hombach J, Farrar J.
    Vaccine. 2013 May 28;31(23):2603-9.

  727. Effectiveness of monovalent and pentavalent rotavirus vaccine
    Cortese MM, Immergluck LC, Held M, Jain S, Chan T, Grizas AP, Khizer S, Barrett C, Quaye O, Mijatovic-Rustemapasic S, Gautam R, Bowen MD, Moore J, Tate JE, Parashar UD, Vazquez M.
    Pediatrics. 2013 Jun 17.

  728. Cost-benefit analysis of hospital based postpartum vaccination with combined tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap)
    Ding Y, Yeh SH, Mink CA, Zangwill KM, Allred NJ, Hay JW.
    Vaccine. 2013 May 24;31(22):2558-64.

  729. Determining the effectiveness of the pentavalent rotavirus vaccine against rotavirus hospitalizations and emergency department visits using two study designs
    Donauer S, Payne DC, Edwards KM, Szilagyi PG, Hornung RW, Weinberg GA, Chappell J, Hall CB, Parashar UD, Staat MA.
    Vaccine. 2013 May 31;31(24):2692-7.

  730. Progress towards demonstrating the impact of Haemophilus influenzae type b conjugate vaccines globally
    Hajjeh R, Mulholland K, Schuchat A, Santosham M.
    J Pediatr. 2013 Jul;163(1 Suppl):S1-3.

  731. Effectiveness of monovalent rotavirus vaccine in Bolivia: case-control study
    Patel MM, Patzi M, Pastor D, Nina A, Roca Y, Alvarez L, Iniguez V, Rivera R, Tam KI, Quaye O, Bowen M, Parashar U, De Oliveira LH.
    BMJ. 2013 ;346:f3726.

  732. Evaluation of the effectiveness of Haemophilus influenzae type b conjugate vaccine introduction against radiologically-confirmed hospitalized pneumonia in young children in Ukraine
    Pilishvili T, Chernyshova L, Bondarenko A, Lapiy F, Sychova I, Cohen A, Flannery B, Hajjeh R.
    J Pediatr. 2013 Jul;163(1 Suppl):S12-8.

  733. Effectiveness of influenza vaccine for preventing laboratory-confirmed influenza hospitalizations in adults, 2011-2012 influenza season
    Talbot HK, Zhu Y, Chen Q, Williams JV, Thompson MG, Griffin MR.
    Clin Infect Dis. 2013 Jun;56(12):1774-7.

  734. Postlicensure surveillance for pre-specified adverse events following the 13-valent pneumococcal conjugate vaccine in children
    Tseng HF, Sy LS, Liu IL, Qian L, Marcy SM, Weintraub E, Yih K, Baxter R, Glanz JM, Donahue J, Naleway A, Nordin J, Jacobsen SJ.
    Vaccine. 2013 May 24;31(22):2578-83.

  735. Mortality rates and cause-of-death patterns in a vaccinated population
    McCarthy NL, Weintraub E, Vellozzi C, Duffy J, Gee J, Donahue JG, Jackson ML, Lee GM, Glanz J, Baxter R, Lugg MM, Naleway A, Omer SB, Nakasato C, Vazquez-Benitez G, Destefano F.
    Am J Prev Med. 2013 Jul;45(1):91-7.

  736. Community diarrhea incidence before and after rotavirus vaccine introduction in Nicaragua
    Becker-Dreps S, Melendez M, Liu L, Enrique Zambrana L, Paniagua M, Weber DJ, Hudgens MG, Caceres M, Kallestall C, Morgan DR, Espinoza F, Pena R.
    Am J Trop Med Hyg. 2013 Jul 1.

  737. Meningococcal vaccines: current issues and future strategies
    Cohn AC, Harrison LH.
    Drugs. 2013 Jul 10.

  738. Impact and cost-effectiveness of Haemophilus influenzae type b conjugate vaccination in India
    Clark AD, Griffiths UK, Abbas SS, Rao KD, Privor-Dumm L, Hajjeh R, Johnson H, Sanderson C, Santosham M.
    J Pediatr. 2013 Jul;163(1 Suppl):S60-72.

  739. Progress towards demonstrating the impact of Haemophilus influenzae Type b conjugate vaccines globally
    Hajjeh R, Mulholland K, Schuchat A, Santosham M.
    J Pediatr. 2013 Jul;163(1 Suppl):S1-3.

  740. Mortality and neurodevelopmental outcomes of acute bacterial meningitis in children aged <5 years in Pakistan
    Khowaja AR, Mohiuddin S, Cohen AL, Khalid A, Mehmood U, Naqvi F, Asad N, Pardhan K, Mulholland K, Hajjeh R, Zaidi AK, Shafqat S.
    J Pediatr. 2013 Jul;163(1 Suppl):S86-S91 e1.

  741. Effectiveness of Haemophilus influenzae type b conjugate vaccine on radiologically-confirmed pneumonia in young children in Pakistan
    Khowaja AR, Mohiuddin S, Cohen AL, Mirza W, Nadeem N, Zuberi T, Salam B, Mubarak F, Rizvi B, Husen Y, Pardhan K, Khan KM, Raza SJ, Zuberi HK, Mustafa S, Sheikh SH, Nizamani A, Lohana H, Mulholland K, Zell E, Hajjeh R, Bosan A, Zaidi AK.
    J Pediatr. 2013 Jul;163(1 Suppl):S79-S85 e1.

  742. Evaluation of the effectiveness of Haemophilus influenzae type b conjugate vaccine introduction against radiologically-confirmed hospitalized pneumonia in young children in Ukraine
    Pilishvili T, Chernyshova L, Bondarenko A, Lapiy F, Sychova I, Cohen A, Flannery B, Hajjeh R.
    J Pediatr. 2013 Jul;163(1 Suppl):S12-8.

  743. Impact of Haemophilus influenzae Type b conjugate vaccine in Mongolia: prospective population-based surveillance, 2002-2010
    Scott S, Altanseseg D, Sodbayer D, Nymadawa P, Bulgan D, Mendsaikhan J, Watt JP, Slack MP, Carvalho MG, Hajjeh R, Edmond KM.
    J Pediatr. 2013 Jul;163(1 Suppl):S8-S11.

  744. Haemophilus influenzae type b disease among children in rural Mozambique: impact of vaccine introduction
    Sigauque B, Vubil D, Sozinho A, Quinto L, Morais L, Sacoor C, Carvalho MG, Verani JR, Alonso PL, Roca A.
    J Pediatr. 2013 Jul;163(1 Suppl):S19-24.

  745. Impact of introduction of the Haemophilus influenzae type b conjugate vaccine into childhood immunization on meningitis in Bangladeshi infants
    Sultana NK, Saha SK, Al-Emran HM, Modak JK, Sharker MA, El-Arifeen S, Cohen AL, Baqui AH, Luby SP.
    J Pediatr. 2013 Jul;163(1 Suppl):S73-8.

  746. U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination
    Griffin MR, Zhu Y, Moore MR, Whitney CG, Grijalva CG.
    N Engl J Med. 2013 Jul 11;369(2):155-163.

  747. TRIVAC decision-support model for evaluating the cost-effectiveness of Haemophilus influenzae type b, pneumococcal and rotavirus vaccination
    Clark A, Jauregui B, Griffiths U, Janusz CB, Bolanos-Sierra B, Hajjeh R, Andrus JK, Sanderson C.
    Vaccine. 2013 Jul 2;31 Suppl 3:C19-29.

  748. Trends in compliance with two-dose influenza vaccine recommendations among children aged 6 months through 8 years
    Pabst LJ, Chaves SS, Weinbaum C.
    Vaccine. 2013 Jun 28;31(31):3116-20.

  749. Effectiveness of the 7-valent pneumococcal conjugate vaccine against vaccine-type invasive disease among children in Uruguay: An evaluation using existing data
    Picon T, Alonso L, Garcia Gabarrot G, Speranza N, Casas M, Arrieta F, Camou T, Rosa R, Helena De Oliveira L, Verani JR.
    Vaccine. 2013 Jul 2;31 Suppl 3:C109-13.

  750. U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination
    Griffin MR, Zhu Y, Moore MR, Whitney CG, Grijalva CG.
    N Engl J Med. 2013 Jul 11;369(2):155-163.

  751. Community diarrhea incidence before and after rotavirus vaccine introduction in Nicaragua
    Becker-Dreps S, Melendez M, Liu L, Enrique Zambrana L, Paniagua M, Weber DJ, Hudgens MG, Caceres M, Kallestall C, Morgan DR, Espinoza F, Pena R.
    Am J Trop Med Hyg. 2013 Jul 1.

  752. Mortality rates and cause-of-death patterns in a vaccinated population
    McCarthy NL, Weintraub E, Vellozzi C, Duffy J, Gee J, Donahue JG, Jackson ML, Lee GM, Glanz J, Baxter R, Lugg MM, Naleway A, Omer SB, Nakasato C, Vazquez-Benitez G, Destefano F.
    Am J Prev Med. 2013 Jul;45(1):91-7.

  753. Meningococcal vaccines: current issues and future strategies
    Cohn AC, Harrison LH.
    Drugs. 2013 Jul 10.

  754. Impact and cost-effectiveness of Haemophilus influenzae type b conjugate vaccination in India
    Clark AD, Griffiths UK, Abbas SS, Rao KD, Privor-Dumm L, Hajjeh R, Johnson H, Sanderson C, Santosham M.
    J Pediatr. 2013 Jul;163(1 Suppl):S60-72.

  755. Progress towards demonstrating the impact of Haemophilus influenzae Type b conjugate vaccines globally
    Hajjeh R, Mulholland K, Schuchat A, Santosham M.
    J Pediatr. 2013 Jul;163(1 Suppl):S1-3.

  756. Mortality and neurodevelopmental outcomes of acute bacterial meningitis in children aged <5 years in Pakistan
    Khowaja AR, Mohiuddin S, Cohen AL, Khalid A, Mehmood U, Naqvi F, Asad N, Pardhan K, Mulholland K, Hajjeh R, Zaidi AK, Shafqat S.
    J Pediatr. 2013 Jul;163(1 Suppl):S86-S91 e1.

  757. Effectiveness of Haemophilus influenzae type b conjugate vaccine on radiologically-confirmed pneumonia in young children in Pakistan
    Khowaja AR, Mohiuddin S, Cohen AL, Mirza W, Nadeem N, Zuberi T, Salam B, Mubarak F, Rizvi B, Husen Y, Pardhan K, Khan KM, Raza SJ, Zuberi HK, Mustafa S, Sheikh SH, Nizamani A, Lohana H, Mulholland K, Zell E, Hajjeh R, Bosan A, Zaidi AK.
    J Pediatr. 2013 Jul;163(1 Suppl):S79-S85 e1.

  758. Evaluation of the effectiveness of Haemophilus influenzae type b conjugate vaccine introduction against radiologically-confirmed hospitalized pneumonia in young children in Ukraine
    Pilishvili T, Chernyshova L, Bondarenko A, Lapiy F, Sychova I, Cohen A, Flannery B, Hajjeh R.
    J Pediatr. 2013 Jul;163(1 Suppl):S12-8.

  759. Impact of Haemophilus influenzae Type b conjugate vaccine in Mongolia: prospective population-based surveillance, 2002-2010
    Scott S, Altanseseg D, Sodbayer D, Nymadawa P, Bulgan D, Mendsaikhan J, Watt JP, Slack MP, Carvalho MG, Hajjeh R, Edmond KM.
    J Pediatr. 2013 Jul;163(1 Suppl):S8-S11.

  760. Haemophilus influenzae type b disease among children in rural Mozambique: impact of vaccine introduction
    Sigauque B, Vubil D, Sozinho A, Quinto L, Morais L, Sacoor C, Carvalho MG, Verani JR, Alonso PL, Roca A.
    J Pediatr. 2013 Jul;163(1 Suppl):S19-24.

  761. Impact of introduction of the Haemophilus influenzae type b conjugate vaccine into childhood immunization on meningitis in Bangladeshi infants
    Sultana NK, Saha SK, Al-Emran HM, Modak JK, Sharker MA, El-Arifeen S, Cohen AL, Baqui AH, Luby SP.
    J Pediatr. 2013 Jul;163(1 Suppl):S73-8.

  762. U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination
    Griffin MR, Zhu Y, Moore MR, Whitney CG, Grijalva CG.
    N Engl J Med. 2013 Jul 11;369(2):155-163.

  763. TRIVAC decision-support model for evaluating the cost-effectiveness of Haemophilus influenzae type b, pneumococcal and rotavirus vaccination
    Clark A, Jauregui B, Griffiths U, Janusz CB, Bolanos-Sierra B, Hajjeh R, Andrus JK, Sanderson C.
    Vaccine. 2013 Jul 2;31 Suppl 3:C19-29.

  764. Trends in compliance with two-dose influenza vaccine recommendations among children aged 6 months through 8 years
    Pabst LJ, Chaves SS, Weinbaum C.
    Vaccine. 2013 Jun 28;31(31):3116-20.

  765. Effectiveness of the 7-valent pneumococcal conjugate vaccine against vaccine-type invasive disease among children in Uruguay: An evaluation using existing data
    Picon T, Alonso L, Garcia Gabarrot G, Speranza N, Casas M, Arrieta F, Camou T, Rosa R, Helena De Oliveira L, Verani JR.
    Vaccine. 2013 Jul 2;31 Suppl 3:C109-13.

  766. U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination
    Griffin MR, Zhu Y, Moore MR, Whitney CG, Grijalva CG.
    N Engl J Med. 2013 Jul 11;369(2):155-163.

  767. Duration of immunity to norovirus gastroenteritis
    Simmons K, Gambhir M, Leon J, Lopman B.
    Emerg Infect Dis. 2013 Aug;19(8):1260-7.

  768. Detection of novel rotavirus strain by vaccine postlicensure surveillance
    Weinberg GA, Teel EN, Mijatovic-Rustempasic S, Payne DC, Roy S, Foytich K, Parashar UD, Gentsch JR, Bowen MD.
    Emerg Infect Dis. 2013 Aug;19(8):1321-3.

  769. Geographic and temporal trends in antimicrobial nonsusceptibility in Streptococcus pneumoniae in the post-vaccine era in the United States
    Link-Gelles R, Thomas A, Lynfield R, Petit S, Schaffner W, Harrison L, Farley MM, Aragon D, Nicols M, Kirley PD, Zansky S, Jorgensen J, Juni BA, Jackson D, Moore M, Lipsitch M.
    J Infect Dis. 2013 Jul 12.

  770. Cost-effectiveness of Haemophilus influenzae Type b conjugate vaccine in low- and middle-income countries: regional analysis and assessment of major determinants
    Griffiths UK, Clark A, Hajjeh R.
    J Pediatr. 2013 Jul;163(1 Suppl):S50-S59 e9.

  771. Number of antigens in early childhood vaccines and neuropsychological outcomes at age 7-10 years
    Iqbal S, Barile JP, Thompson WW, Destefano F.
    Pharmacoepidemiol Drug Saf. 2013 Jul 12.

  772. Childhood intussusception: a literature review
    Jiang J, Jiang B, Parashar U, Nguyen T, Bines J, Patel MM.
    PLoS One. 2013 ;8(7):e68482.

  773. Population immunity to polioviruses in the context of a large-scale wild poliovirus type 1 outbreak in Tajikistan, 2010
    Khetsuriani N, Pallansch MA, Jabirov S, Saparova N, Oberste MS, Wannemuehler K, Ursu P, Wassilak S, Martin R.
    Vaccine. 2013 Jul 24.

  774. Seroepidemiology of diphtheria and tetanus among children and young adults in Tajikistan: nationwide population-based survey, 2010
    Khetsuriani N, Zakikhany K, Jabirov S, Saparova N, Ursu P, Wannemuehler K, Wassilak S, Efstratiou A, Martin R.
    Vaccine. 2013 Jul 13.

  775. Uptake and effectiveness of monovalent influenza A (H1N1) pandemic 2009 vaccine among healthcare personnel in Kenya, 2010
    Njuguna H, Ahmed J, Oria PA, Arunga G, Williamson J, Kosgey A, Muthoka P, Mott JA, Breiman RF, Katz MA.
    Vaccine. 2013 Jul 13.

  776. Potential influence of seasonal influenza vaccination requirement versus traditional vaccine promotion strategies on unvaccinated healthcare personnel
    Thompson MG, McIntyre AF, Naleway AL, Black C, Kennedy ED, Ball S, Walker DK, Henkle EM, Gaglani MJ.
    Vaccine. 2013 Jul 8.

  777. Effectiveness of monovalent and pentavalent rotavirus vaccine
    Cortese MM, Immergluck LC, Held M, Jain S, Chan T, Grizas AP, Khizer S, Barrett C, Quaye O, Mijatovic-Rustempasic S, Gautam R, Bowen MD, Moore J, Tate JE, Parashar UD, Vazquez M.
    Pediatrics. 2013 Jul;132(1):e25-33.

  778. Pandemic influenza A(H1N1) in Cote d'Ivoire: health-care providers' knowledge of influenza and attitudes towards vaccination
    Coulibaly D, Nzussouo NT, Kadjo HA, Traore Y, Ekra DK, Cherif D, Kouassi PD, N'Gattia A K, Dagnan SN.
    J Infect Dev Ctries. 2013 ;7(7):499-506.

  779. Adults with diabetes hospitalized with pandemic influenza A(H1N1)pdm09--U.S. 2009
    Ganatra RB, McKenna JJ, Bramley AM, Skarbinski J, Fry AM, Finelli L, Jain S.
    Diabetes Care. 2013 Jul;36(7):e94.

  780. Can clinical tests help monitor human papillomavirus vaccine impact?
    Meites E, Lin C, Unger ER, Steinau M, Patel S, Markowitz LE, Hariri S.
    Int J Cancer. 2013 Sep 1;133(5):1101-6.

  781. Safety of meningococcal polysaccharide-protein conjugate vaccine in pregnancy: a review of the Vaccine Adverse Event Reporting System
    Zheteyeva Y, Moro PL, Yue X, Broder K.
    Am J Obstet Gynecol. 2013 Jun;208(6):478 e1-6.

  782. Inactivated influenza vaccine during pregnancy and risks for adverse obstetric events
    Kharbanda EO, Vazquez-Benitez G, Lipkind H, Naleway A, Lee G, Nordin JD.
    Obstet Gynecol. 2013 Aug 5.

  783. Measles vaccination using a microneedle patch
    Edens C, Collins ML, Ayers J, Rota PA, Prausnitz MR.
    Vaccine. 2013 Jul 25;31(34):3403-9.

  784. Roadmap for the international collaborative epidemiologic monitoring of safety and effectiveness of new high priority vaccines
    Izurieta HS, Zuber P, Bonhoeffer J, Chen RT, Sankohg O, Laserson KF, Sturkenboom M, Loucq C, Weibel D, Dodd C, Black S.
    Vaccine. 2013 Aug 2;31(35):3623-7.

  785. Increasing adolescent immunization rates in primary care: strategies physicians use and would consider implementing
    Humiston SG, Serwint JR, Szilagyi PG, Vincelli PA, Dhepyasuwan N, Rand CM, Schaffer SJ, Blumkin AK, Curtis CR.
    Clin Pediatr (Phila). 2013 Aug;52(8):710-20.

  786. Intussusception and rotavirus vaccination - balancing risk against benefit
    Parashar UD, Orenstein WA.
    Clin Infect Dis. 2013 Aug 19.

  787. Vaccination coverage levels among children enrolled in the Vaccine Safety Datalink
    McCarthy NL, Irving S, Donahue JG, Weintraub E, Gee J, Belongia E, Baggs J.
    Vaccine. 2013 Oct 14.

  788. The role of attitudes about vaccine safety, efficacy, and value in explaining parents reported vaccination behavior
    LaVail K, Kennedy A.
    Health Education & Behavior. 2013 ;40(5):544-551.

  789. Impact of varicella vaccination on varicella-related hospitalizations among American Indian/Alaska Native people
    Singleton RJ, Holman RC, Person MK, Steiner CA, Redd JT, Hennessy TW, Groom A, Holve S, Seward JF.
    Pediatr Infect Dis J. 2013 Oct 16.

  790. The role of attitudes about vaccine safety, efficacy, and value in explaining parents reported vaccination behavior
    LaVail K, Kennedy A.
    Health Education & Behavior. 2013 ;40(5):544-551.

  791. Vaccination coverage levels among children enrolled in the Vaccine Safety Datalink
    McCarthy NL, Irving S, Donahue JG, Weintraub E, Gee J, Belongia E, Baggs J.
    Vaccine. 2013 Oct 14.

  792. Impact of varicella vaccination on varicella-related hospitalizations among American Indian/Alaska Native people
    Singleton RJ, Holman RC, Person MK, Steiner CA, Redd JT, Hennessy TW, Groom A, Holve S, Seward JF.
    Pediatr Infect Dis J. 2013 Oct 16.

  793. Cost-effectiveness of administering 13-valent pneumococcal conjugate vaccine in addition to 23-valent pneumococcal polysaccharide vaccine to adults with immunocompromising conditions
    Cho BH, Stoecker C, Link-Gelles R, Moore MR.
    Vaccine. 2013 Oct 19.

  794. Evaluating the safety of influenza vaccine using a claims-based health system
    McCarthy NL, Gee J, Lin ND, Thyagarajan V, Pan Y, Su S, Turnbull B, Chan KA, Weintraub E.
    Vaccine. 2013 Oct 19.

  795. Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis
    Udell JA, Zawi R, Bhatt DL, Keshtkar-Jahromi M, Gaughran F, Phrommintikul A, Ciszewski A, Vakili H, Hoffman EB, Farkouh ME, Cannon CP.
    JAMA. 2013 Oct 23;310(16):1711-20.

  796. Maternal underestimation of child's sexual experience: suggested implications for HPV vaccine uptake at recommended ages
    Liddon N, Michael SL, Dittus P, Markowitz LE.
    J Adolesc Health. 2013 Nov;53(5):674-6.

  797. Progress toward elimination of hepatitis B virus transmission in Oman: impact of hepatitis B vaccination
    Al Awaidy ST, Bawikar SP, Al Busaidy SS, Al Mahrouqi S, Al Baqlani S, Al Obaidani I, Alexander J, Patel MK.
    Am J Trop Med Hyg. 2013 Oct;89(4):811-5.

  798. Hepatitis B vaccination coverage among health-care personnel in the United States
    Byrd KK, Lu PJ, Murphy TV.
    Public Health Rep. 2013 Nov;128(6):498-509.

  799. A multi-country evaluation of Neisseria meningitidis serogroup B factor H-binding proteins and implications for vaccine coverage in different age groups
    Hoiseth SK, Murphy E, Andrew L, Vogel U, Frosch M, Hellenbrand W, Abad R, Vazquez JA, Borrow R, Findlow J, Taha MK, Deghmane AE, Caugant DA, Kriz P, Musilek M, Mayer LW, Wang X, Macneil JR, York L, Tan CY, Jansen KU, Anderson AS.
    Pediatr Infect Dis J. 2013 Oct;32(10):1096-101.

  800. Uptake, coverage, and completion of quadrivalent human papillomavirus vaccine in the Vaccine Safety Datalink, July 2006-June 2011
    Schmidt MA, Gold R, Kurosky SK, Daley MF, Irving SA, Gee J, Naleway AL.
    J Adolesc Health. 2013 Nov;53(5):637-41.

  801. Which newborns missed the hepatitis B birth dose vaccination among U.S. children?
    Zhao Z, Murphy TV.
    Prev Med. 2013 Nov;57(5):613-7.

  802. Maternal underestimation of child's sexual experience: suggested implications for HPV vaccine uptake at recommended ages
    Liddon N, Michael SL, Dittus P, Markowitz LE.
    J Adolesc Health. 2013 Nov;53(5):674-6.

  803. Progress toward elimination of hepatitis B virus transmission in Oman: impact of hepatitis B vaccination
    Al Awaidy ST, Bawikar SP, Al Busaidy SS, Al Mahrouqi S, Al Baqlani S, Al Obaidani I, Alexander J, Patel MK.
    Am J Trop Med Hyg. 2013 Oct;89(4):811-5.

  804. Hepatitis B vaccination coverage among health-care personnel in the United States
    Byrd KK, Lu PJ, Murphy TV.
    Public Health Rep. 2013 Nov;128(6):498-509.

  805. A multi-country evaluation of Neisseria meningitidis serogroup B factor H-binding proteins and implications for vaccine coverage in different age groups
    Hoiseth SK, Murphy E, Andrew L, Vogel U, Frosch M, Hellenbrand W, Abad R, Vazquez JA, Borrow R, Findlow J, Taha MK, Deghmane AE, Caugant DA, Kriz P, Musilek M, Mayer LW, Wang X, Macneil JR, York L, Tan CY, Jansen KU, Anderson AS.
    Pediatr Infect Dis J. 2013 Oct;32(10):1096-101.

  806. Uptake, coverage, and completion of quadrivalent human papillomavirus vaccine in the Vaccine Safety Datalink, July 2006-June 2011
    Schmidt MA, Gold R, Kurosky SK, Daley MF, Irving SA, Gee J, Naleway AL.
    J Adolesc Health. 2013 Nov;53(5):637-41.

  807. Which newborns missed the hepatitis B birth dose vaccination among U.S. children?
    Zhao Z, Murphy TV.
    Prev Med. 2013 Nov;57(5):613-7.

  808. Molecular resistance mechanisms of macrolide-resistant invasive streptococcus pneumoniae isolates from Alaska, 1986 to 2010
    Rudolph K, Bulkow L, Bruce M, Zulz T, Reasonover A, Harker-Jones M, Hurlburt D, et al.
    Antimicrob Agents Chemother. 2013 Nov;57(11):5415-22.

  809. Template protocol for clinical trials investigating vaccines-focus on safety elements
    Bonhoeffer J, Imoukhuede EB, Aldrovandi G, Bachtiar NS, Chan ES, Chang S, Chen RT, et al.
    Vaccine. 2013 Nov 12;31(47):5602-20.

  810. Safety and immunogenicity of inactivated poliovirus vaccine based on Sabin strains with and without aluminum hydroxide: A phase I trial in healthy adults
    Verdijk P, Rots NY, van Oijen MG, Oberste MS, Boog CJ, Okayasu H, Sutter RW, et al.
    Vaccine. 2013 Nov 12;31(47):5531-6.

  811. Unexpected benefits of immunization: Rotavirus vaccines reduce childhood seizures
    Weinberg G.
    Clin Inf Dis. 2013 .

  812. Genetic variants within the MHC region are associated with immune responsiveness to childhood vaccinations
    Yucesoy B, Talzhanov Y, Johnson VJ, Wilson NW, Biagini RE, Wang W, Frye B, Weissman DN, Germolec DR, Luster MI, Barmada MM.
    Vaccine. 2013 Nov 4;31(46):5381-91.

  813. Statewide pandemic influenza vaccination reminders for children with chronic conditions
    Dombkowski KJ, Cowan AE, Potter RC, Dong S, Kolasa M, Clark SJ.
    Am J Public Health. 2013 Nov 14.

  814. Population impact of HPV vaccines: summary of early evidence
    Hariri S, Markowitz LE, Dunne EF, Unger ER.
    J Adolesc Health. 2013 Dec;53(6):679-82.

  815. Reaching children never previously vaccinated for influenza through a school-located vaccination program
    Kansagra SM, Papadouka V, Geevarughese A, Hansen MA, Konty KJ, Zucker JR.
    Am J Public Health. 2013 Nov 14.

  816. Acceptability of hypothetical dengue vaccines among travelers
    Benoit CM, Macleod WB, Hamer DH, Sanchez-Vegas C, Chen LH, Wilson ME, Karchmer AW, et al.
    J Travel Med. 2013 Nov;20(6):346-51.

  817. A systematic evaluation of different methods for calculating adolescent vaccination levels using immunization information system data
    Gowda C, Dong S, Potter RC, Dombkowski KJ, Stokley S, Dempsey AF.
    Public Health Rep. 2013 Nov;128(6):489-97.

  818. Barriers to human papillomavirus vaccination among US adolescents: A systematic review of the literature
    Holman DM, Benard V, Roland KB, Watson M, Liddon N, Stokley S.
    JAMA Pediatr. 2013 Nov 25.

  819. Effect of vaccination coordinators on socioeconomic disparities in immunization among the 2006 connecticut birth cohort
    Kattan JA, Kudish KS, Cadwell BL, Soto K, Hadler JL.
    Am J Public Health. 2013 Nov 14.

  820. Mumps vaccine effectiveness and risk factors for disease in households during an outbreak in New York City
    Livingston KA, Rosen JB, Zucker JR, Zimmerman CM.
    Vaccine. 2013 Nov 16.

  821. Effectiveness of seasonal trivalent influenza vaccine for preventing influenza virus illness among pregnant women: a population-based case-control study during the 2010-2011 and 2011-2012 influenza seasons
    Thompson MG, Li DK, Shifflett P, Sokolow LZ, Ferber JR, Kurosky S, Bozeman S, et al.
    Clin Infect Dis. 2013 Nov 26.

  822. Statewide pandemic influenza vaccination reminders for children with chronic conditions
    Dombkowski KJ, Cowan AE, Potter RC, Dong S, Kolasa M, Clark SJ.
    Am J Public Health. 2013 Nov 14.

  823. Population impact of HPV vaccines: summary of early evidence
    Hariri S, Markowitz LE, Dunne EF, Unger ER.
    J Adolesc Health. 2013 Dec;53(6):679-82.

  824. Reaching children never previously vaccinated for influenza through a school-located vaccination program
    Kansagra SM, Papadouka V, Geevarughese A, Hansen MA, Konty KJ, Zucker JR.
    Am J Public Health. 2013 Nov 14.

  825. Acceptability of hypothetical dengue vaccines among travelers
    Benoit CM, Macleod WB, Hamer DH, Sanchez-Vegas C, Chen LH, Wilson ME, Karchmer AW, et al.
    J Travel Med. 2013 Nov;20(6):346-51.

  826. A systematic evaluation of different methods for calculating adolescent vaccination levels using immunization information system data
    Gowda C, Dong S, Potter RC, Dombkowski KJ, Stokley S, Dempsey AF.
    Public Health Rep. 2013 Nov;128(6):489-97.

  827. Barriers to human papillomavirus vaccination among US adolescents: A systematic review of the literature
    Holman DM, Benard V, Roland KB, Watson M, Liddon N, Stokley S.
    JAMA Pediatr. 2013 Nov 25.

  828. Effect of vaccination coordinators on socioeconomic disparities in immunization among the 2006 connecticut birth cohort
    Kattan JA, Kudish KS, Cadwell BL, Soto K, Hadler JL.
    Am J Public Health. 2013 Nov 14.

  829. Mumps vaccine effectiveness and risk factors for disease in households during an outbreak in New York City
    Livingston KA, Rosen JB, Zucker JR, Zimmerman CM.
    Vaccine. 2013 Nov 16.

  830. Effectiveness of seasonal trivalent influenza vaccine for preventing influenza virus illness among pregnant women: a population-based case-control study during the 2010-2011 and 2011-2012 influenza seasons
    Thompson MG, Li DK, Shifflett P, Sokolow LZ, Ferber JR, Kurosky S, Bozeman S, et al.
    Clin Infect Dis. 2013 Nov 26.

  831. A global perspective of vaccination of healthcare personnel against measles: systematic review
    Fiebelkorn AP, Seward JF, Orenstein W.
    Vaccine. 2013 Nov 23.

  832. Tetanus, diphtheria and acellular pertussis (Tdap) vaccination among healthcare personnel - United States, 2011
    Lu PJ, Graitcer SB, O'Halloran A, Liang JL.
    Vaccine. 2013 Dec 2.

  833. Seasonal influenza vaccination coverage among adult populations in the United States, 2005-2011
    Lu PJ, Singleton JA, Euler GL, Williams WW, Bridges CB.
    Am J Epidemiol. 2013 Nov 1;178(9):1478-87.

  834. Transmission of vaccinia virus, possibly through sexual contact, to a woman at high risk for adverse complications
    Said MA, Haile C, Palabindala V, Barker N, Myers R, Thompson R, Wilson L, Allan-Martinez F, Montgomery J, Monroe B, Tack D, Reynolds M, Damon I, Blythe D.
    Mil Med. 2013 Dec;178(12):e1375-8.

  835. Effectiveness of nonadjuvanted monovalent influenza A(H1N1)pdm09 vaccines for preventing reverse transcription polymerase chain reaction-confirmed pandemic influenza hospitalizations: case-control study of children and adults at 10 US Influenza Surveillance Network sites
    Thompson MG, Sokolow LZ, Almendares O, Openo K, Farley MM, Meek J, Ray J, Kirley PD, Reingold A, Aragon D, Hancock E, Baumbach J, Schaffner W, Lynfield R, Ryan P, Monroe M, Cheng PY, Fry AM, Shay DK.
    Clin Infect Dis. 2013 Dec;57(11):1587-92.

  836. Beta-defensin 2 enhances immunogenicity and protection of an adenovirus-based H5N1 influenza vaccine at an early time
    Vemula SV, Amen O, Katz JM, Donis R, Sambhara S, Mittal SK.
    Virus Res. 2013 Dec 26;178(2):398-403.

  837. Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005-2009
    Weinmann S, Chun C, Schmid DS, Roberts M, Vandermeer M, Riedlinger K, Bialek SR, Marin M.
    J Infect Dis. 2013 Dec;208(11):1859-68.

  838. Highly divergent type 2 and 3 vaccine-derived polioviruses isolated from sewage in Tallinn, Estonia
    Al-Hello H, Jorba J, Blomqvist S, Raud R, Kew O, Roivainen M.
    J Virol. 2013 Dec;87(23):13076-80.

  839. Hepatitis B vaccine immunogenicity among adults vaccinated during an outbreak response in an assisted living facility-Virginia, 2010
    Bender TJ, Sharapov U, Utah O, Xing J, Hu D, Rybczynska J, Drobeniuc J, Kamili S, Spradling PR, Moorman AC.
    Vaccine. 2013 Dec 23.

  840. Determinants and coverage of vaccination in children in Western Kenya from a 2003 cross-sectional survey
    Calhoun LM, van Eijk AM, Lindblade KA, Odhiambo FO, Wilson ML, Winterbauer E, Slutsker L, Hamel MJ.
    Am J Trop Med Hyg. 2013 Dec 16.

  841. Impact of immunosuppression on recall immune responses to influenza vaccination in stable renal transplant recipients
    Cowan M, Chon WJ, Desai A, Andrews S, Bai Y, Veguilla V, Katz JM, Josephson MA, Wilson PC, Sciammas R, Chong AS.
    Transplantation. 2013 Dec 19.

  842. Pre-exposure rabies vaccination among US international travelers: findings from the Global TravEpiNet Consortium
    Dolan SB, Jentes ES, Sotir MJ, Han P, Blanton JD, Rao SR, Larocque RC, Ryan E, The Global Travepinet Consortium .
    Vector Borne Zoonotic Dis. 2013 Dec 20.

  843. Examination of links between herpes zoster incidence and childhood varicella vaccination
    Hales CM, Harpaz R, Joesoef MR, Bialek SR.
    Ann Intern Med. 2013 Dec 3;159(11):739-45.

  844. Immediate hypersensitivity reactions following monovalent 2009 pandemic influenza A (H1N1) vaccines: Reports to VAERS
    Halsey NA, Griffioen M, Dreskin SC, Dekker CL, Wood R, Sharma D, Jones JF, Larussa PS, Garner J, Berger M, Proveaux T, Vellozzi C.
    Vaccine. 2013 Dec 9;31(51):6107-12.

  845. Progress and challenges in RSV prophylaxis and vaccine development
    Haynes LM.
    J Infect Dis. 2013 Dec;208 Suppl 3:S177-83.

  846. Impact of prior seasonal H3N2 influenza vaccination or infection on protection and transmission of emerging variants of influenza A(H3N2)v virus in ferrets
    Houser KV, Pearce MB, Katz JM, Tumpey TM.
    J Virol. 2013 Dec;87(24):13480-9.

  847. Effect of age on the risk of fever and seizures following immunization with measles-containing vaccines in children
    Rowhani-Rahbar A, Fireman B, Lewis E, Nordin J, Naleway A, Jacobsen SJ, Jackson LA, Tse A, Belongia EA, Hambidge SJ, Weintraub E, Baxter R, Klein NP.
    JAMA Pediatr. 2013 Dec 1;167(12):1111-7.

  848. Adult immunization policies in advanced economies: vaccination recommendations, financing, and vaccination coverage
    Wu LA, Kanitz E, Crumly J, D'Ancona F, Strikas RA.
    Int J Public Health. 2013 Dec;58(6):865-74.

  849. Serum antibody response to M2 surface protein following natural infection with 2009 pandemic H1N1 influenza A virus in humans
    Zhong W, Reed C, Blair PJ, Katz JM, Hancock K.
    J Infect Dis. 2013 Dec 10.

  850. Seasonal influenza vaccination at school: a randomized controlled trial
    Humiston SG, Schaffer SJ, Szilagyi PG, Long CE, Chappel TR, Blumkin AK, Szydlowski J, Kolasa MS.
    Am J Prev Med. 2014 Jan;46(1):1-9.

  851. The evolution and diversity of a low complexity vaccine candidate, merozoite surface protein 9 (MSP-9), in Plasmodium vivax and closely related species
    Chenet SM, Pacheco MA, Bacon DJ, Collins WE, Barnwell JW, Escalante AA.
    Infect Genet Evol. 2013 Dec;20:239-48.

  852. Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine-type invasive pneumococcal disease among young children
    Conklin L, Loo JD, Kirk J, Fleming-Dutra KE, Deloria Knoll M, Park DE, Goldblatt D, O'Brien KL, Whitney CG.
    Pediatr Infect Dis J. 2014 Jan;33 Suppl 2:S109-18.

  853. Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on immunogenicity
    Deloria Knoll M, Park DE, Johnson TS, Chandir S, Nonyane BA, Conklin L, Fleming-Dutra KE, Loo JD, Goldblatt D, Whitney CG, O'Brien KL.
    Pediatr Infect Dis J. 2014 Jan;33 Suppl 2:S119-29.

  854. Would young women attending sexually transmitted disease clinics benefit from human papillomavirus vaccination? An assessment of human papillomavirus DNA and seropositivity from human papillomavirus sentinel surveillance, 2003-2005
    Dunne EF, Flagg EW, Unger ER, Hsu K, Ghanen K, Kerndt P, Shlay JC, Koutsky LA, Datta DS, Panicker G, Zaidi A, Weinstock H, Markowitz LE.
    Sex Transm Dis. 2014 Jan;41(1):46-9.

  855. Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine-type nasopharyngeal carriage
    Fleming-Dutra KE, Conklin L, Loo JD, Knoll MD, Park DE, Kirk J, Goldblatt D, Whitney CG, O'Brien KL.
    Pediatr Infect Dis J. 2014 Jan;33 Suppl 2:S152-60.

  856. Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on prevention of pneumonia
    Loo JD, Conklin L, Fleming-Dutra KE, Deloria Knoll M, Park DE, Kirk J, Goldblatt D, O'Brien KL, Whitney CG.
    Pediatr Infect Dis J. 2014 Jan;33 Suppl 2:S140-51.

  857. Systematic review of the indirect effect of pneumococcal conjugate vaccine dosing schedules on pneumococcal disease and colonization
    Loo JD, Conklin L, Fleming-Dutra KE, Knoll MD, Park DE, Kirk J, Goldblatt D, O'Brien KL, Whitney CG.
    Pediatr Infect Dis J. 2014 Jan;33 Suppl 2:S161-71.

  858. Reports to the Vaccine Adverse Event Reporting System after hepatitis A and hepatitis AB vaccines in pregnant women
    Moro PL, Museru OI, Niu M, Lewis P, Broder K.
    Am J Obstet Gynecol. 2013 Dec 27.

  859. The differential impact of coadministered vaccines, geographic region, vaccine product and other covariates on pneumococcal conjugate vaccine immunogenicity
    Park DE, Johnson TS, Nonyane BA, Chandir S, Conklin L, Fleming-Dutra KE, Loo JD, Goldblatt D, Whitney CG, O'Brien KL, Deloria Knoll M.
    Pediatr Infect Dis J. 2014 Jan;33 Suppl 2:S130-9.

  860. Effect of reduced dose schedules and intramuscular injection of anthrax vaccine adsorbed on immunological response and safety profile: a randomized trial
    Wright JG, Plikaytis BD, Rose CE, Parker SD, Babcock J, Keitel W, El Sahly H, Poland GA, Jacobson RM, Keyserling HL, Semenova VA, Li H, Schiffer J, Dababneh H, Martin SK, Martin SW, Marano N, Messonnier NE, Quinn CP.
    Vaccine. 2013 Dec 24.

  861. Rotavirus vaccines: successes and challenges
    Glass RI, Parashar U, Patel M, Gentsch J, Jiang B.
    J Infect. 2014 Jan;68 Suppl 1:S9-s18.

  862. Assessment of vaccine exemptions among Wyoming school children, 2009 and 2011
    Pride KR, Geissler AL, Kolasa MS, Robinson B, Van Houten C, McClinton R, Bryan K, Murphy T.
    J Sch Nurs. 2014 Jan 9.

  863. Risk of intussusception after monovalent rotavirus vaccination
    Weintraub ES, Baggs J, Duffy J, Vellozzi C, Belongia EA, Irving S, Klein NP, Glanz JM, Jacobsen SJ, Naleway A, Jackson LA, Destefano F.
    N Engl J Med. 2014 Jan 14.

  864. Parent attitudes about school-located influenza vaccination clinics
    Brown DS, Arnold SE, Asay G, Lorick SA, Cho BH, Basurto-Davila R, Messonnier ML.
    Vaccine. 2014 Jan 15.

  865. Oral polio vaccine response in breast fed infants with malnutrition and diarrhea
    Haque R, Snider C, Liu Y, Ma JZ, Liu L, Nayak U, Mychaleckyj JC, Korpe P, Mondal D, Kabir M, Alam M, Pallansch M, Oberste MS, Weldon W, Kirkpatrick BD, Petri WA.
    Vaccine. 2014 Jan 16;32(4):478-82.

  866. Can routinely collected national data on childhood morbidity and mortality from diarrhea be used to monitor health impact of rotavirus vaccination in Africa? Examination of pre-vaccine baseline data from Rwanda
    Ngabo F, Gatera M, Karema C, Donnen P, Lepage P, Parashar UD, Tate JE, Mwenda JM, Rugambwa C, Binagwaho A.
    Pediatr Infect Dis J. 2014 Jan;33 Suppl 1:S89-93.

  867. Systematic review of human papillomavirus vaccine coadministration
    Noronha AS, Markowitz LE, Dunne EF.
    Vaccine. 2014 Jan 8.

  868. Vaccine strain varicella-zoster virus-induced central nervous system vasculopathy as the presenting feature of DOCK8 deficiency
    Sabry A, Hauk PJ, Jing H, Su HC, Stence NV, Mirsky DM, Nagel MA, Abbott JK, Dragone LL, Armstrong-Wells J, Curtis DJ, Cohrs R, Schmid DS, Gilden D, Gelfand EW.
    J Allergy Clin Immunol. 2014 Jan 10.

  869. Vaccination benefits and cost-sharing policy for non-institutionalized adult Medicaid enrollees in the United States
    Stewart AM, Lindley MC, Chang KH, Cox MA.
    Vaccine. 2014 Jan 23;32(5):618-23.

  870. Guillain-Barre syndrome, influenza and influenza vaccination--the epidemiologic evidence
    Vellozzi C, Iqbal S, Broder K.
    Clin Infect Dis. 2014 Jan 9.

  871. Evaluation of the feasibility of a state-based vaccine safety advice network
    Williams SE, Vellozzi C, Edwards KM, Moore KL, Sharma D, Creech CB.
    Vaccine. 2014 Jan 9.

  872. Characteristics of antibody responses in West Nile virus-seropositive blood donors
    Carson PJ, Prince HE, Biggerstaff BJ, Lanciotti R, Tobler LH, Busch M.
    J Clin Microbiol. 2014 Jan;52(1):57-60.

  873. Influenza vaccines and influenza antiviral drugs in Africa: are they available and do guidelines for their use exist?
    Duque J, McMorrow ML, Cohen AL.
    BMC Public Health. 2014 ;14(1):41.

  874. Rotavirus vaccines - balancing intussusception risks and health benefits
    Glass RI, Parashar UD.
    N Engl J Med. 2014 Jan 14.

  875. Protective association between rotavirus vaccination and childhood seizures in the year following vaccination in US children
    Payne DC, Baggs J, Zerr DM, Klein NP, Yih K, Glanz J, Curns AT, Weintraub E, Parashar UD.
    Clin Infect Dis. 2014 Jan;58(2):173-7.

  876. Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates
    Ohmit SE, Thompson MG, Petrie JG, Thaker SN, Jackson ML, Belongia EA, Zimmerman RK, Gaglani M, Lamerato L, Spencer SM, Jackson L, Meece JK, Nowalk MP, Song J, Zervos M, Cheng PY, Rinaldo CR, Clipper L, Shay DK, Piedra P, Monto AS.
    Clin Infect Dis. 2014 Feb;58(3):319-27.

  877. Delay and refusal of human papillomavirus vaccine for girls, National Immunization Survey - Teen, 2010
    Dorell C, Yankey D, Jeyarajah J, Stokley S, Fisher A, Markowitz L, Smith PJ.
    Clin Pediatr (Phila). 2014 Jan 24.

  878. CDC Grand Rounds: reducing the burden of HPV-associated cancer and disease
    Dunne EF, Markowitz LE, Saraiya M, Stokley S, Middleman A, Unger ER, Williams A, Iskander J.
    MMWR Morb Mortal Wkly Rep. 2014 Jan 31;63(4):69-72.

  879. Notes from the field: rotavirus vaccine administration errors - United States, 2006-2013
    Hibbs BF, Miller ER, Shimabukuro T.
    MMWR Morb Mortal Wkly Rep. 2014 Jan 31;63(4):81.

  880. Vitamin E, vitamin A, and zinc status are not related to serologic response to influenza vaccine in older adults: an observational prospective cohort study
    Sundaram ME, Meydani SN, Vandermause M, Shay DK, Coleman LA.
    Nutr Res. 2014 Feb;34(2):149-54.

  881. Demographic, socio-economic and geographic determinants of seasonal influenza vaccine uptake in rural western Kenya, 2011
    Otieno NA, Nyawanda BO, Audi A, Emukule G, Lebo E, Bigogo G, Ochola R, Muthoka P, Widdowson MA, Shay DK, Burton DC, Breiman RF, Katz MA, Mott JA.
    Vaccine. 2014 Jan 22.

  882. Advisory Committee on Immunization Practices recommended immunization schedules for persons aged 0 through 18 years - United States, 2014
    Akinsanya-Beysolow I.
    MMWR Morb Mortal Wkly Rep. 2014 Feb 7;63(5):108-9.

  883. Positive network assortativity of influenza vaccination at a high school: implications for outbreak risk and herd immunity
    Barclay VC, Smieszek T, He J, Cao G, Rainey JJ, Gao H, Uzicanin A, Salathe M.
    PLoS One. 2014 ;9(2):e87042.

  884. Advisory Committee on Immunization Practices recommended immunization schedule for adults aged 19 years or older - United States, 2014
    Bridges CB, Coyne-Beasley T.
    MMWR Morb Mortal Wkly Rep. 2014 Feb 7;63(5):110-2.

  885. Effectiveness of the 2010 and 2011 Southern Hemisphere trivalent inactivated influenza vaccines against hospitalization with influenza-associated acute respiratory infection among Thai adults aged >/=50 years
    Dawood FS, Prapasiri P, Areerat P, Ruayajin A, Chittaganpitch M, Muangchana C, Baggett HC, Olsen SJ.
    Influenza Other Respir Viruses. 2014 Feb 3.

  886. Minor consent and delivery of adolescent vaccines
    Ford CA, Skiles MP, English A, Cai J, Agans RP, Stokley S, Markowitz L, Koumans EH.
    J Adolesc Health. 2014 Feb;54(2):183-9.

  887. Workplace-based influenza vaccination promotion practices among large employers in the United States
    Graves MA, Harris JR, Hannon PA, Hammerback K, Ahmed F, Zhou C.
    J Occup Environ Med. 2014 Jan 31.

  888. Prevalence of human papillomavirus types in invasive cervical cancers from 7 US cancer registries before vaccine introduction
    Hopenhayn C, Christian A, Christian WJ, Watson M, Unger ER, Lynch CF, Peters ES, Wilkinson EJ, Huang Y, Copeland G, Cozen W, Saber MS, Goodman MT, Hernandez BY, Steinau M, Lyu C, Tucker TT, Saraiya M.
    J Low Genit Tract Dis. 2014 Jan 28.

  889. Risk factors for transmission of mumps in a highly vaccinated population in Orange County, NY, 2009-2010
    Kutty PK, McLean HQ, Lawler J, Schulte C, Hudson JM, Blog D, Wallace G.
    Pediatr Infect Dis J. 2014 Feb;33(2):121-5.

  890. Hepatitis B vaccination for healthcare personnel in American Samoa: pre-implementation survey for policy decision
    Ly KN, Roberts H, Williams RE, Masunu-Faleafaga Y, Drobeniuc J, Kamili S, Teshale EH.
    Epidemiol Infect. 2014 Jan 24:1-6.

  891. Global control and regional elimination of measles, 2000-2012
    Perry RT, Gacic-Dobo M, Dabbagh A, Mulders MN, Strebel PM, Okwo-Bele JM, Rota PA, Goodson JL.
    MMWR Morb Mortal Wkly Rep. 2014 Feb 7;63(5):103-7.

  892. Noninfluenza vaccination coverage among adults - United States, 2012
    Williams WW, Lu PJ, O'Halloran A, Bridges CB, Pilishvili T, Hales CM, Markowitz LE.
    MMWR Morb Mortal Wkly Rep. 2014 Feb 7;63(5):95-102.

  893. Cost-effectiveness of alternative strategies for annual influenza vaccination among children aged 6 months to 14 years in four provinces in China
    Zhou L, Situ S, Feng Z, Atkins CY, Fung IC, Xu Z, Huang T, Hu S, Wang X, Meltzer MI.
    PLoS One. 2014 ;9(1):e87590.

  894. Deep sequencing of viral genomes provides insight into the evolution and pathogenesis of varicella zoster virus and its vaccine in humans
    Depledge DP, Kundu S, Jensen NJ, Gray ER, Jones M, Steinberg S, Gershon A, Kinchington PR, Schmid DS, Balloux F, Nichols RA, Breuer J.
    Mol Biol Evol. 2014 Feb;31(2):397-409.

  895. Diarrhoea-related hospitalizations in children before and after implementation of monovalent rotavirus vaccination in Mexico
    Esparza-Aguilar M, Gastanaduy P, Sanchez-Uribe E, Desai R, Parashar UD, Richardson V, Patel M.
    Bull World Health Organ. 2014 ;92(2):117-125.

  896. Cost-effectiveness of a potential group B streptococcal vaccine program for pregnant women in South Africa
    Kim SY, Russell LB, Park J, Verani JR, Madhi SA, Cutland CL, Schrag SJ, Sinha A.
    Vaccine. 2014 Feb 11.

  897. Factors associated with influenza vaccine receipt in community dwelling adults and their children
    Malosh R, Ohmit SE, Petrie JG, Thompson MG, Aiello AE, Monto AS.
    Vaccine. 2014 Feb 12.

  898. Hepatitis A vaccination for post-exposure prophylaxis in persons aged 40 years and older
    Nelson NP, Murphy TV, McMahon BJ.
    Vaccine. 2014 Feb 12.

  899. Microneedle patches: usability and acceptability for self-vaccination against influenza
    Norman JJ, Arya JM, McClain MA, Frew PM, Meltzer MI, Prausnitz MR.
    Vaccine. 2014 Feb 11.

  900. Measles resurgence in southern Africa: challenges to measles elimination
    Shibeshi ME, Masresha BG, Smit SB, Biellik RJ, Nicholson JL, Muitherero C, Shivute N, Walker O, Reggis K, Goodson JL.
    Vaccine. 2014 Feb 12.

  901. Cumulative risk of Guillain-Barre syndrome among vaccinated and unvaccinated populations during the 2009 H1N1 influenza pandemic
    Vellozzi C, Iqbal S, Stewart B, Tokars J, Destefano F.
    Am J Public Health. 2014 Feb 13.

  902. Use of vaccines as probes to define disease burden
    Feikin DR, Scott JA, Gessner BD.
    Lancet. 2014 Feb 14.

  903. Interim estimates of 2013-14 seasonal influenza vaccine effectiveness - United States, February 2014
    Flannery B, Thaker SN, Clippard J, Monto AS, Ohmit SE, Zimmerman RK, Nowalk MP, Gaglani M, Jackson ML, Jackson LA, Belongia EA, McLean HQ, Berman L, Foust A, Sessions W, Spencer S, Fry AM.
    MMWR Morb Mortal Wkly Rep. 2014 Feb 21;63(7):137-42.

  904. A sham case-control study of effectiveness of DTP-Hib-hepatitis B vaccine against rotavirus acute gastroenteritis in Kenya
    Khagayi S, Tate JE, Onkoba R, Parashar U, Odhiambo F, Burton D, Laserson K, Feikin DR.
    BMC Infect Dis. 2014 ;14(1):77.

  905. The potential impact of expanding target age groups for polio immunization campaigns
    Duintjer Tebbens RJ, Kalkowska DA, Wassilak SG, Pallansch MA, Cochi SL, Thompson KM.
    BMC Infect Dis. 2014 ;14:45.

  906. Impact of rotavirus vaccine on childhood diarrheal hospitalization after introduction into the South African public immunization program
    Msimang VM, Page N, Groome MJ, Moyes J, Cortese MM, Seheri M, Kahn K, Chagan M, Madhi SA, Cohen C.
    Pediatr Infect Dis J. 2013 Dec;32(12):1359-64.

  907. Prevention and control of Haemophilus influenzae type b disease: recommendations of the Advisory Committee on Immunization Practices (ACIP)
    Briere EC, Rubin L, Moro PL, Cohn A, Clark T, Messonnier N.
    MMWR Recomm Rep. 2014 Feb 28;63(Rr-01):1-14.

  908. Effectiveness of 2 rotavirus vaccines against rotavirus disease in Taiwanese infants
    Chang WC, Yen C, Wu FT, Huang YC, Lin JS, Huang FC, Yu HT, Chi CL, Lin HY, Tate JE, Parashar UD, Wu HS, Hsiung CA.
    Pediatr Infect Dis J. 2014 Mar;33(3):e81-6.

  909. School-located vaccination of adolescents with insurance billing: cost, reimbursement, and vaccination outcomes
    Daley MF, Kempe A, Pyrzanowski J, Vogt TM, Dickinson LM, Kile D, Fang H, Rinehart DJ, Shlay JC.
    J Adolesc Health. 2014 Mar;54(3):282-8.

  910. Hepatitis B vaccine response among infants born to hepatitis B surface antigen-positive women
    Ko SC, Schillie SF, Walker T, Veselsky SL, Nelson N, Lazaroff J, Crowley S, Dusek C, Loggins K, Onye K, Fenlon N, Murphy TV.
    Vaccine. 2014 Feb 20.

  911. Two-dose varicella vaccination coverage among children aged 7 years - six sentinel sites, United States, 2006-2012
    Lopez AS, Cardemil C, Pabst LJ, Cullen KA, Leung J, Bialek SR.
    MMWR Morb Mortal Wkly Rep. 2014 Feb 28;63(8):174-7.

  912. Toward global prevention of sexually transmitted infections (STIs): The need for STI vaccines
    Gottlieb SL, Low N, Newman LM, Bolan G, Kamb M, Broutet N.
    Vaccine. 2014 Feb 25.

  913. Impact of requiring influenza vaccination for children in licensed child care or preschool programs - Connecticut, 2012-13 influenza season
    Hadler JL, Yousey-Hindes K, Kudish K, Kennedy ED, Sacco V, Cartter ML.
    MMWR Morb Mortal Wkly Rep. 2014 Mar 7;63(9):181-5.

  914. Survey of poliovirus antibodies in Kano, Northern Nigeria
    Iliyasu Z, Nwaze E, Verma H, Mustapha AO, Weldegebriel G, Gasasira A, Wannemuehler KA, Pallansch MA, Gajida AU, Pate M, Sutter RW.
    Vaccine. 2014 Mar 10;32(12):1414-20.

  915. An unusual case of influenza-like illness after yellow fever vaccination
    Lamson DM, Ramani R, Kleabonas M, Metcalfe M, Humphrey C, St George K.
    J Clin Virol. 2014 Feb 4.

  916. Influenza vaccine response in adults exposed to perfluorooctanoate and perfluorooctanesulfonate
    Looker C, Luster MI, Calafat AM, Johnson VJ, Burleson GR, Burleson FG, Fletcher T.
    Toxicol Sci. 2014 Mar;138(1):76-88.

  917. Neisseria meningitidis serogroup W, Burkina Faso, 2012
    Macneil JR, Medah I, Koussoube D, Novak RT, Cohn AC, Diomande FV, Yelbeogo D, Kambou JL, Tarbangdo TF, Ouedraogo-Traore R, Sangare L, Hatcher C, Vuong J, Mayer LW, Djingarey MH, Clark TA, Messonnier NE.
    Emerg Infect Dis. 2014 Mar;20(3).

  918. Maternal influenza vaccine and risks for preterm or small for gestational age birth
    Nordin JD, Kharbanda EO, Vazquez Benitez G, Lipkind H, Vellozzi C, Destefano F.
    J Pediatr. 2014 Feb 26.

  919. Fatal varicella due to the vaccine-strain varicella-zoster virus
    Leung J, Siegel S, Jones JF, Schulte C, Blog D, Scott Schmid D, Bialek SR, Marin M.
    Hum Vaccin Immunother. 2013 Aug 27;10(1).

  920. Effectiveness of hospital-based postpartum procedures on pertussis vaccination among postpartum women
    Yeh S, Mink C, Kim M, Naylor S, Zangwill KM, Allred NJ.
    Am J Obstet Gynecol. 2014 Mar;210(3):237.e1-6.

  921. Surveillance for yellow fever virus in non-human primates in southern Brazil, 2001-2011: a tool for prioritizing human populations for vaccination
    Almeida MA, Cardoso Jda C, Dos Santos E, da Fonseca DF, Cruz LL, Faraco FJ, Bercini MA, Vettorello KC, Porto MA, Mohrdieck R, Ranieri TM, Schermann MT, Sperb AF, Paz FZ, Nunes ZM, Romano AP, Costa ZG, Gomes SL, Flannery B.
    PLoS Negl Trop Dis. 2014 Mar;8(3):e2741.

  922. Changing pertussis epidemiology: everything old is new again
    Clark TA.
    J Infect Dis. 2014 Apr;209(7):978-81.

  923. Prevalence of influenza-like illness and seasonal and pandemic H1N1 influenza vaccination coverage among workers - United States, 2009-10 influenza season
    Luckhaupt SE, Calvert GM, Li J, Sweeney M, Santibanez TA.
    MMWR Morb Mortal Wkly Rep. 2014 Mar 14;63(10):217-21.

  924. Vaccine preventable diseases: time to re-examine global surveillance data?
    Macneil A, Dietz V, Cherian T.
    Vaccine. 2014 Mar 10.

  925. Yellow fever outbreaks in unvaccinated populations, Brazil, 2008-2009
    Romano AP, Costa ZG, Ramos DG, Andrade MA, Jayme Vde S, Almeida MA, Vettorello KC, Mascheretti M, Flannery B.
    PLoS Negl Trop Dis. 2014 Mar;8(3):e2740.

  926. Influence of pre-existing hemagglutination inhibition titers against historical influenza strains on antibody response to inactivated trivalent influenza vaccine in adults 50-80 years of age
    Ross TM, Lin CJ, Nowalk MP, Huang HH, Spencer SM, Shay DK, Sambhara S, Sundaram ME, Friedrich T, Sauereisen S, Bloom CE, Zimmerman RK.
    Hum Vaccin Immunother. 2014 Mar 10;10(5).

  927. Molecular epidemiology of silent introduction and sustained transmission of wild poliovirus type 1, Israel, 2013
    Shulman L, Gavrilin E, Jorba J, Martin J, Burns C, Manor Y, Moran-Gilad J, Sofer D, Hindiyeh M, Gamzu R, Mendelson E, Grotto I.
    Euro Surveill. 2014 ;19(7).

  928. The 2010 outbreak of poliomyelitis in Tajikistan: epidemiology and lessons learnt
    Yakovenko M, Gmyl A, Ivanova O, Eremeeva T, Ivanov A, Prostova M, Baykova O, Isaeva O, Lipskaya G, Shakaryan A, Kew O, Deshpande J, Agol V.
    Euro Surveill. 2014 ;19(7).

  929. Update on vaccine-derived polioviruses - worldwide, July 2012-December 2013
    Diop OM, Burns CC, Wassilak SG, Kew OM.
    MMWR Morb Mortal Wkly Rep. 2014 Mar 21;63(11):242-8.

  930. Evaluation of the antigenic relatedness and cross-protective immunity of the neuraminidase between human influenza A (H1N1) virus and highly pathogenic avian influenza A (H5N1) virus
    Lu X, Liu F, Zeng H, Sheu T, Achenbach JE, Veguilla V, Gubareva LV, Garten R, Smith C, Yang H, Stevens J, Xu X, Katz JM, Tumpey TM.
    Virology. 2014 April;454-455(1):169-175.

  931. 116E rotavirus vaccine development: a successful alliance
    Madhi SA, Parashar UD.
    Lancet. 2014 Mar 11.

  932. Combined use of inactivated and oral poliovirus vaccines in refugee camps and surrounding communities - Kenya, December 2013
    Sheikh MA, Makokha F, Hussein AM, Mohamed G, Mach O, Humayun K, Okiror S, Abrar L, Nasibov O, Burton J, Unshur A, Wannemuehler K, Estivariz CF.
    MMWR Morb Mortal Wkly Rep. 2014 Mar 21;63(11):237-41.

  933. Prediction and characterization of helper T-cell epitopes from pneumococcal surface adhesin A
    Singh R, Gupta P, Sharma PK, Ades EW, Hollingshead SK, Singh S, Lillard JW.
    Immunology. 2014 Apr;141(4):514-530.

  934. Risk of fever after pediatric trivalent inactivated influenza vaccine and 13-valent pneumococcal conjugate vaccine
    Stockwell MS, Broder K, Larussa P, Lewis P, Fernandez N, Sharma D, Barrett A, Sosa J, Vellozzi C.
    JAMA Pediatr. 2014 Mar 1;168(3):211-9.

  935. Effectiveness of influenza vaccine against life-threatening RT-PCR-confirmed influenza illness in US children, 2010-2012
    Ferdinands JM, Olsho LE, Agan AA, Bhat N, Sullivan RM, Hall M, Mourani PM, Thompson M, Randolph AG.
    J Infect Dis. 2014 Mar 26.

  936. Efficiency of points of dispensing for influenza A(H1N1)pdm09 vaccination, Los Angeles County, California, USA, 2009
    Saha S, Dean B, Teutsch S, Borse RH, Meltzer MI, Bagwell D, Plough A, Fielding J.
    Emerg Infect Dis. 2014 Mar;20(3):590-5.

  937. Effectiveness of the monovalent rotavirus vaccine in Colombia: a case-control study
    Cotes-Cantillo K, Paternina-Caicedo A, Coronell-Rodriguez W, Alvis-Guzman N, Parashar UD, Patel M, De la Hoz-Restrepo F.
    Vaccine. 2014 Mar 31.

  938. Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP-IPV) vaccine
    Daley MF, Yih WK, Glanz JM, Hambidge SJ, Narwaney KJ, Yin R, Li L, Nelson JC, Nordin JD, Klein NP, Jacobsen SJ, Weintraub E.
    Vaccine. 2014 Mar 31.

  939. Effect of breastfeeding on immunogenicity of oral live-attenuated human rotavirus vaccine: a randomized trial in HIV-uninfected infants in Soweto, South Africa
    Groome MJ, Moon SS, Velasquez D, Jones S, Koen A, van Niekerk N, Jiang B, Parashar UD, Madhi SA.
    Bull World Health Organ. 2014 Apr 1;92(4):238-45.

  940. Distribution of pandemic influenza vaccine and reporting of doses administered, New York, New York, USA
    Marcello RK, Papadouka V, Misener M, Wake E, Mandell R, Zucker JR.
    Emerg Infect Dis. 2014 Apr;20(4):525-31.

  941. Progress toward measles preelimination - African Region, 2011-2012
    Masresha BG, Kaiser R, Eshetu M, Katsande R, Luce R, Fall A, Dosseh AR, Naouri B, Byabamazima CR, Perry R, Dabbagh AJ, Strebel P, Kretsinger K, Goodson JL, Nshimirimana D.
    MMWR Morb Mortal Wkly Rep. 2014 Apr 4;63(13):285-91.

  942. Barriers and facilitators to influenza vaccination and vaccine coverage in a cohort of health care personnel
    Naleway AL, Henkle EM, Ball S, Bozeman S, Gaglani MJ, Kennedy ED, Thompson MG.
    Am J Infect Control. 2014 Apr;42(4):371-5.

  943. Safety and immunogenicity of a plant-produced recombinant monomer hemagglutinin-based influenza vaccine derived from influenza A (H1N1)pdm09 virus: a Phase 1 dose-escalation study in healthy adults
    Cummings JF, Guerrero ML, Moon JE, Waterman P, Nielsen RK, Jefferson S, Gross FL, Hancock K, Katz JM, Yusibov V.
    Vaccine. 2014 Apr 17;32(19):2251-9.

  944. Military healthcare providers reporting of adverse events following immunizations to the vaccine adverse event reporting system
    Li R, McNeil MM, Pickering S, Pemberton MR, Duran LL, Collins LC, Nelson MR, Engler RJ.
    Mil Med. 2014 Apr;179(4):435-41.

  945. Impact of a targeted typhoid vaccination campaign following Cyclone Tomas, Republic of Fiji, 2010
    Scobie HM, Nilles E, Kama M, Kool JL, Mintz E, Wannemuehler KA, Hyde TB, Dawainavesi A, Singh S, Korovou S, Jenkins K, Date K.
    Am J Trop Med Hyg. 2014 Apr 7.

  946. Economic evaluation of the routine childhood immunization program in the United States, 2009
    Zhou F, Shefer A, Wenger J, Messonnier M, Wang LY, Lopez A, Moore M, Murphy TV, Cortese M, Rodewald L.
    Pediatrics. 2014 Apr;133(4):577-85.

  947. Pertussis resurgence: perspectives from the Working Group Meeting on Pertussis on the causes, possible paths forward, and gaps in our knowledge
    Burns DL, Meade BD, Messionnier NE.
    J Infect Dis. 2014 Apr;209 Suppl 1:S32-5.

  948. Effectiveness of ten-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in Brazil: a matched case-control study
    Domingues CM, Verani JR, Montenegro Renoiner EI, de Cunto Brandileone MC, Flannery B, de Oliveira LH, Santos JB, de Moraes JC.
    Lancet Respir Med. 2014 Apr 10.

  949. Impact of rotavirus vaccination on diarrhea-related hospitalizations in Sao Paulo State, Brazil
    Fernandes EG, Sato HK, Leshem E, Flannery B, Konstantyner TC, Veras MA, Patel MM.
    Vaccine. 2014 Apr 12.

  950. Vaccine preventable disease incidence as a complement to vaccine efficacy for setting vaccine policy
    Gessner BD, Feikin DR.
    Vaccine. 2014 Apr 11.

  951. National and state-specific estimates of place of influenza vaccination among adult populations - United States, 2011-12 influenza season
    Lu PJ, O'Halloran A, Ding H, Williams WW, Bridges CB, Kennedy ED.
    Vaccine. 2014 Apr 11.

  952. Safety of influenza vaccination during pregnancy: a review of subsequent maternal obstetric events and findings from two recent cohort studies
    Naleway AL, Irving SA, Henninger ML, Li DK, Shifflett P, Ball S, Williams JL, Cragan J, Gee J, Thompson MG.
    Vaccine. 2014 Apr 14.

  953. Influenza epidemiology and vaccine effectiveness among patients with influenza-like illness, viral watch sentinel sites, South Africa, 2005-2009
    Ntshoe GM, McAnerney JM, Tempia S, Blumberg L, Moyes J, Buys A, Naidoo D, Venter M, Besselaar T, Schoub BD, Harris BN, Cohen C.
    PLoS One. 2014 ;9(4):e94681.

  954. Herpes zoster caused by vaccine-strain varicella zoster virus in an immunocompetent recipient of zoster vaccine
    Tseng HF, Schmid DS, Harpaz R, Larussa P, Jensen NJ, Rivailler P, Radford K, Folster J, Jacobsen SJ.
    Clin Infect Dis. 2014 Apr;58(8):1125-8.

  955. Age-specific strategies for immunization reminders and recalls: a registry-based randomized trial
    Dombkowski KJ, Costello LE, Harrington LB, Dong S, Kolasa M, Clark SJ.
    Am J Prev Med. 2014 Apr 18.

  956. Effect of the 13-valent pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae - Alaska, 2008-2012
    Gounder PP, Bruce MG, Bruden DJ, Singleton RJ, Rudolph K, Hurlburt DA, Hennessy TW, Wenger J.
    J Infect Dis. 2014 Apr;209(8):1251-8.

  957. Prevaccine era human papillomavirus types 6, 11, 16 and 18 seropositivity in the USA, National Health and Nutrition Examination Surveys, 2003-2006
    Introcaso CE, Dunne EF, Hariri S, Panicker G, Unger ER, Markowitz LE.
    Sex Transm Infect. 2014 Apr 19.

  958. Reduction of racial/ethnic disparities in vaccination coverage, 1995-2011
    Walker AT, Smith PJ, Kolasa M.
    MMWR Surveill Summ. 2014 Apr 18;63:7-12.

  959. Benefits from immunization during the Vaccines for Children program era - United States, 1994-2013
    Whitney CG, Zhou F, Singleton J, Schuchat A.
    MMWR Morb Mortal Wkly Rep. 2014 Apr 25;63(16):352-5.

  960. Rotavirus vaccines: current status and future considerations
    Yen C, Tate JE, Hyde TB, Cortese MM, Lopman BA, Jiang B, Glass RI, Parashar UD.
    Hum Vaccin Immunother. 2014 Apr 22;10(6).

  961. School-located influenza vaccination with third-party billing: what do parents think?
    Kempe A, Daley MF, Pyrzanowski J, Vogt TM, Campagna EJ, Dickinson LM, Hambidge SJ, Shlay JC.
    Acad Pediatr. 2014 May-Jun;14(3):241-8.

  962. Absence of associations between influenza vaccines and increased risks of seizures, Guillain-Barre syndrome, encephalitis, or anaphylaxis in the 2012-2013 season
    Kawai AT, Li L, Kulldorff M, Vellozzi C, Weintraub E, Baxter R, Belongia EA, Daley MF, Jacobsen SJ, Naleway A, Nordin JD, Lee GM.
    Pharmacoepidemiol Drug Saf. 2014 May;23(5):548-53.

  963. School-located influenza vaccination with third-party billing: outcomes, cost, and reimbursement
    Kempe A, Daley MF, Pyrzanowski J, Vogt T, Fang H, Rinehart DJ, Morgan N, Riis M, Rodgers S, McCormick E, Hammer A, Campagna EJ, Kile D, Dickinson M, Hambidge SJ, Shlay JC.
    Acad Pediatr. 2014 May-Jun;14(3):234-40.

  964. Evaluation of sex, race, body mass index and pre-vaccination serum progesterone levels and post-vaccination serum anti-anthrax protective immunoglobulin G on injection site adverse events following anthrax vaccine adsorbed (AVA) in the CDC AVA human clinical trial
    Pondo T, Rose CE, Martin SW, Keitel WA, Keyserling HL, Babcock J, Parker S, Jacobson RM, Poland GA, McNeil MM.
    Vaccine. 2014 Apr 23.

  965. The effectiveness of seasonal trivalent inactivated influenza vaccine in preventing laboratory confirmed influenza hospitalisations in Auckland, New Zealand in 2012
    Turner N, Pierse N, Bissielo A, Huang QS, Baker MG, Widdowson MA, Kelly H.
    Vaccine. 2014 Apr 22.

  966. Influenza seasonality: timing and formulation of vaccines
    Cox N.
    Bull World Health Organ. 2014 May;92(5):311-311.

  967. Modeling the effect of different vaccine effectiveness estimates on the number of vaccine prevented influenza associated hospitalizations in older adults
    Fry AM, Kim IK, Reed C, Thompson M, Chaves SS, Finelli L, Bresee J.
    Clin Infect Dis. 2014 May 6.

  968. Yellow fever in Africa: estimating the burden of disease and impact of mass vaccination from outbreak and serological data
    Garske T, Van Kerkhove MD, Yactayo S, Ronveaux O, Lewis RF, Staples JE, Perea W, Ferguson NM.
    PLoS Med. 2014 May;11(5):e1001638.

  969. Non dermatomal rash and pancytopenia in a 5 year old child
    Khandelwal P, Marsh R, Schmid DS, Folster J, Radford KW, Davies SM, Filipovich A.
    J Clin Virol. 2014 Apr 13.

  970. Trends in racial/ethnic disparities in influenza vaccination coverage among adults during the 2007-08 through 2011-12 seasons
    Lu PJ, O'Halloran A, Bryan L, Kennedy ED, Ding H, Graitcer SB, Santibanez TA, Meghani A, Singleton JA.
    Am J Infect Control. 2014 May 2.

  971. Cluster randomized trial of a toolkit and early vaccine delivery to improve childhood influenza vaccination rates in primary care
    Zimmerman RK, Nowalk MP, Lin CJ, Hannibal K, Moehling KK, Huang HH, Matambanadzo A, Troy J, Allred NJ, Gallik G, Reis EC.
    Vaccine. 2014 Apr 29.

  972. Effectiveness and impact of rotavirus vaccines in the United States - 2006-2012
    Rha B, Tate JE, Payne DC, Cortese MM, Lopman BA, Curns AT, Parashar UD.
    Expert Rev Vaccines. 2014 ;13(3):365-376.

  973. Seasonal influenza immunisation in Europe. Overview of recommendations and vaccination coverage for three seasons: pre-pandemic (2008/09), pandemic (2009/10) and post-pandemic (2010/11)
    Mereckiene J, Cotter S, Nicoll A, Lopalco P, Noori T, Weber J, D'Ancona F, Levy-Bruhl D, Dematte L, Giambi C, Valentiner-Branth P, Stankiewicz I, Appelgren E, O. Flanagan D.
    Euro Surveill. 2014 ;19(16).

  974. Influenza seasonality and vaccination timing in tropical and subtropical areas of southern and south-eastern Asia
    Saha S, Chadha M, Al Mamun A, Rahman M, Sturm-Ramirez K, Chittaganpitch M, Pattamadilok S, Olsen SJ, Dwi Sampurno O, Setiawaty V, Nur Andriana Pangesti K, Samaan G, Archkhawongs S, Vongphrachanh P, Phonekeo D, Corwin A, Sok T, Buchy P, Chea N, Kitsutani P, Le Quynh M, Vu Dinh T, Lin R, Low C, Chong Chee K, Ismail N, Apandi Yusof M, Tandoc Iii A, Roque Jr V, Mishra A, Moen AC, Widdowson M, Partridge J, Lal RB.
    Bull World Health Organ. 2014 ;92(5):318-330.

  975. System factors to explain H1N1 state vaccination rates for adults in US emergency response to pandemic
    Davila-Payan C, Swann J, Wortley PM.
    Vaccine. 2014 May 23;32(25):3088-93.

  976. Booster immune response in children 6-7 years of age, randomly assigned to four groups with two MMR vaccines applied by aerosol or by injection
    Diaz-Ortega JL, Bennett JV, Castaneda-Desales D, Quintanilla DM, Martinez D, Castro JF.
    Vaccine. 2014 May 14.

  977. Timely versus delayed early childhood vaccination and seizures
    Hambidge SJ, Newcomer SR, Narwaney KJ, Glanz JM, Daley MF, Xu S, Shoup JA, Rowhani-Rahbar A, Klein NP, Lee GM, Nelson JC, Lugg M, Naleway AL, Nordin JD, Weintraub E, DeStefano F.
    Pediatrics. 2014 May 19.

  978. A qualitative analysis of the impact of healthcare personnel influenza vaccination requirements in California
    Khodyakov D, Uscher-Pines L, Lorick SA, Lindley MC, Shier V, Harris K.
    Vaccine. 2014 May 23;32(25):3082-7.

  979. Modeling the potential impact of vaccination on the epidemiology of congenital cytomegalovirus infection
    Lanzieri TM, Bialek SR, Ortega-Sanchez IR, Gambhir M.
    Vaccine. 2014 May 13.

  980. Effectiveness of typhoid vaccination in US travelers
    Mahon BE, Newton AE, Mintz ED.
    Vaccine. 2014 May 14.

  981. Duration of protection after infant hepatitis B vaccination series
    Middleman AB, Baker CJ, Kozinetz CA, Kamili S, Nguyen C, Hu DJ, Spradling PR.
    Pediatrics. 2014 May 19.

  982. Persistence of serogroup C antibody responses following quadrivalent meningococcal conjugate vaccination in United States military personnel
    Patel M, Romero-Steiner S, Broderick MP, Thomas CG, Plikaytis BD, Schmidt DS, Johnson SE, Milton AS, Carlone GM, Clark TA, Messonnier NE, Cohn AC, Faix DJ.
    Vaccine. 2014 May 13.

  983. Etiology of childhood diarrhea following rotavirus vaccine introduction: a prospective, population-based study in Nicaragua
    Becker-Dreps S, Bucardo F, Vilchez S, Zambrana LE, Liu L, Weber DJ, Pena R, Barclay L, Vinje J, Hudgens MG, Nordgren J, Svensson L, Morgan DR, Espinoza F, Paniagua M.
    Pediatr Infect Dis J. 2014 May 29.

  984. The impact of pre-existing antibody on subsequent immune responses to meningococcal A-containing vaccines
    Idoko OT, Okolo SN, Plikaytis B, Akinsola A, Viviani S, Borrow R, Carlone G, Findlow H, Elie C, Kulkarni PS, Preziosi MP, Ota M, Kampmann B.
    Vaccine. 2014 May 23.

  985. Progress toward polio eradication - worldwide, 2013-2014
    Moturi EK, Porter KA, Wassilak SG, Tangermann RH, Diop OM, Burns CC, Jafari H.
    MMWR Morb Mortal Wkly Rep. 2014 May 30;63(21):468-72.

  986. Direct effect of 10-valent conjugate pneumococcal vaccination on pneumococcal carriage in children Brazil
    Andrade AL, Ternes YM, Vieira MA, Moreira WG, Lamaro-Cardoso J, Kipnis A, Cardoso MR, Brandileone MC, Moura I, Pimenta FC, da Gloria Carvalho M, Saraiva FO, Toscano CM, Minamisava R.
    PLoS One. 2014 Jun 3;9(6):e98128.

  987. Influenza activity - United States, 2013-14 season and composition of the 2014-15 influenza vaccines
    Epperson S, Blanton L, Kniss K, Mustaquim D, Steffens C, Wallis T, Dhara R, Leon M, Perez A, Chaves SS, Elal AA, Gubareva L, Xu X, Villanueva J, Bresee J, Cox N, Finelli L, Brammer L.
    MMWR Morb Mortal Wkly Rep. 2014 Jun 6;63(22):483-90.

  988. Quantification of viral proteins of the avian H7 subtype of influenza virus: an isotope dilution mass spectrometry method applicable for producing more rapid vaccines in the case of an influenza pandemic
    Santana WI, Williams TL, Winne EK, Pirkle JL, Barr JR.
    Anal Chem. 2014 May 6;86(9):4088-95.

  989. A rapid immunization strategy with a live-attenuated tetravalent dengue vaccine elicits protective neutralizing antibody responses in non-human primates
    Ambuel Y, Young G, Brewoo JN, Paykel J, Weisgrau KL, Rakasz EG, Haller AA, Royals M, Huang CY, Capuano S, Stinchcomb DT, Partidos CD, Osorio JE.
    Front Immunol. 2014 Jun 5;5:263.

  990. Neurovirulence and immunogenicity of attenuated recombinant vesicular stomatitis viruses in nonhuman primates
    Clarke DK, Nasar F, Chong S, Johnson JE, Coleman JW, Lee M, Witko SE, Kotash CS, Abdullah R, Megati S, Luckay A, Nowak B, Lackner A, Price RE, Little P, Kalyan N, Randolf V, Javadian A, Zamb TJ, Parks CL, Egan MA, Eldridge J, Hendry M, Udem SA.
    J Virol. 2014 Jun 15;88(12):6690-6701.

  991. An outbreak of measles in an undervaccinated community
    Gahr P, DeVries AS, Wallace G, Miller C, Kenyon C, Sweet K, Martin K, White K, Bagstad E, Hooker C, Krawczynski G, Boxrud D, Liu G, Stinchfield P, LeBlanc J, Hickman C, Bahta L, Barskey A, Lynfield R.
    Pediatrics. 2014 Jun 9.

  992. Immunization information systems to increase vaccination rates: a Community Guide systematic review
    Groom H, Hopkins DP, Pabst LJ, Morgan JM, Patel M, Calonge N, Coyle R, Dombkowski K, Groom AV, Kurilo MB, Rasulnia B, Shefer A, Town C, Wortley PM, Zucker J.
    J Public Health Manag Pract. 2014 Jun 6.

  993. Control of Japanese encephalitis in Asia: the time is now
    Hills S, Martin R, Marfin A, Fischer M.
    Expert Rev Anti Infect Ther. 2014 Jun 13:1-4.

  994. Rotavirus vaccines and health care utilization for diarrhea in the United States (2007-2011)
    Leshem E, Moritz RE, Curns AT, Zhou F, Tate JE, Lopman BA, Parashar UD.
    Pediatrics. 2014 Jun 9.

  995. Progress toward measles elimination - Eastern Mediterranean Region, 2008-2012
    Teleb N, Lebo E, Ahmed H, Hossam AR, El Sayed el T, Dabbagh A, Strebel P, Rota P, Alexander J.
    MMWR Morb Mortal Wkly Rep. 2014 Jun 13;63(23):511-5.

  996. Impact of different dosing schedules on the immunogenicity of the human rotavirus vaccine in infants in Pakistan - a randomized trial
    Ali SA, Kazi AM, Cortese MM, Fleming JA, Parashar UD, Jiang B, McNeal MM, Steele D, Bhutta Z, Zaidi A.
    J Infect Dis. 2014 Jun 16.

  997. Effectiveness of seven-valent pneumococcal conjugate vaccine (PCV-7) against invasive pneumococcal disease in HIV-infected and -uninfected children in South Africa: a matched case-control study
    Cohen C, von Mollendorf C, de Gouveia L, Naidoo N, Meiring S, Quan V, Nokeri V, Smidt MF, Malope-Kgokong B, Moore D, Reubenson G, Moshe M, Madhi SA, Eley B, Hallbauer U, Kularatne R, Conklin L, O'Brien KL, Zell ER, Klugman K, Whitney CG, von Gottberg A.
    Clin Infect Dis. 2014 Jun 9.

  998. Influenza vaccination among persons with work-related asthma
    Mazurek JM, White GE, Moorman JE, Storey E.
    Am J Prev Med. 2014 Jun 17.

  999. Coxsackievirus B1 reveals strain specific differences in plasmacytoid dendritic cell mediated immunogenicity
    Hamalainen S, Nurminen N, Ahlfors H, Oikarinen S, Sioofy-Khojine AB, Frisk G, Oberste MS, Lahesmaa R, Pesu M, Hyoty H.
    J Med Virol. 2014 Aug;86(8):1412-20.

  1000. Receipt of pertussis vaccine during pregnancy across 7 Vaccine Safety Datalink Sites
    Kharbanda EO, Vazquez-Benitez G, Lipkind H, Naleway AL, Klein NP, Craig Cheetham T, Hambidge SJ, Vellozzi C, Nordin JD.
    Prev Med. 2014 Jun 18.

  1001. Use of MenACWY-CRM vaccine in children aged 2 through 23 months at increased risk for meningococcal disease: recommendations of the Advisory Committee on Immunization Practices, 2013
    MacNeil JR, Rubin L, McNamara L, Briere EC, Clark TA, Cohn AC.
    MMWR Morb Mortal Wkly Rep. 2014 Jun 20;63(24):527-30.

  1002. Ischemic cardiac events and other adverse events following ACAM2000 smallpox vaccine in the Vaccine Adverse Event Reporting System
    McNeil MM, Cano M, Miller E, Petersen BW, Engler RJ, Bryant-Genevier MG.
    Vaccine. 2014 Jun 18.

  1003. Characterization of rotavirus genotypes before and after the introduction of a monovalent rotavirus vaccine in Colombia
    Pelaez-Carvajal D, Cotes-Cantillo K, Paternina-Caicedo A, Gentsch J, de la Hoz-Restrepo F, Patel M.
    J Med Virol. 2014 Jun;86(6):1083-6.

  1004. Waning vaccine protection against influenza A (H3N2) illness in children and older adults during a single season
    Belongia EA, Sundaram ME, McClure DL, Meece JK, Ferdinands J, VanWormer JJ.
    Vaccine. 2014 Jun 21.

  1005. Uptake of human papillomavirus vaccine among adolescent males and females: Immunization Information System sentinel sites, 2009-2012
    Cullen KA, Stokley S, Markowitz LE.
    Acad Pediatr. 2014 Jun 19.

  1006. Antibody response to influenza A(H1N1)pdm09 among healthcare personnel receiving trivalent inactivated vaccine: effect of prior monovalent inactivated vaccine
    Gaglani M, Spencer S, Ball S, Song J, Naleway A, Henkle E, Bozeman S, Reynolds S, Sessions W, Hancock K, Thompson M.
    J Infect Dis. 2014 Jun 1;209(11):1705-14.

  1007. Shigella isolates from the Global Enteric Multicenter Study (GEMS) inform vaccine development
    Livio S, Strockbine N, Panchalingam S, Tennant SM, Barry EM, Marohn ME, Antonio M, Hossain A, Mandomando I, Ochieng JB, Oundo JO, Qureshi S, Ramamurthy T, Tamboura B, Adegbola RA, Hossain MJ, Saha D, Sen S, Faruque AS, Alonso PL, Breiman RF, Zaidi AK, Sur D, Sow SO, Berkeley LY, O'Reilly C, Mintz ED, Biswas K, Cohen D, Farag TH, Nasrin D, Wu Y, Blackwelder WC, Kotloff KL, Nataro JP, Levine MM.
    Clin Infect Dis. 2014 Jun 23.

  1008. Influenza vaccination and treatment in children with neurologic disorders
    Havers F, Fry A, Peacock G, Finelli L.
    Ther Adv Vaccines. 2014 Jul;2(4):95-105.

  1009. Influenza vaccination and treatment in children with neurologic disorders
    Havers F, Fry A, Peacock G, Finelli L.
    Ther Adv Vaccines. 2014 Jul;2(4):95-105.

 

To subscribe to CDC Science Clips email updates, enter your email address:

Contact Us:
  • Centers for Disease Control and Prevention
    1600 Clifton Rd
    Atlanta, GA 30333
  • 800-CDC-INFO
    (800-232-4636)
    TTY: (888) 232-6348
    24 Hours/Every Day
  • cdcinfo@cdc.gov
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #